Patent Grant
12144964
This disclosure is directed to portable infusion devices, systems, and methods of using the same for dispensing materials. In some cases, the devices, systems and methods may be used for infusing a material such as medicament, e.g., insulin, into a body in need thereof.
There are many applications in academic, industrial, and medical fields, as well as others, that may benefit from devices and methods that are capable of accurately and controllably delivering fluids, including liquids and gases that have a beneficial effect when administered in known and controlled quantities. This may be particularly true in the medical field where much of the treatment for a large percentage of patients includes the administration of a known amount of a substance at predetermined intervals. The treatment of diabetes often involves just such a regimented dosage of materials, in particular, the administration of insulin. In addition, the administration of insulin for a diabetic patient is one of a few medical indications wherein the patient routinely administers the medicament to themselves by a subcutaneous modality, such as a hypodermic syringe injection. As such, providing a patient with the means to safely, reliably and comfortably administer required doses of medication may be particularly important in order to facilitate patient compliance and accurate treatment of the condition.
Blood glucose is an important factor for metabolism and the provision of energy and proper organ functioning in mammals. The accurate regulation of blood glucose is, therefore, an essential task necessary for the well being of the mammal. For instance, the neurons of the brain of an organism depend on glucose for fueling their functioning. Hence, blood glucose levels are typically regulated by feedback loops between the brain and the pancreas. The pancreas functions in response to various hormones released by the brain by itself releasing hormones that regulate the uptake, e.g., storage, of blood sugar, or the release of stored blood sugar. For instance, two essential hormones in the regulation of blood sugar levels are insulin and glucagon, both of which are synthesized by specialized cells in the pancreas. Specifically, the β cells of the islets of Langerhans function to synthesize insulin, while the α cells of the islets of Langerhans function to synthesize glucagon.
Maintaining appropriate blood glucose homeostasis is an important factor for promoting the length and quality of life. However, there are many factors that affect the body's ability to maintain such homeostasis. For instance, factors such as the body's ability to produce or respond to insulin, one's physiological condition and/or health, the quantity and type of food one eats, one's metabolic rate, activity level, the types of activities and the exertion level in which one engages, as well as other such factors that make up a person's daily life and/or routine, all play important roles in effecting the body's ability to maintain homeostasis.
Continuous subcutaneous insulin injection and/or infusion therapy is initiated for the replacement of insulin and thereby the treatment of diabetes. Such therapy may include the regular and/or continuous injection or infusion of insulin into the skin of a person suffering from diabetes. Injection is the traditional and most common method for administering insulin. Typically the diabetic will measure his or her blood glucose level, and depending on the level thereof may prepare a syringe or injection pen with insulin to be injected transdermally into the body. However, recently, insulin injecting pumps have been developed for the administration of insulin for those suffering from both type I and II diabetes. Insulin pumps are medical devices used for the administration of insulin in the treatment of diabetes and offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen. They also allow for continuous insulin therapy.
There are, however, several drawbacks associated with the use of subcutaneous injection syringes and/or some currently available infusion pumps for the delivery of insulin. Patient compliance, for instance, is a major problem with respect to the use of insulin syringes. A high percent of subjects suffering from diabetes experience dread when it comes to insulin injections due to the anxiety and discomfort associated with regular use of a the needle therefore. Further complications involve the cost of the syringes, which cost may lead to the spread of infections and diseases, such as human immunodeficiency virus (HIV) and hepatitis, through the sharing and/or reusing of needles. In addition, diabetes patients who choose to use commercially available pumps to avoid the disadvantages of syringe delivery often find that wearing them together with their required infusion set tubing is uncomfortable or unwieldy, particularly while participating in sporting activities or while sleeping.
Some commercially available pumps are designed to be smaller than others, but typically include a patch type element that may be adhered directly to the skin. Such a pump may contain the insulin reservoir, pumping mechanism, power supply as well as an infusion set and automated insert. The patch may be quite a bit heavier than typical infusion set patches. This may pose the problem of the infusion set slowly being pulled out of the patient due to the weight of the patch itself resulting in waste and inaccuracies in treatment. Once the patch is inadvertently knocked off the skin or loosened there may be no means to reinsert the infusion set also resulting in waste and added expense.
Furthermore, the smaller the size of an infusion pump, the more difficult it is for a patient to interface with the device. Commercially available pumps typically have a single screen and one or more hard buttons for enabling a user to navigate through multiple menus and screens. A drawback of requiring a user to navigate through multiple menus and pages to set up a delivery of insulin may be that the user finds the process too complex and time consuming to properly use the infusion device to its fullest potential. As a result, some users tend to “set-it and forget-it”.
Generally a patient's insulin requirements vary greatly, as mentioned above, and may be influenced by a variety of factors (e.g., caloric intake, physiological conditions). Therefore, there is a need for a user friendly portable infusion device that has the ability to tailor appropriate insulin delivery profiles to a user. There is also a need for an infusion device providing an interface that facilitates its use.
Some embodiments are directed to an infusion pump kit configured for delivering a therapeutic fluid to a patient. The device may include a first pump device including a first housing and a first drive mechanism, a second pump device comprising a second housing and a second drive mechanism, and an infusion cartridge. The infusion cartridge may further include a fluid reservoir configured to be filled with a volume of the therapeutic fluid sufficient for a prolonged single infusion protocol. The infusion cartridge may additionally include a delivery mechanism having a distal end in fluid communication with an interior volume of the fluid reservoir and a proximal end configured to couple to either the first drive mechanism or the second drive mechanism and be translated between a plurality of linear positions to deliver the therapeutic fluid to the patient. In addition, the infusion cartridge may be configured to be interchangeably coupled to, and alternated between, the first pump device and the second pump device during the single infusion protocol of the therapeutic fluid to the patient.
Some embodiments are directed to a method of delivering a therapeutic fluid to a patient. The method may include providing a first pump device having a full featured user interface, installing a disposable infusion cartridge on the first pump device, and removing the disposable infusion cartridge from the first pump device. In addition, the method may include installing the disposable infusion cartridge onto a second pump device while maintaining the sterility of the fluid disposed within a reservoir of the disposable infusion cartridge.
Some embodiments of the device may additionally include a fluid delivery system for delivering a therapeutic fluid to a patient. The system may include a pump housing comprising a drive mechanism translatable between a plurality of linear positions to deliver the therapeutic fluid to the patient and an infusion cartridge removably coupled to the pump housing. The infusion cartridge may include a fillable fluid reservoir and a delivery mechanism comprising a distal end in fluid communication with an interior volume of the fluid reservoir and a drive coupling disposed at a proximal end. The drive coupling may be further configured to receive and couple to a drive portion of the drive mechanism independent of the linear position of the drive mechanism.
Some embodiments of the device are directed at a method of coupling a disposable fluid reservoir cartridge to an infusion pump device. The method may include providing an infusion pump device including a drive portion of a drive mechanism that includes a ball or capturable feature at an end of a drive shaft. The method may further include providing a disposable fluid reservoir cartridge including a drive coupling of a delivery mechanism that comprises a flexible female receptacle configured to snap fit over the ball of the drive shaft with the ball introduce from either a lateral direction or axial direction. The method may additionally include returning the ball of the drive mechanism to a home position at a proximal position of a drive stroke, inserting the disposable fluid reservoir cartridge onto the infusion pump device, and advancing the ball of the drive shaft of the drive mechanism from the proximal position to engage and snap fit with the flexible female receptacle of the delivery mechanism of the cartridge.
Some embodiments are directed to a method of switching a fluid reservoir cartridge from a first pump device to a second pump device. The method may include providing a first infusion pump device including a drive portion of a drive mechanism that includes a ball or capturable feature at an end of a drive shaft. The method may further include providing a disposable fluid reservoir cartridge including a drive coupling of a delivery mechanism that comprises a flexible female receptacle which is snap fit over the ball of the drive shaft and which is configured to release the ball from either a lateral direction or axial direction. The method may additionally include returning the ball of the drive mechanism to a home position at a proximal position of a drive stroke, inserting the disposable fluid reservoir cartridge onto the infusion pump device, and advancing the drive shaft of the drive mechanism from the proximal position to engage and snap fit with the flexible female receptacle of the delivery mechanism of the cartridge.
Some embodiments of the infusion pump system may include a housing and a disposable cartridge. The disposable cartridge may further include a collapsible reservoir surrounded by a flexible material and a substantially rigid container sealed around the flexible material of the collapsible reservoir. Furthermore, the cartridge may be releasably secured to the housing. The infusion pump may further include a disposable delivery mechanism disposed within the disposable cartridge and having a reservoir inlet port in fluid communication with an interior volume of the reservoir. The infusion pump may additionally include a drive mechanism including a motor disposed in the housing and detachably coupled to a spool member of the delivery mechanism with the drive mechanism being operatively coupled to the spool member. The infusion pump may further include at least one pressure sensor disposed in a volume disposed between the outside surface of the flexible material of the reservoir and an inside surface of the substantially rigid container/case, a graphic user interface operatively coupled to a controller, and a power storage cell. Additionally, the infusion pump may include a vent inlet port disposed on the delivery mechanism in fluid communication with the volume disposed between the outside surface of the flexible material of the reservoir and an inside surface of the substantially rigid container/case and a controller including at least one processor and a memory device. The controller may be operatively coupled to the drive mechanism, GUI, and at least one pressure sensor and configured to generate a signal to the drive mechanism to displace the spool of the delivery mechanism.
Some embodiments of the infusion pump system may include a pump device including a housing, a drive mechanism with a motor, a controller operatively coupled to the drive mechanism and a slot configured to accept a disposable fluid cartridge. The infusion pump system may further include a disposable fluid cartridge which may be operatively coupled to the housing. The disposable fluid cartridge may further include a delivery mechanism, a collapsible reservoir having an interior volume surrounded by a flexible fluid tight membrane, and the interior volume being in fluid communication with a reservoir inlet port. The cartridge may also include a substantially rigid shell disposed over the reservoir and forming a second interior volume between an outside surface of the reservoir and an inside surface of the rigid shell with a vent inlet port in communication with the second interior volume. Additionally, the infusion pump system may include a pressure sensor disposed between an interior surface of the rigid case and an exterior surface of the collapsible reservoir shell, a bore within a pump body of the delivery mechanism, and a spool. In addition, the spool may be slidingly disposed in the bore having a collapsible first volume which is configured to communicate with the reservoir inlet port and outlet/dispense port of the bore independently of each other, and a second volume isolated from the first collapsible volume, the second volume configured to be moveable between a position that allows a vent inlet port to communicate with a vent outlet port and a position where the vent inlet and outlet ports are isolated from each other.
Some embodiments are directed to an infusion pump for dispensing fluid to a patient. The device may include a disposable fluid cartridge. The cartridge may include a delivery mechanism, which may include a delivery mechanism body. Additionally, a bore may be disposed in the delivery mechanism body, which may further include a distal end, a proximal end disposed towards a drive mechanism of the infusion pump, an interior volume, a reservoir inlet port, a fluid dispense port, a vent inlet port, and a vent outlet port. The infusion pump may further include a spool slidingly disposed within the bore. The spool may further include a collapsible first volume which is positionable to overlap the reservoir inlet port independent of an overlap of the fluid dispense port and which is formed between a first seal around the spool, a second seal around the spool, an outer surface of the spool body between the first and second seal and an interior surface of the bore between the first and second seal. Furthermore, the first and second seals may be axially moveable relative to each other. The spool may additionally include a vent second volume, which is positionable to overlap the vent inlet port and vent outlet port simultaneously and which is formed by a third seal around the spool, a fourth seal around the spool, an outside surface of the spool between the third and fourth seal, and an inside surface of the bore between the third and fourth seal. The infusion pump may further include a collapsible fluid reservoir bounded by a flexible membrane and including an interior volume in fluid communication with the reservoir inlet port. The infusion pump may further include a substantially rigid shell disposed about the collapsible fluid reservoir with an interior volume that contains the collapsible fluid reservoir and a vented volume disposed between an outer surface of the flexible membrane and an interior surface of the rigid shell, the vent inlet port being in fluid communication with the vented volume. Additionally, the infusion pump may include a drive mechanism operatively coupled to the spool of the delivery mechanism, a user interface configured to accommodate user data input regarding fluid delivery, a controller having a processor and memory device operatively coupled to the drive mechanism, and a power cell. The power cell may further be operatively coupled to the controller, the GUI, and the drive mechanism.
Some embodiments of the device are directed at a method of venting a cartridge of an infusion pump system. The method may include providing an infusion pump system, which may further include a disposable fluid reservoir cartridge. The cartridge may include a delivery mechanism, which may further include a delivery mechanism body. The device may further include a bore disposed in the delivery mechanism body including a distal end, a proximal end disposed towards a drive mechanism of the infusion pump, an interior volume, a reservoir inlet port, a fluid dispense port, a vent inlet port and a vent outlet port. The device may further include a spool slidingly disposed within the bore, which may further include a collapsible first volume. The collapsible first volume may be positionable to overlap the reservoir inlet port independent of an overlap of the fluid dispense port and which is formed between a first seal around the spool, a second seal around the spool, an outer surface of the spool body between the first and second seal and an interior surface of the bore between the first and second seal, the first and second seals being axially moveable relative to each other. The spool may also include a vent second volume which is positionable to overlap the vent inlet port and vent outlet port simultaneously and which is formed by a third seal around the spool, a fourth seal around the spool, an outside surface of the spool between the third and fourth seal and an inside surface of the bore between the third and fourth seal. The device may further include a collapsible fluid reservoir bounded by a flexible membrane and including an interior volume in fluid communication with the reservoir inlet port. The device may additionally include a substantially rigid shell disposed about the collapsible fluid reservoir with an interior volume that contains the collapsible fluid reservoir and a vented volume disposed between an outer surface of the flexible membrane and an interior surface of the rigid shell, with the vent inlet port being in fluid communication with the vented volume. The device may further include a drive mechanism operatively coupled to the spool of the delivery mechanism. The method of venting a cartridge of an infusion pump system may further include initiating a dispense cycle by driving the spool with the drive mechanism to a position with the collapsible first volume in communication with the reservoir inlet port. The method may further include driving the spool so as to separate the first and second seals of the collapsible first volume and draw fluid into the first volume through the reservoir inlet port from the reservoir and decrease the pressure within the vented volume. The method may additionally include driving the spool with the drive mechanism to a position with the collapsible first volume in communication with the fluid dispense port, driving the spool so as to at least partially collapse the collapsible first volume and dispense fluid from the collapsible first volume through the fluid dispense port, and driving the spool to a position with the vent second volume in simultaneous communication with the inlet vent port and vent outlet port to allow the vent second volume to arrive at the same pressure as the vent outlet port.
Some embodiments are directed to a delivery mechanism for an infusion pump. The delivery mechanism of an infusion pump may include a bore disposed in a delivery mechanism body, a spool disposed in the bore which is axially displaceable within the bore, and a collapsible volume. The collapsible volume may be bounded by an outside surface of the spool, an inside surface of the bore, a first seal between the spool and the bore that is axially fixed relative to the spool but displaceable relative to an inside surface of the bore and a second seal between the spool and inside surface of the bore which is configured to slide over a slide portion of the spool disposed in an aperture of the second seal, which forms a substantially fluid tight but displaceable seal between an outside surface of the second seal and the inside surface of the bore and which forms a fluid tight but displaceable seal between an outside surface of the slide portion and the second seal.
Some embodiments may be directed to an infusion pump for dispensing fluid to a patient. The device may further include a disposable fluid cartridge, which may include a delivery mechanism. The delivery mechanism may further include a delivery mechanism body. The device may additionally include a bore disposed in the delivery mechanism body including a distal end, a proximal end disposed towards a drive mechanism of the infusion pump, an interior volume, a reservoir inlet port, a fluid dispense port, a vent inlet port and a vent outlet port. The device may further include a spool slidingly disposed within the bore, which may further include a collapsible first volume. The collapsible first volume may be bounded by an outside surface of the spool, an inside surface of the bore, a first seal between the spool and the bore that is axially fixed relative to the spool but displaceable relative to an inside surface of the bore and a second seal between the spool and inside surface of the bore which is configured to slide over a slide portion of the spool disposed in an aperture of the second seal, which forms a substantially fluid tight but displaceable seal between an outside surface of the second seal and the inside surface of the bore and which forms a fluid tight but displaceable seal between an outside surface of the slide portion and the second seal. The spool may further include a vent second volume which may be positionable to overlap the vent inlet port and vent outlet port simultaneously and which may be formed by a third seal around the spool, a fourth seal around the spool, an outside surface of the spool between the third and fourth seal and an inside surface of the bore between the third and fourth seal. The device may further include a collapsible fluid reservoir bounded by a flexible membrane and including an interior volume in fluid communication with the reservoir inlet port, a substantially rigid shell disposed about the collapsible fluid reservoir with an interior volume that contains the collapsible fluid reservoir, and a vented volume disposed between an outer surface of the flexible membrane and an interior surface of the rigid shell, the vent inlet port being in fluid communication with the vented volume.
Some embodiments of the device may include an o-ring seal, which may have a gland for seating an o-ring. The seating may further include an outer circumferential groove extending circumferentially around a longitudinal axis of a cylindrical body, with the circumferential groove including an angled first edge and an angled second edge opposite the angled first edge and an inner overflow channel disposed below the angled first and second edges. The o-ring seal may further include an o-ring disposed in the gland with a first circumferential band of the o-ring resting on the first angled edge and a second circumferential band of the o-ring resting on the second angled edge above the overflow channel with the o-ring in a substantially uncompressed state.
Some embodiments of the device may include a delivery mechanism of an infusion pump for dispensing fluid to a patient. The delivery mechanism may include a spool slidingly disposed in a bore of a delivery mechanism housing, and an o-ring seal disposed on the spool. The o-ring seal may further include a gland for seating an o-ring, which may include an outer circumferential groove extending circumferentially around a longitudinal axis of a cylindrical body of the spool. The circumferential groove may further include an angled first edge and an angled second edge opposite the angled first edge and an inner overflow channel disposed below the angled first and second edges. The delivery mechanism may further include an o-ring disposed in the gland with a first circumferential band of the o-ring resting on the first angled edge and a second circumferential band of the o-ring resting on the second angled edge above the overflow channel with the o-ring in a substantially uncompressed state.
Some embodiments of the portable infusion device may be configured for generating an estimate of an amount of a fluid to be delivered to a body of a user. The device may further include a processor that may be coupled to a memory and configured for receiving user input data from the memory and using the input data for generating an estimate of an amount of fluid to be delivered to the body. The memory may be configured for receiving and storing user input data coupled to the processor and may be further configured for communicating that data to the processor. The device may further include a touch sensitive screen configured for displaying at least one request for user input, where said display is further configured for receiving user input in response to the request and communicating the input to the memory.
Some embodiments of the portable infusion device may be configured for generating an estimate of an amount of a fluid to be delivered to a body of a user. The device may further include a reservoir for storing the fluid, a delivery mechanism for effecting the delivery of the fluid, and a processor coupled to a memory and configured for receiving user input data from the memory and using the input data for generating an estimate of an amount of fluid to be delivered to the body. The device may further include a memory for receiving and storing user input data coupled to the processor and configured for communicating that data to the processor. The device may additionally include a display configured for displaying a request for a user to input data, wherein the display is further configured for receiving user input data in response to the request and communicating that data to the memory.
Some embodiments of the portable infusion device may be directed at a method for delivering an amount of a fluid to a body of a user. The method may include providing a portable infusion device, which may further include a reservoir for storing the fluid, a delivery mechanism for delivering the fluid, and a processor for generating an estimate of an amount of fluid to be delivered to the body in response to user input data and for controlling the delivery mechanism. The device may further include a data input interface for communicating with the processor the data input interface is configured for receiving user input data. The device may additionally include a display for displaying the estimate of an amount of a fluid to be delivered and inputting externally supplied values into the data input interface. The input may include data that the input interface receives and the user input data may be communicated to the processor. The processor may further receive the user input data, generate an estimate of an amount of a fluid to be delivered to the body of the user, and communicate the estimate to the display. The device may be further configured for receiving the generated estimate of an amount of fluid to be delivered on the display of the portable infusion device and receiving a request for a user input on the display of the portable infusion device. Furthermore, the request may require the user to make a selection before delivering the amount of fluid to the body of the user or making a selection based on the estimate such that once the selection is made the portable infusion device delivers the quantity of fluid to the body in response to the selection.
Some embodiments of the portable infusion device may be configured for generating an estimate of an amount of fluid to be delivered to a body and delivering the amount of fluid to the body of a user in accordance with the generated estimate. The system may further include a remote commander that includes a processor, for generating an estimate of an amount of fluid to be delivered to a body in response to user input data. The system may further include a data input interface for communicating with the processor such that the data input interface is configured for receiving user input data. The system may further include a memory coupled to the processor for receiving and storing user input data. The system may further include a display for displaying the estimate of an amount of a fluid to be delivered and a transmitter for transmitting a command to an infuser device such that the command instructs the infuser device to deliver an amount of fluid in accordance with the generated and confirmed estimate. The system may further include a portable infusion device configured for delivering an amount of a fluid to be delivered to a body of a user in accordance with a generated estimate. The portable infusion device may include a reservoir for storing the fluid, a delivery mechanism for effectuating the delivery of the fluid, a receiver for receiving the command from the transmitter of the remote commander; and a processor for instructing the reservoir and delivery mechanism to deliver the amount of fluid to the body of a user in accordance with the generated estimate.
Some embodiments may be directed at a kit. The kit may include an infusion device and instructions for using the system. Some embodiments of the portable infusion device may be configured for facilitating instructing a user on how to operate a portable infusion device, which may include a portable infusion device, a processor functionally linked to the portable infusion device, and a user-interactive touch screen display functionally linked to the processor. The portable infusion device may further include processor instructions that are accessible by the processor and configured to instruct the processor to load a program. Furthermore, the program file may include data corresponding to an arrangement of at least one of a text and graphic, that when displayed on the user-interactive touch screen display, provides information to the user. In addition, at least one of the text and graphic may be displayed on the user-interactive touch screen that is animated.
Some embodiments may be directed to a method of using a portable infusion device to provide information to a user. The method of using the device may include providing a user with a portable infusion device that has a user-interactive touch screen display that displays a graphical user interface. Furthermore, the user-interactive touch screen may display at least one object relating to at least one of a text and a graphic that may provide information to a user. In addition, at least one object displayed on said user-interactive touch screen display may be animated.
Some embodiments may be directed to a system for facilitating user error prevention of a portable infusion device. The user error prevention feature may include a portable infusion device having a processor functionally linked to the portable infusion device. In addition, the portable infusion device may include a user-interactive touch screen display functionally linked to the processor and processor instructions that are accessible by the processor and are configured to instruct the processor to display a plurality of objects on the user-interactive touch screen display. Furthermore, at least two objects representing different user input may be displayed to allow a user to select at least one displayed object as user input and prevent a user from selecting at least one displayed object as user input.
Some embodiments are directed to a method of using a portable infusion device for facilitating user error prevention. The method may include displaying a graphical user interface on a user-interactive touch screen display, which displays a plurality of objects with at least two objects representing a different user input. The method may further include allowing a user to select at least one object as a user input and preventing a user from selecting at least one object as user input.
Some embodiments are directed to a portable infusion device including a processor functionally linked to the portable infusion device and a user-interactive touch screen display functionally linked to the processor. The touch screen display may further include a display area that also operates as a touch input area, which may simultaneously display a plurality of touch sensitive modifiable objects representing various information. Furthermore, the user-interactive touch screen display and processor may allow a user to touch any one of the touch sensitive modifiable objects for at least one of viewing, inputting, and modifying information associated with the object touched by the user.
Some embodiments are directed to a device configured for generating an estimate of an amount of a fluid to be delivered to a body of a user. The device may include a processor coupled to a memory, wherein the processor is configured for receiving user input data from the memory and using the input data for generating an estimate of an amount of fluid to be delivered to the body. The user input data may include one or more of a blood glucose level, a stress level, a physiological condition, a complexity of a meal to be ingested, an activity level, user history, and the like. The processor may also be configured for receiving non-user entered data and using the non-user entered data in generating the estimate of the amount of fluid to be delivered. The non-user entered data may include sensor data, data received from a wireless communication device, and the like.
Some embodiments of the portable infusion device may include a processor that executes instructions for generating an estimate of an amount of fluid for delivery to a body of a user. The infusion device may also include a touch sensitive display configured for displaying at least one display object, so that user interaction with the display object generates a user input value. In addition, the infusion device may include a data interface configured for receiving the user input value from the display in response to user interaction with the display object such that the user input value is communicated from the data interface to the processor for generating the estimate.
Some embodiments of the portable infusion device may be configured for delivery of a fluid to a body of a user and may include a fluid interface for receiving the fluid and a delivery mechanism for effectuating the delivery of the fluid. In addition, the infusion device may include a processor that executes instructions for generating an estimate of an amount of the fluid for delivery. The infusion device may further include a touch sensitive display configured for displaying at least one display object such that user interaction with the display object generates a user input value. The infusion device may further include a data interface configured for receiving the user input value from the touch sensitive display in response to user interaction with the display object such that the received user input value is communicated from the data interface to the processor for generating the estimate.
Some embodiments of the portable infusion device are directed at a method for delivering an amount of a fluid to a body of a user. The method may include receiving user interaction from a touch sensitive display configured for displaying at least one display object, such that user interaction with the display object generates a user input value. The method may further include generating an estimate of an amount of fluid to be delivered to the body in response to the user input value, and displaying a confirmation display object on the touch sensitive display, such that the confirmation display object requests a confirmation input from the user for confirmation before delivery of the amount of fluid to the body of the user. The method may further include initiating delivery of the fluid in response to receiving the confirmation input.
Some embodiments of the system for generating an estimate of an amount of fluid to be delivered to a body and delivering the amount of fluid to the body of a user in accordance with the generated estimate may include a remote commander. The remote commander may include a display configured for displaying at least one display object, such that the display object indicates a value such that user interaction with the display object generates a user input value. The remote commander may further include a data interface configured for receiving the user input value from the display in response to user interaction with the display, and a processor that receives the user input value from the data interface and generates an estimate of the amount of fluid to be delivered to the body. Furthermore, the processor may provide the estimate to the data interface for display of the estimate on the display. The processor may further generate an infusion command in response to receiving a confirmation input from the data interface. In addition, the confirmation input may include a user interaction with the display in response to display of a confirmation display object on the display, such that the confirmation display object requests a confirmation input from the user for confirmation before delivery of the amount of fluid to the body of the user. The remote commander may further include a transmitter that transmits the infusion command, with the infusion command comprising an instruction for delivery of the amount of the fluid in accordance with the generated estimate and confirmation input. The system may further include an infusion device. The infusion device may include a fluid interface configured for receiving the fluid, a delivery mechanism configured for effectuating the delivery of the fluid, and a receiver configured for receiving the infusion command from the transmitter of the remote commander. In addition, the system may include a processor that receives the infusion command from the receiver and initiates delivery of the amount of the fluid from the fluid interface to the body of the user in accordance with the generated estimate.
Some embodiments of the system may facilitate instructing a user on how to operate a portable infusion device. The system may include a touch sensitive display configured for displaying at least one display object, such that user interaction with the touch sensitive display generates a user input value. In addition, the system may include a processor functionally linked to the touch sensitive display and configured for receiving the user input value. The system may further include a program file for execution by the processor, which may include data corresponding to an arrangement of at least one of a text and a graphic, such that when the program file is executed by the processor the at least one of the text and graphic is displayed on the touch sensitive display and provides information to the user about operation of the portable infusion device. In addition, at least one of the text and graphic displayed on the touch sensitive display may be animated. Furthermore, the processor may execute the program file in response to the user input value corresponding to a request for the information.
Some embodiments of the device may be directed at a method of providing information to a user of a portable infusion device. The method may include displaying at least one display object on a touch sensitive display of the portable infusion device. In addition, the at least one display object may relate to at least one of a text and a graphic providing information to the user about the portable infusion device. The method may also include the portable infusion device detecting user interaction with the touch sensitive display and being responsive to the detected user interaction. In addition, the method may include animating at least one display object displayed on the touch sensitive display.
Some embodiments of the system for facilitating user error prevention of a portable infusion device may include a touch sensitive display configured for displaying at least one display object. In addition, the touch sensitive display may be configured such that user interaction with the display generates a user input value. The system may further include a processor functionally linked to the display and configured for receiving the user input value and processor instructions that are accessible by the processor and are configured to instruct the processor to execute a number of tasks. In addition, some tasks may include displaying a plurality of objects on the touch sensitive display such that the plurality of objects include at least two objects, each of which represents a different user input value. Furthermore, processor tasks may include receiving a user selection of one displayed object and corresponding it to a represented user input value. Additionally, processor tasks may include ignoring the received user selection if the represented user input value is not an acceptable value for operation of the portable infusion device, and otherwise accept the received user selection as a user input value for operation of the portable infusion device.
Some embodiments may be directed at a method of using a portable infusion device for facilitating user error prevention. The method may include displaying a plurality of objects on a touch sensitive display of the portable infusion device, such that the plurality of objects including at least two objects where each of which represents a different user input value. Additionally, the method may include receiving a user selection of one displayed object on the touch sensitive display, such that the user selection corresponding to a represented user input value. Furthermore, the method may include ignoring the received user selection if the represented user input value is not an acceptable value for operation of the portable infusion device, and otherwise accepting the received user selection as a user input value for operation of the portable infusion device.
Some embodiments may include a portable infusion device, which may include a processor and a touch screen display functionally linked to the processor and having a display area that operates as a touch input area that detects user interaction therewith. In addition, the portable infusion device may include a plurality of modifiable objects displayed on the touch screen display, such that the plurality of modifiable objects representing various information may be simultaneously displayed in the touch input area of said touch screen display. Additionally, the touch screen display and processor may respond to a user touch to any one of said modifiable objects on the touch screen display for at least one of viewing, inputting, and modifying information associated with the object touched by said user.
Some embodiments of the device may further include a memory for receiving and storing user input data which memory is coupled to the processor and is configured for communicating that data to the processor.
Some embodiments of the device may additionally include a display such as a display that is configured for displaying a request for a user to input data. The display may further be configured for receiving user input data in response to the request and communicating that data to the memory. The display may additionally be configured for displaying a request for additional user interaction prior to delivering the fluid to the body. The request for additional user interaction includes one or more of an acceptance of delivery, a rejection of delivery, or a request for more information.
In certain instances, device embodiments may include a reservoir for storing a fluid such as insulin to be delivered to a body of a user and a delivery mechanism, for effecting the delivery of the fluid. In such an embodiment, the processor may further be configured for controlling one or both of the delivery mechanism and reservoir in accordance with the generated estimate of the amount of fluid to be delivered to the body.
Some embodiments are directed to a method for delivering an amount of a fluid to a body of a user. The method may include providing an infusion device such as a device described above having at least a data input interface, a processor, and a display. The method may further include inputting externally supplied values into the data input interface, wherein the data input interface receives the user input data and communicates that data to the processor, the processor receives the user input data, generates an estimate of an amount of a fluid to be delivered to the body of the user, and communicates the estimate to the display. The method may additionally include receiving the generated estimate of an amount of fluid to be delivered on the display of the device and receiving a request for a user input on the display of the device. Furthermore, the request may require the user to make a selection before delivering the amount of fluid to the body of the user and making a selection based on the estimate so that once the selection is made, the device delivers the quantity of fluid to the body in response to the selection. The user input data includes one or more of a blood glucose level, a stress level, a physiological condition, a complexity of a meal to be ingested, an activity level, user history, and the like.
Some embodiments are directed to a system for generating an estimate of an amount of fluid to be delivered to a body and delivering the amount of fluid to the body of a user in accordance with the generated estimate. The system may include a remote commander, which may include one or more of a processor for generating an estimate of an amount of fluid to be delivered to a body in response to user input data, and a data input interface for communicating with the processor. Furthermore, the data input interface may be configured for receiving user input data. The system may further include a memory coupled to the processor for receiving and storing user input data, a display for displaying the estimate of an amount of a fluid to be delivered, and/or a transmitter for transmitting a command to an infuser device. In addition, the command may instruct the infuser device to deliver an amount of fluid in accordance with the generated and confirmed estimate. The system may further include an infuser device, such as one described above, configured for delivering an amount of a fluid to be delivered to a body of a user in accordance with a generated estimate. For instance, the device may include a reservoir, for storing the fluid, a delivery mechanism for effectuating the delivery of the fluid, a receiver for receiving the command from the transmitter of the remote commander, and a processor for instructing the reservoir and delivery mechanism to deliver the amount of fluid to the body of a user in accordance with the generated estimate. In an additional aspect, the disclosure is directed to a kit including one or more of an infusion device and/or a remote commander, as described above, and instructions for using the same.
Certain embodiments are described further in the following description, examples, claims and drawings. These features of embodiments will become more apparent from the following detailed description when taken in conjunction with the accompanying exemplary drawings.
The drawings illustrate embodiments of the technology and are not limiting. For clarity and ease of illustration, the drawings may not be made to scale and, in some instances, various aspects may be shown exaggerated or enlarged to facilitate an understanding of particular embodiments.
As discussed above generally, there is a need for an infusion device that is capable of taking into account factors in determining an appropriate amount of medicament (e.g., insulin) to be delivered to the body so as to achieve blood glucose homeostasis. Medicament infuser embodiments are discussed herein that are configured in hardware, software, and/or user interface so as to receive user input and/or other data, which may be input by the users interaction with an intuitive user interface, processed to determine an estimate of an amount and/or rate of medicament delivery, which estimate may then be accepted, rejected, or manipulated by the user, so as to effectuate the delivery of the appropriate amount of medicament and thereby maintain homeostasis.
Some infusion device, system, and the method embodiments discussed herein may account for a wide range of variables in determining an amount of medicament, e.g., insulin, to be infused into a patient over a given period of time. Further, some embodiments discussed herein may allow for fine regulation of the amount of medicament delivered as well as the time during which the medicament is delivered. Some embodiments may include advances both in the internal components and the control circuitry as well as improvements in a user interface. The advances may allow for a more fine tuned regulation of blood glucose levels than is currently attainable by the devices, systems, and methods that are available at this time. Although embodiments described herein may be discussed in the context of the controlled delivery of medicaments such as insulin, other indications and applications are also contemplated. Device and method embodiments discussed herein may be used for pain medication, chemotherapy, iron cleation, immunoglobulin treatment, dextrose or saline IV delivery, or any other suitable indication or application. Non-medical applications are also contemplated.
Maintaining appropriate blood glucose homeostasis is an important factor for promoting the length and quality of life of a diabetic patient. Different types of pumps provide a user with various advantages, some of which can be mutually exclusive. For example, a pump device having a large output display can be easier to read and use compared to a pump device with a smaller output display. But that pump may also have a housing that is generally larger and may require a greater power usage. Large and bulky pump devices can be uncomfortable or unwieldy which can contribute to problems with user compliance. For example, a user may be less likely to wear a larger pump device while sleeping or when involved in certain activities. Smaller and more discreet pump systems known in the art can be more easily worn at night, but do not provide all the features patients have come to rely upon for safety and convenience. And once removed from the skin, known pump devices and their associated insulin cartridges cannot be used again.
A single insulin infusion cartridge can be used with a pump device to supply a user with insulin over an extended period of days, such as 3 days. During this time period a user's needs with respect to pump features can change. As mentioned above, full-featured pumps offer certain advantages that a user may not desire at other times such as during sleep or busy weekend activities. Because known insulin cartridges and infusion sets are not interchangeable they cannot be used again once the sterile field is broken and the infusion set and cartridge is used with one pump device. Known infusion sets and insulin cartridges must be thrown out once they are disconnected from a patient.
Provided herein is an interchangeable pump assembly that provides a user with the flexibility and convenience to alternate between pump devices having various features and advantages at any given moment during a single treatment protocol. In some cases a single insulin cartridge can be alternated between pump devices, such as a smaller, more discreet pumping device having fewer features and a larger, full-featured pumping device, during a single treatment without compromising the sterility, and thus wasting the cartridge.
Turning now to the figures,
Variations of the pump devices and features described herein may exist. For example, the full-featured pump device 12 may include a number of features that may or may not be included in the basic pump device 14. The features of each of the pump devices may vary and one or both pump devices may include certain features that are described herein. For example, although the full-featured pump device 12 may be described in an embodiment as having a metal housing 26, the full featured pump 12 may also have a plastic housing 26. Conversely, although the more basic pump device 14 may be described in an embodiment as having a plastic housing 28 it should be appreciated that it can also have a metal housing 28. In general, the full-featured pump device embodiments 12 described herein may include features that ultimately account for the difference in size and weight compared to the basic pumping device 14. It should be appreciated that because a feature or characteristic is described herein as being present on the full-featured pump device 12, that same feature or characteristic is not necessarily missing or different on the more basic pump device 14. The description below provides examples of some of the features that may be incorporated into one or both of the full-featured pump device 12 and the basic pump device 14.
The housing 26 of the first pump device 12 (see
Still with respect to
The pump devices 12 or 14 may have wired or wireless communication capability such as for the sending and receiving of data as is known in the art. The wireless capability may be used for a variety purposes, including updating of any software or firmware for the processor of the device. The wireless communication capability may vary including, e.g., a transmitter and/or receiver, radiofrequency (RF) transceiver, WIFI connection, infrared or Bluetooth® communication device. The wired communication capability may also vary including, e.g., USB or SD port, flash drive port, or the like. In some embodiments, the first pump device 12 and the second pump device 14 each has a transmitter/receiver 32, such as a radiofrequency (RF) transceiver, that allows the first and second pump devices 12 and 14 to communicate with one another and be used interchangeably without loss of data or information during an infusion protocol with a single infusion cartridge 16. A user can alternate between the full-featured first pump device 12 and the more basic, second pump device 14 during a single infusion protocol and the transfer of data between the two can be automatic. The first pump device 12 may also act as a PDA or controller to wirelessly control the second pump device 14. For such an embodiment, data may be transferred between the controller of the first pump device and second pump device by radio signal, optical transmission or any other suitable means. Both the first and second pump devices 12 and 14 may be used as stand-alone devices as well.
One or more of the pump devices 12 or 14 may also include GPS functionality, phone functionality, warning and/or alarm programming; music storage and replay functionality, e.g., an MP3 player; a camera or video mechanism; auto scaling capabilities, and/or one or more video type games or other applications developed by third parties for use thereon. One or more of the pump devices 12 or 14 may also include an accelerometer, for instance, which may be used for changing presented estimates, wherein instead of scrolling through a menu of options or using a numerical keypad, values can be input or changed via the accelerometer, such as by gesturing with or otherwise shaking the device.
As shown in
The processors 42 and 60 may also include additional programming to allow the processor to learn user preferences and/or user characteristics and/or user history data, for instance, to implement changes in use suggestions based on detected trends, such as weight gain or loss; and may include programming that allows the device to generate reports, such as reports based upon user history, compliance, trending, and/or other such data. Additionally, pump device embodiments of the disclosure may include a “power off” or “suspend” function for suspending one or more functions of the device, such as suspending a delivery protocol, and/or for powering off the device or the delivery mechanism thereof. For some embodiments, two or more processors may be used for controller function of the pumps, including a high power controller and a low power controller used to maintain programming and pump functions in low power mode in order to save battery life.
The first pump device 12 and the second pump device 14 may each include a memory device 30 and 56. The memory devices 30 and 56 may be any type of memory capable of storing data and communicating that data to one or more other components of the device, such as the processor. The memory may be one or more of a Flash memory, SRAM, ROM, DRAM, RAM, EPROM, dynamic storage, and the like. For instance, the memory may be coupled to the processor and configured to receive and store input data and/or store one or more template or generated delivery patterns. For example, the memory can be configured to store one or more personalized (e.g., user defined) delivery profiles, such as a profile based on a user's selection and/or grouping of various input factors (as described below); past generated delivery profiles; recommended delivery profiles; one or more traditional delivery profiles, e.g., square wave, dual square wave, basal and bolus rate profiles; and/or the like. The memory can also store user information, history of use, glucose measurements, compliance, an accessible calendar of events, and the like. The first pump device 12 may have a relatively large memory compared to the memory of the second pump device 14. In some embodiments, the memory 30 of the first pump device 12 may be up to about 10 GB, more specifically, up to about 3 GB, even more specifically, about 1 MB to about 200 MB. In some embodiments, the memory 56 of the second pump 14 may be up to about 3 GB, more specifically, up to about 500 MB, and even more specifically, about 200 kB to about 200 MB.
The first and second pump devices 12 and 14 may include a power charging mechanism in some cases, such as a USB port, induction charger, or the like. The power charging system may be used to charge a power storage cell such as a rechargable battery of the pump device. Some embodiments may use a rechargable battery such as a NiCad battery, LiPo battery, NiMH battery or the like. In some embodiments, the power charging mechanism 68 of the first pump 12 may be a USB port. As such, all data may be kept in the first pump device 12 for quick and easy downloading of data to a computer, other pump device, network etc. using the USB port. The USB port 68 of the first pump device 12 may also provide the first pump device 12 with power charging. In some instances, the power charging mechanism 70 of the second pump device 14 may be an induction charging device. In some cases, an advantage of having interchangeable pumping devices 12 and 14 may be that while one pump device is being used for infusion, the other pump device can be charging. Further, the use of dual pump devices may provide a user of the pumps with a back-up in case of failure of one pump device.
The first pump 12 may also include programming to allow processor 42 to make a recommendation regarding a variety of treatment parameters. For instance, the processor 42 may include one or more estimator functionalities 50, which may allow the processor 42 to receive data from various sources, parse the data, collate the same, and generate an estimate based on the same. For instance, the processor 42 may receive user input data and/or data from one or more sensors or other external sources, which the processor 42 can process and thereby use to generate an estimate, such as an estimate of an amount of fluid to deliver to a body, a rate of fluid delivery, and/or a specific fluid delivery profile. For example, the processor 42 may be configured to process data pertinent to a current or predicted condition and to generate an estimate, represented as an amount, rate, profile, etc. of fluid to be delivered based on that data, which estimate may then be displayed to a user, thereby allowing the user to interact with the estimate to accept, decline, and/or otherwise modify the estimate.
Still with respect to
As shown in
Now with respect to
As mentioned above, the attachment mechanism 82 may act as an alignment device to ensure proper insertion of the needle 86 through the septum 88 and proper coupling of the delivery mechanism 90 with the drive mechanism 92. The infusion cartridge 16 and pump devices 12 and 14 may include additional alignment mechanisms that ensure proper coupling occurs to prevent inadvertent lateral translation and delivery of insulin or other medicament to the patient. For example, the pump device 12 or 14 may also include a horse collar type device or other feature positioned near a location where the delivery mechanism 90 couples to the drive mechanism 92. Such a feature may prevent lateral movement of the infusion cartridge 16 (and in turn the delivery mechanism 90) for some configurations as it couples with the pump device 12 and 14 such that inadvertent delivery of insulin to the patient upon insertion of the cartridge into the pump device is prevented. The head 94 of the cartridge 16 which contains the delivery mechanism 90 may also be held using a rail system as will be described in more detail below. A snap system including corresponding male and female parts that allow the infusion cartridge 16 to snap into place in operable contact with the pump devices 12 and 14 may also be used.
Some embodiments of the pump assembly 12 or 14 may also include a removable glucose meter 20 (
As described above, each of the pump devices 12 and 14 may have a receiving slot 22 or 24 into which the infusion cartridge 16 or the glucose meter 20 may be inserted. Like the infusion cartridge 16, the glucose meter 20 may be a reversibly removable and interchangeable element that can be inserted in either the receiving slot 22 of the first pump device 12 or the receiving slot 24 of the second pump device 14. The housing 96 of the glucose meter 20 may have the same or similar dimensions as the housing 72 of the infusion or reservoir cartridge 16 and include the same attachment mechanism 84 as that of the cartridge 16. As described above, each of the pump housings 26 and 28 may include an attachment mechanism 82 (see
The glucose meter 20 may be inserted into the same receiving slot 22 or 24 as the infusion cartridge 16. The assembly therefore may have the added advantage of fewer devices for which the user must mind. For example, while the infusion cartridge 16 is inserted into the receiving slot 22 of the first pump device 12 and being used for a treatment infusion protocol, the glucose meter 20 may be inserted within the receiving slot 24 of the second pump device 14 while that pump device 14 is not being used or is charging. Thus, the receiving slot 22 or 24 of the pump device 12 or 14 not being actively used provides a storage location for the glucose meter 20 (see
For some embodiments, the pump system 110 may include a disposable fluid reservoir cartridge 112. The disposable cartridge 112 may include a fluid interface configured to receive a fluid such as collapsible reservoir 126. The collapsible reservoir 126 may be formed from a flexible material or membrane 128 that is disposed about an interior volume of the reservoir 126. The cartridge 112 also includes a substantially rigid container 130 sealed around the flexible material of the collapsible reservoir 126. A disposable delivery mechanism 132 is disposed within the disposable cartridge 112 and may have a fill port 134 with a re-sealable septum 136 sealed over the fill port 134, a reservoir inlet port 138 in fluid communication with an interior volume 140 of the collapsible reservoir 126, a fluid dispense port 142 in fluid communication with a bore 144 of the delivery mechanism 132, a vent inlet port 146 and a vent outlet port 148 both in fluid communication with the bore 144. The collapsible reservoir 126 may have a bag-like structure with flexible walls that can collapse and expand depending upon the amount of material in the volume of the reservoir. The interior volume of the reservoir may be in fluid isolation from the remaining interior volume of the rigid container 130.
For some embodiments, the reservoir may be formed from a membrane having a thickness of about 0.001 inches to about 0.005 inches, more specifically, about 0.002 inches to about 0.004 inches. In some cases, the membrane of the reservoir may be made from polymers such as PET, SiO, linear low density polyethylene or the like. Some embodiments of the reservoir may have an interior volume in a fully expanded state of about 1 ml to about 10 ml, more specifically, about 3 ml to about 5 ml. The membrane of the reservoir 126 may have a generally enclosed configuration with a top portion in sealed relation to the housing of the delivery mechanism. The membrane may be sealed and bonded to the housing of the delivery mechanism by heat welding, adhesive bonding or any other suitable method. The rigid container 130 of the cartridge may have an interior volume of about 2 to about 15 ml, more specifically, about 3 ml to about 5 ml. The shell 130 may be made from any suitable material, and particularly moldable materials, including polymers and specific materials such as polycarbonate or the like. The shell may have a nominal wall thickness of about 0.03 inches to about 0.08 inches, more specifically, about 0.04 inches to about 0.06 inches.
The cartridge 112 may be releasably and operatively secured to a housing 124 of the pump device 114. The housing 124 may be configured to house a drive mechanism 150 including a motor 152 and gear box 154 disposed in the housing 124 and detachably coupled to a spool member 156 of the delivery mechanism 132. The drive mechanism 150 may be detachably and operatively coupled to the spool 156 member of the delivery mechanism 132. At least one pressure sensor 158 may be disposed in a volume 160 between an outside surface 162 of the flexible material or membrane 128 of the collapsible reservoir 126 and an inside surface 164 of the substantially rigid shell or case 130. As shown in
Other components such as the vibratory motor 175, speaker 178, battery 174 and motor 152 of the drive mechanism 150 may also be operatively coupled to the controller 168. Connective circuitry may include conductive wiring such as copper wiring, fiber optic conduits, RF conduits and the like. For some embodiments, the fluid reservoir cartridge 112, and any of the fluid reservoir cartridges discussed herein, may include an encoder or bar code type strip (not shown). The encoder strip or device may be configured to be scanned and read by a reader device of the pump 114 with the reader device in operative communication with the controller 168 or processor 170 thereof. The encoder device may alternatively be an RFID chip or the like that transmits data to a reader such as a data receiving processor or the like. Such encoder device embodiments may include the ability to securely transmit and store data, such as, via, encryption, to prevent unauthorized access or tampering with such data. The identification of the fluid reservoir cartridge 112 may be used by the controller 168 to set or to adjust certain dispense parameters or any other suitable parameters.
For the embodiment shown, the vent inlet port 146 may be disposed on the delivery mechanism 132 in fluid communication with the volume 160 disposed between the outside surface 162 of the flexible material or membrane 128 of the collapsible reservoir 126 and an inside surface 164 of the substantially rigid shell or case 130 of the infusion cartridge. The controller 168 may include at least one processor 170 and a memory device 172, the controller 168 being operatively coupled to the drive mechanism 150, GUI 166, and at least one pressure sensor 158. The controller may be configured to generate a signal to the drive mechanism 150 to displace the spool 156 of the delivery mechanism 132.
As shown in
The pneumatic tap 179 may include an inner channel 184 running therethrough. The channel 184 may allow the tap 179 to fluidly connect the inner chamber volume 160 of the infusion cartridge 112 to the pump device 114 once the tap 179 is inserted through the port. The inner channel 184 of the tap 179 may connect to a pocket 186 of the pump device 114 that may be filled with a fluid such as air. In some embodiments, the pocket 186 in the pump may hold approximately 1 mL of the air. When the fluid reservoir of the infusion cartridge may be filled with 3 mL insulin or other medicament a residual volume of the inner chamber may exist. This residual volume may be, for example, 1 mL of air. Upon connection between the infusion cartridge 112 and the pump device 114, the residual volume of air within the inner chamber on volume 160 and the air within the pocket 186 may equalize and equilibrate in both temperature and pressure. The volume of the pocket 186 and volume 160 of the cartridge may also be in sealed relation with respect to each other and with respect to the surrounding environment. Thus, the pressure within volume 160 will equalize with the pressure in the pocket 186, thus, the pressure or pressure changes within volume 160 may be measured by the pressure sensor 158 in the pocket 186.
The pump devices 114 and others described herein may include a thermistor or other temperature sensor 188 including an optical or infrared sensor that measures the temperature of the insulin or other medicament within the reservoir 126 upon coupling the infusion cartridge 112 with the pump device 114. Taking the temperature of the air may be important in measuring how much insulin or other medicament is in the fluid reservoir. In some embodiments, the sensor 188 can be integrated with the attachment mechanism 176. For example, in the embodiment shown in
In some cases, the infusion cartridge 112 and the pump device 114 may be reversibly attached to and detached from each other regardless of the stage of treatment of a particular infusion cartridge 112 or position of the drive mechanism 150. As best shown in
In some embodiments, the ball feature 194 of the rack 190 or drive shaft may attach to the coupling element 196 in at least two general directions. The coupling element 196 may be snapped down over the ball feature 194 of the rack 190 in a lateral direction as shown by the arrow 198 in
The ball or capturable feature 194 may be axially advanced until the flange of the coupling element 196 of the spool 156 snaps around the ball feature 194. At any stage during the infusion protocol, the infusion cartridge 112 may be removed from the pump device 114. The infusion cartridge 112 may be slid vertically upwards with respect to the pump housing 124 of the infusion device 110 such that the ball feature 194 exits the coupling element 196 of the spool 156 of the delivery mechanism 132 through the lateral opening 198 of the socket 200. The infusion cartridge 112 may then be re-inserted into another pump device by sliding it in a vertical direction downward through a slot of another housing until the ball feature 194 inserts through a lateral opening of a coupling element of the other pump device. The cartridge 112 may be advanced into the second pump device once again until the flange of the coupling element 196 snaps down from the top around a ball feature on the rack of the drive mechanism 150 of the second pump device.
The delivery mechanism 132 of the infusion cartridge 112 may remain in position providing a patient with the flexibility of changing pump devices during a single treatment protocol with a single infusion cartridge 112 regardless of the position of the drive mechanism 150. The method of switching between pump devices is described in more detail below. Although a ball-hitch type of configuration is shown in the figures, the configuration of the attachment between the rack 190 and the delivery or spool element 156 can vary. For example, the ball 194 and socket 196 of the embodiment shown may be reversed with the socket 196 on the drive shaft 190 and the ball element 194 on the spool or delivery element 156 of the delivery mechanism 132. In addition, the capturable element 194 of the detachable coupling may also include a different shape such as the oval capturable feature 206 shown in
In some cases, it may be desirable for the ball feature 194 and socket 196 of the coupling element to be configured to snap or otherwise detachably couple together such that there is little or no appreciable axial play between the drive shaft 190 of the drive mechanism 150 and the spool 156 of the delivery mechanism 132. Any of these embodiments or similar embodiments of capturable features 194 may be used and detachably captured by a resilient socket or bore 200 in an axial or lateral direction as discussed above with regard to the spool embodiment 156. In addition, the pump devices 114 between which the patient is switching may be configured to communicate and prepare themselves to receive an infusion cartridge 112 such that the drive mechanism 150 translates to the appropriate position to maintain consistency in infusion protocols as will be described in more detail below.
As discussed above,
For some embodiments, inadvertent lateral movement of the infusion cartridge 112 and, in turn, lateral movement of the delivery mechanism 132 relative to the ball feature 194 may result in inadvertent delivery of fluid to the patient 127 upon insertion of the cartridge 112. The rail system shown is configured to hold the head 216 of the infusion cartridge 112 in a proper and stable position once the delivery mechanism 132 inserts over the ball feature 194. The rails 212 of the rail system for some embodiments may also have a tapered configuration as shown in cut away illustration of
For some embodiments, the taper or flare angle of the rails 212 and slots 214 may be about 0.5 degrees to about 3 degrees. The outer housing 130 of the infusion cartridge 112 may also have three-dimensional features such as slots, knurling or any other suitable type of finger grips 218 that may aid a user during the installation and removal of the cartridge from the pump device. Some embodiments may also include a slot (not shown) that bridges the structure of the cartridge 112 and pump housing that is configured to allow a coin to be inserted into the slot and twisted to leverage the disengagement of the cartridge 112 from the pump housing. Typically, both halves of the slot would be aligned when the cartridge is fully engaged with the pump 114. In some cases, the rail system or slot of the pump housing generally may be configured to couple the cartridge to the pump with the top or head of the cartridge in a transversely fixed or secured arrangement to prevent any unwanted displacement between the delivery mechanism 132 and the drive mechanism 150. The coupling between the cartridge 112 and pump 114 at the attachment mechanism end may be configured to allow for some transverse play between the cartridge and the pump housing. The play between the cartridge and the pump may allow the attachment mechanism and receiving mechanism to be self-aligning.
A possible advantage of some system embodiments discussed herein may be that the infusion cartridge 112 even after being inserted within a receiving slot 122 of a first pump device 114 can be removed and re-inserted into the receiving slot of a second pump device without resetting the second pump device. In some cases, the spool 156 of the delivery mechanism 132 of the infusion cartridge 112 maintains its axial position and air is not pulled into the pump chamber 220 or fluid dispensed during the change. Further, in some cases, the first and second pump devices 114 involved in the transfer for switch of the cartridge 112 from one pump 114 to another may be configured to communicate either directly or wirelessly with each other. Such communication between pumps 114 or controllers 168 thereof may allow the position of the drive mechanism 150 of the second pump to be set to the position of the first pump 114 at the time the infusion cartridge 112 was removed thus, providing seamless interchangeability during a single infusion protocol. In addition, after being inserted within a receiving slot of a given pump device, the infusion cartridge 112 can be removed and re-inserted into the same receiving slot of that pump device without resetting the pump device. In this way, system embodiments are contemplated wherein the infusion cartridge 112 (a) is interchangeable between and/or among one or more different pump devices without those pump devices having to be reset, and which pump devices may be identical or different in any of their features, sizes, and functionalities, and (b) may be removed from and re-inserted into a receiving slot on a single given pump device without resetting the given pump. Such a transfer with communication between pumps 114, and other pump embodiments, allows the transfer to be made without changing the axial position of the spool 156 of the delivery mechanism 132 relative to the various ports of the delivery mechanism 132. For some embodiments, the socket or bore 200 of the coupling element 196 of the spool 156 may be configured to be self-centering such that the ball or capturable element 194 of the drive shaft 190 will be engaged and snapped into place even if the axial alignment of the ball element 194 and socket 196 are not perfectly aligned at the time of insertion or engagement.
In some cases, a new infusion cartridge 112 may be removed from its sterile packaging and inserted into the receiving slot of a first pump device 114. The attachment mechanism 176 of the first pump device 114 may couple with the receiving mechanism 178 of the infusion cartridge 112. The drive mechanism 150 at this stage may remain physically unconnected to the delivery mechanism 132. Once the cartridge 112 is secured to the pump 114, a patient 127 can fill the infusion cartridge 112 with insulin or other suitable medicament using a syringe having a hypodermic needle 222 inserted through a septum 136 of the fill port 134 (see, for example,
The pressure increase of 22 psi may then be used by the controller to determine the amount of insulin or other medicament or fluid that has been put into the reservoir 126. Pressure change measurements may also be used to measure an amount or amounts of fluid dispensed from the reservoir 126. Other means of measuring fluid volumes or changes of fluid volumes may also be useful in some embodiments. In some cases, methods and devices for determination of a fluid volume as used in any suitable application discussed herein may include acoustic sensors, including a loud speaker and one or more microphones which may be used for acoustic volume determination, optical devices, capacitive measurement devices, deflection measurement methods, thermal time of flight methods or any other suitable methods. The change in pressure in the system may be used to determine the volume of fluid added or dispensed from the reservoir by means of a ideal gas law calculation. If the volume of the system is known, i.e., the volume of the pocket 186 and volume of the shell 130 are known, then the ideal gas law equation PV=nRT where P is pressure, V is volume, T is temperature and n and R are constants, may be used to calculate changes in volume based on changes in pressure assuming the temperature is also known. The temperature of the gas within the cartridge may be measured by a temperature sensor within the pocket 186 such that when fluid is added or dispensed from the reservoir, the pressure sensor will measure a change in pressure. The change in pressure is then used to calculate the change in volume that caused the pressure change. This method of volume measurement, as well as the other methods discussed above, may be used a redundancy check on electrical volume measurements, error detection within the pump system 110 or components thereof, or any other suitable purpose. The use of the ideal gas law for volume measurement may also be useful for dispensing fluids, including medicaments such as insulin or any other suitable medicament or material, without directly contacting the fluid.
The pressure inside the infusion cartridge 112, and particularly the vented volume 160 of the infusion cartridge 112, may be measured by a pressure sensor 158 disposed in the infusion cartridge 112 or in the pump device 114 in a volume, such as pocket 186. Pocket 186 is an interior volume disposed within the pump device 114 and in fluid communication with an interior volume of the fluid cartridge 112. The pocket 186 is in sealed relation with the interior volume 160 of the cartridge. As such, a pressure sensor 158 disposed within the volume of the pocket 186 will read the pressure of the volume 160 in the cartridge, but can remain with the pump device 114 after disposal of the disposable cartridge 112. This configuration lowers the cost of the cartridge while providing the means of pressure measurement within the cartridge 112. In some embodiments, data from the pressure sensor 158 may be used to provide a measurement of how much insulin or other medicament is being delivered by the first pump device 114.
Once the infusion cartridge 112 is filled, the drive mechanism 150 of the first pump device 114 may then connect to the delivery element or spool 156 of the infusion cartridge 112. For example as in
The priming protocol may be used to prepare the infusion cartridge 112 and the first pump device 114 for delivery of a desired fluid to a patient 127. The patient 127 can input externally supplied values into the data input interface 228 of the first pump device 114. The data input interface 228 may receive the user input data and communicate that data to the processor 170 of the controller 168. For some embodiments, the controller 168 may be programmed or otherwise configured to generate an estimate of an amount of the insulin or other medicament to be delivered to the patient 127 as either a baseline, bolus or any other suitable type of fluid delivery regimen. The controller 168 may then communicate the estimate to the display 230 for patient evaluation. The first pump device 114 may then deliver an approved quantity of medicament to the patient 127 according to the selected protocol. The user input data may include one or more of a blood glucose level, a stress level, a physiological condition, a complexity of a meal to be ingested, an activity level, user history, and the like.
At any stage during an infusion protocol, the patient 127 may slide the infusion cartridge 112 vertically through the slot 122 up away from the attachment mechanism 176 of the first pump device 114. In some cases it may be desirable for the patient 127 to enter data into the interface of the first pump 114 which is indicative that the cartridge 112 is going to be removed from the pump 114. As discussed above, the controller 168 of the first pump 114 may use this data to configure the position of the spool 156 of the delivery mechanism 132 of the first pump 114 or communicate information regarding the position of the spool 156 of the first pump 114 to the controller 168 of the second pump. In this way, the controller 168 of the second pump may use this information to configure the drive shaft 190 of the drive mechanism 150 to facilitate engagement of the cartridge 112 with the second pump. The controller 168 may also be configured to halt an ongoing delivery protocol including any axial advancement or cycling of the delivery element 156 at this time to avoid removal of cartridge 112 during delivery of fluid to the patient 127.
During removal of the cartridge 112 from the first pump 114, the ball feature 194 on the rack or drive shaft 190 may snap through the lateral opening 198 in the coupling element 196 until the delivery mechanism 132 of the cartridge 112 is free of the drive mechanism 150 of the first pump 114. The removal of the infusion cartridge 112 from the first pump device 114 may require a certain degree of force imparted by the patient 127 such that inadvertent removal or uncoupling of the infusion cartridge 112 from the pump device 114 is avoided. The finger grips 218 or other three-dimensional feature on the outer housing 130 of the infusion cartridge 112 may aid a patient 127 in the removal of a cartridge 112 from the pump device 114. As discussed above, once the attachment and receiving mechanisms 176 and 178 are uncoupled, the first pump device 114 may send a signal to the second pump device such that the second pump device may configure itself in preparation for receiving the infusion cartridge 112. Such a signal may be a radiofrequency signal, for example. In some embodiments, the drive shaft 190 of the drive mechanism 150 of the second pump device may be adjusted in an axial direction in accordance with the data sent by the first pump 114.
In some cases, the axial position of the drive shaft 190 of the second pump may be adjusted to the proper position such that when the infusion cartridge 112 is inserted into the slot of the second pump device the ball feature 194 of the rack 190 may be directly inserted through the lateral opening 198 on the coupling element 196 without causing axial displacement of the coupling element 196. The coupling element 196 then snaps over the ball 194 in a top-down direction. In some embodiments, rather than adjusting the rack 190 to match an axial position of the rack 190 of the first pump, the rack 190 of the second pump may instead be fully proximally retracted upon the initiation of a transfer process. In such a process, the infusion cartridge 112 may be inserted into the slot 122 of the second pump without any mechanical engagement between the coupling element 196 of the delivery mechanism 132 or the ball 194 of the drive mechanism 150.
Once the cartridge 112 is engaged with the pump 114, the controller 168 may then instruct the drive shaft or rack 190 of the drive mechanism 150 to advance in a distal direction until pushing the spool 156 of the delivery mechanism 132 to a hard stop 226 within the bore 220. Once the spool 156 is upon the hard stop 226, further axial advancement of the drive shaft 190 in a distal direction will force the ball feature 194 of the drive shaft 190 into the socket 196 of the spool or delivery element 156 until it snaps into place and is mechanically captured by the socket 196. If a glucose meter 20 is being stored within the slot 122 of the second pump device, it may be removed prior to inserting the infusion cartridge 112 into the slot 122 and replaced into the slot 122 of the first pump device 114.
The patient's infusion set 125 may remain connected to the infusion cartridge 112 via the set connector 232 during transfer between the first and second pump devices. The sterility of the infusion cartridge 112 and the infusion set 125 is maintained regardless of how many times the infusion cartridge 112 is removed and re-inserted into a pump device 114. Neither the drive mechanism 150 nor the attachment mechanism 132 of the pump devices 114 breaks the sterile field of the fluid reservoir 126. Similarly, connection between the pneumatic tap 179 and the port 182 of the receiving element does not break the sterile field of the fluid reservoir 126. The insulin or other medicament is contained within the fluid reservoir 126 which may be a closed sterile environment that is not broken or exposed during repeated installations between the first and second pump devices 114.
Referring to
Such devices and methods for measuring and/or confirming a volume of material dispensed and the like from a delivery mechanism 132 or flow metering device are discussed in co-pending, commonly owned U.S. patent application Ser. No. 12/714,299, filed Feb. 26, 2010, by M. Rosinko et al., titled Methods and Devices for Determination of Flow Reservoir Volume, which is incorporate by reference herein in its entirety. The methods and devices discussed therein include measuring a pressure increase in a vented volume of a fluid reservoir cartridge between the rigid shell and flexible membrane of the fluid reservoir as discussed herein. Such pressure measurements may be used to determine or confirm an amount of fluid dispensed, as well as detect malfunctions in the components of a delivery mechanism 132 or drive mechanism 150 of a pump system 110.
Other methods and devices used for calculating and measuring flow volumes dispensed are discussed in U.S. Pat. No. 7,008,403, filed on Jul. 19, 2002, by Scott Mallett, titled Infusion Pump and Method for Use, U.S. Pat. No. 7,341,581, filed on Jan. 27, 2006, by Scott Mallet, titled Infusion Pump and Method for Use, U.S. Pat. No. 7,374,556, filed on Jan. 31, 2006, by Scott Mallett, titled Infusion Pump and Method for Use, 2007/0264130, filed on May 4, 2007, by Scott Mallett, titled Infusion Pumps and Method for Use, and 2009/0191067, filed on Jan. 25, 2008, by Paul DiPerna, titled Two Chamber Pumps and Related Methods, which are all incorporated by reference herein in their entirety. Some embodiments discussed in these references include the use of the ideal gas law or Boyle's law, for determination of a volume of material dispensed from a device 110 or reservoir 126 thereof. Such methods and devices may be used in conjunction with or as part of suitable embodiments 10 or 110 discussed herein.
Referring again to
The collapsible first volume 244 of the delivery mechanism 132 may be positionable to overlap the reservoir inlet port 138 independent of an overlap of the fluid dispense port 142. The collapsible first volume 244 may be formed between a first seal 248 around the spool 156, a second seal 250 around the spool, an outer surface of the spool body between the first and second seal 250 and an interior surface 252 of the bore 220 between the first and second seal 248 and 250. The first and second seals 248 and 250 are axially moveable relative to each other so as to increase a volume of the collapsible volume 244 when the first and second seals 248 and 250 are moved away from each other and decrease the collapsible volume 244 when the seals 248 and 250 are moved closer together.
The second seal 250 is disposed on a main section 254 of the spool 156 of the delivery mechanism 132 and moves in conjunction with movement of the rest of the spool. A proximal end 256 of the spool 156 is coupled to a ball portion 194 of a drive shaft 190 of the drive mechanism 150 of the pump device 114. The drive mechanism 150 includes a rack and pinion mechanism actuated by an electric motor 152 through a gear box 154. As such, the second seal 250 moves or translates axially in step with axial translation of the spool 156 and drive shaft 190. The first seal 248, however, is disposed on a distal section 258 of the spool 156 which is axially displaceable with respect to the main section 254 of the spool 156. The distal section of the spool 156 is coupled to the main section of the spool by an axial extension 260 that is mechanically captured by a cavity 261 in the main section 254 of the spool 156. This configuration allows a predetermined amount of relative free axial movement between the distal section 258 of the spool and the nominal main section 254 of the spool 156.
For some embodiments, a volume of a “bucket” of fluid dispensed by a complete and full dispense cycle of the spool 156 may be approximately equal to the cross section area of the bore 220 multiplied by the length of displacement of the captured axial extension of the spool 156 for the distal section 258. The complete bucket of fluid may also be dispensed in smaller sub-volumes in increments as small as a resolution of the drive mechanism 150 allows. For some embodiments, a dispense volume or bucket defined by the complete collapsible volume 244 of the delivery mechanism 132 may be divided into about 10 to about 100 sub-volumes to be delivered or dispensed. In some cases, the maximum axial displacement between the distal section and main section of the spool may be about 0.01 inch to about 0.04 inch, more specifically, about 0.018 inch, to about 0.022 inch.
For some embodiments, the bore 220 of the delivery mechanism may have a transverse dimension or diameter of about 0.04 inches to about 0.5 inches, more specifically, about 0.08 inches to about 0.15 inches. For some embodiments, the spool 156 may have a length of about 10 mm to about 40 mm, more specifically, about 15 mm to about 20 mm. The spool 156 and housing of the delivery mechanism 132 may be made from any suitable material or materials including polymers or plastics such as polycarbonate, PEEK, thermoplastics, cyclic olefin copolymer, and the like. In some cases, the seals disposed on the spool may have an outer transverse dimension or diameter that is slightly larger than that of the spool 156. In some instances, the seals on the spool may have an axial thickness of about 0.01 inches to about 0.03 inches and may be made from materials such as butyl, silicone, polyurethanes or the like having a shore hardness of about 65A to about 75A, more specifically, about 70A.
In some instances, a vent second volume 246 of the delivery mechanism 132 may be formed by the spool 156 and bore 220 of the delivery mechanism 132. For some embodiments, the vent second volume 246 may be formed by a third seal 262 disposed around the spool 156 and a fourth seal 264 also disposed around the spool and axially separated from the third seal 264. The axial separation between the third and fourth seals 262 and 264 forming the vent second volume 246 may be greater than the axial separation between the vent inlet port 146 and vent outlet port 148 of the bore 220 in some instances. The vent second volume 246 is also formed by an outside surface 266 of the spool 156 between the third and fourth seal 262 and 264 and an inside surface 252 of the bore 220 between the third and fourth seal 262 and 264.
The vent second volume 246 may be axially displaceable with the movement of the spool 156 and may also be positionable by such axial displacement in order to simultaneously overlap the vent second volume 246 with the vent inlet port 146 and vent outlet port 148 of the bore 220. Such an overlap of both the vent inlet port 146 and vent outlet port 148 puts these ports in fluid communication with each other and allows an equilibration of pressure between the vented volume 160 of the reservoir cartridge 112 and the environment surrounding the vent outlet port 148. In most cases, the vent outlet port 148 will be in communication with the atmosphere and air will pass from the environment surrounding the vent outlet port 148, through the vent second volume 246 of the bore 220 and into the vent volume 160 to replace the fluid dispensed subsequent to the last vent cycle. When the vent inlet port 146 and vent outlet port 148 do not share a common volume formed by the spool and bore of the delivery mechanism 132, they are typically isolated and no venting of the vented volume takes place.
A collapsible fluid reservoir 126 of the infusion cartridge 112 shown in
In operation, the spool 156 and the particular volumes formed between the spool 156, the bore 220 and the circumferential seals 248, 250, 262 and 264 disposed on the spool of the delivery mechanism 132 are typically translated in a proximal and distal direction in order to move the volumes into and out of communication with the various ports of the bore 220. This axial movement in alternating proximal and distal directions of the spool 156 within the bore 220 may be used to put the various ports in fluid communication with translatable volumes of the delivery mechanism 132 and other ports of the mechanism. For reliable operation, it may be desirable in some circumstances for the spool 156 and the circumferential seals 248, 250, 262 and 264 disposed about the spool 156 to move smoothly within the bore 220 of the delivery mechanism 132 while maintaining a seal between an outside surface 266 of the spool 156 and an inside surface 252 of the bore. It may also be desirable for the seals 248, 250, 262 and 264 disposed on the spool 156 to move axially back and forth within the bore 220 while maintaining a seal and with a minimum of friction. Achieving these features of the spool 156 may be facilitated with the use of particular seal configurations or gland configurations used to house the seals of the spool embodiments.
Referring to
The angled surfaces or edges may be configured to compress an o-ring semi-axially and rely on the elastic memory of the seal or o-ring material to create a dynamic seal. The angled surfaces or any other suitable configuration may provide both axial stability of the seal as well as outward radial support of the seal to provide positive and sealing contact with an inside surface of the bore or any other appropriate sealing surface. The mixed radial and axial support provided by the angles edges or surfaces may also be useful for allowing substantially equal distribution of tension of the seal around the gland which may also provide a centering function of the body of the seal with respect to a longitudinal axis of the spool or other sealed element. The o-ring or seal may be sealed around at least one of the angled edges or surfaces and an inside surface of the bore 220 to prevent an axial flow of fluid past the seal. The overflow channel provides a volume of the gland adjacent the seal that accommodates a flow of excess seal material when the seal is compressed between two elements. A typical grooved gland used for o-ring type seals may force a flow or overflow of seal material into the gap between the two sealed elements resulting in excessive or inconsistent friction or stiction between the elements. The overflow channel provides a volume for the excess seal material to flow into instead of a gap between sealed surfaces. The gland embodiment shown in
For some gland embodiments 270, the angled first and second edges 276 and 278 may form a total inclusive angle with each other of about 20 degrees to about 60 degrees, as indicated by the arrow 286 in
Some gland embodiments, such as the gland 306 shown in
In use, referring again to
A reservoir fill port 134 is disposed on a top portion of the bore 220 substantially opposite the bore 220 of the reservoir inlet port 138. With the spool 156 and seals 248, 250, 262 and 264 thereof so positioned, a patient may then obtain an amount of a desired fluid to be dispensed. In some cases, if the desired fluid to be dispensed is insulin or other suitable medicament, the patient 127 typically stores the insulin in a refrigerated glass container. The insulin is then accessed with a hypodermic needle 222 of a syringe device and drawn into an interior volume of the syringe (not shown). The tip of the hypodermic needle 222 of the syringe may then be pushed through a septum membrane 136 that seals the reservoir fill port 134 as shown and fluid manually dispensed from the interior volume of the syringe, through the hypodermic needle 222, through a bubble trap volume 314 in the bore 220 of the delivery mechanism 132 and into the interior volume 140 of the collapsible reservoir 126 of the cartridge 112 as shown by the arrow 318 in
As discussed above with regard to other embodiments of the delivery mechanism 132, the vented volume 160 of the cartridge 112 disposed between an outside surface 162 of the flexible membrane 128 of the collapsible reservoir 126 and an inside surface 164 of the rigid shell 130 may include or be in operative communication with a pressure sensor 158 (not shown). The pressure sensor 158 may be used to monitor the pressure within the vented volume 160 during the filling of the collapsible reservoir 126. The controller 168 of the pump system 114 may be programmed with information regarding the fixed volume of the rigid shell 130 of the cartridge 112 and configured to calculate the volume of fluid loaded into the collapsible reservoir 126 based on the pressure rise within the rigid shell 130 upon filling of the collapsible reservoir 126. The data regarding the volume of fluid loaded into the collapsible reservoir 126 may be stored and used to calculate and display data later in the use cycle such as fluid remaining in the collapsible reservoir 126 and the like.
Once the collapsible reservoir 126 contains a desired amount of a fluid 121 to be dispensed, a dispense cycle may be initiated by driving the spool 156 with the drive mechanism 150 based on commands from a controller 168 of the pump device to a position with the collapsible first volume 244 in communication with the reservoir inlet port 138. The had stop position shown in
The collapsible volume 244 of the delivery mechanism 132 may be completely filled by proximally retracting the main section 254 and second seal 250 of the spool 156 relative to the first seal 248 and distal section 258 of the spool 156 as shown by arrow 322 on spool 156 in
Once filled, the spool 156 and filled collapsible volume 244 may be proximally displaced with the drive mechanism 150 to a position with the collapsible first volume 244 in communication with the fluid dispense port 142 of the bore 220 as shown in
Once the spool 156 is positioned as shown in
After filling of the collapsible volume 244 of the delivery mechanism 132 as shown in
In some cases, the vented volume 160 of the cartridge is vented about every 2 dispense cycles to about every 10 dispense cycles. In some cases, the vented volume 160 may be vented about every 3 dispense cycles to about every 7 dispense cycles. However, any desired interval of venting cycles to dispense cycles may be used. For some embodiments, the venting of the vented volume 160 of the infusion cartridge 112 may be triggered by the detection or measurement of a pressure difference threshold in the vented volume 160. That is, if the pressure measured in the vented volume 160 of the infusion cartridge 112 is above or below a predetermined valued relative to the ambient pressure, the controller 168 will initiate a venting cycle to vent the vented volume 160 and equalize the pressure in the vented volume 160. For some embodiments, the magnitude of such a threshold pressure difference may be up to about 1 psi gauge, more specifically, up to about 0.1 psi gauge.
In some cases, the collapsible first volume 344 of the delivery mechanism 342 includes a volume bounded by at least one distal seal 346 that is axially displaceable relative to a slide section of the spool body 348 and which may form a substantially fluid tight seal between an outside surface 350 of the seal 346 and an inside surface 252 of the bore 220. A fluid tight seal may also be formed between an outside surface 352 of a slide portion 354 of the spool 340 and an inside surface or inside diameter 356 of the seal. More specifically, the delivery mechanism 342 of an infusion pump system 358 may include the bore 220 disposed in the delivery mechanism 132 body and the spool 340 disposed in the bore 220 which is axially displaceable within the bore 220. The delivery mechanism 342 also includes a collapsible volume 344 bounded by an outside surface 358 of the spool 340, an inside surface 252 of the bore 220, the distal seal disposed between the spool 340 and the bore 220 and a proximal seal 360 disposed and sealed between the spool 340 and the bore 220. The proximal 360 seal is axially fixed relative to the spool 340 but displaceable relative to an inside surface 252 of the bore 220. The slide portion 354 of the spool 340 may be disposed in a central aperture 362 of the distal seal 346.
An outer surface of the aperture 362 of the distal seal 346 may form a substantially fluid tight seal over an outside surface 352 of the slide portion 354 of the spool 340, while also being axially displaceable over the slide portion 354 once the friction there between is overcome. The distal seal 346 also forms a seal between an outside surface 350 of the distal seal 346 and the inside surface 252 of the bore 220 while being axially displaceable within the bore 220 once the friction between the distal seal 346 and surface 252 of the bore 220 is overcome. The slide portion 254 of the spool 340 may be a substantially cylindrical section of the spool 340 which as a smooth and uniform outside surface 352. The slide portion 354 may be bounded at both the proximal end 364 and distal end 366 of the slide portion 354 by a proximal shoulder portion 368 and a distal shoulder portion 370 respectively. The shoulder portions 368 and 370 may serve to limit the axial translation of the distal seal 346 over the slide portion 354 of the spool 340. The separation of the shoulder portions 368 and 370 may serve to determine the maximum and minimum volume of the collapsible volume 344 of such a spool embodiment 340. In some embodiments, the friction between inside surface 252 of bore 220 and distal seal 346 is greater than friction between outside surface 352 of slide portion 354 of spool 340 and aperture 362 of the distal seal 346.
In some instances, the proximal and distal seals 346 and 360 may include an o-ring. In some embodiments, the spool 340 includes an elongate cylindrical member having a transverse dimension of about 0.5 mm to about 10 mm, In some cases, the maximum axial displacement of the distal seal 346 between the proximal and distal shoulder portions may be about 0.01 inch to about 0.04 inch, more specifically, about 0.018 inch, to about 0.022 inch. For some embodiments, the bore 220 of the delivery mechanism 342 may have a transverse dimension or diameter of about 0.04 inches to about 0.5 inches, more specifically, about 0.08 inches to about 0.15 inches. For some embodiments, the spool 340 may have a length of about 10 mm to about 40 mm, more specifically, about 15 mm to about 20 mm. The spool 340 and housing of the delivery mechanism 342 may be made from any suitable material or materials including polymers or plastics such as polycarbonate, PEEK, thermoplastics, cyclic olefin copolymer, and the like. In some cases, the seals disposed on the spool 342 may have an outer transverse dimension or diameter that is slightly larger than that of the spool 156. In some instances, the seals on the spool 342 may have an axial thickness of about 0.01 inches to about 0.03 inches and may be made from materials such as butyl, silicone, polyurethanes or the like having a shore hardness of about 65A to about 75A, more specifically, about 70A.
In use, the spool embodiment 340 incorporating the sliding seal arrangement shown in
During proximal withdrawal of the spool 340 and proximal seal 360, the distal seal 346 may remain substantially stationary with respect to the bore 220 due to the static frictional force between an inside surface of the bore and an outside surface of the distal seal 346. This process also may require that the slide portion of the spool moves axially in a proximal direction through an inner diameter of the annular distal seal 346 while maintaining a fluid tight sealed condition therebetween. It may also require that the static frictional force between the inside surface of the bore 220 and outside surface of the distal seal 346 is greater than the frictional force between the slide portion 354 of the spool and inside aperture or diameter of the distal seal 346. In this way the spool 340 and proximal seal can translate within the bore 220 while the distal seal 346 remains stationary. The proximal withdrawal and filling of the collapsible volume 344 may continue until the distal seal 346 contacts the distal shoulder portion 370 of the spool 340. Thereafter, the spool 340, distal seal 346 and proximal seal 360 may be proximally translated in unison until the collapsible volume is disposed in fluid communication with the dispense port 142.
Once the collapsible volume 344 is disposed in fluid communication with the dispense port 142, the filling process for the collapsible volume 344 discussed above may be reversed. In this case, the spool 340 is distally advanced along with the proximal seal 360 while the distal seal 346 again remains substantially axially stationary. This has the effect of collapsing the collapsible volume 344 and dispensing the fluid 121 from the dispense port 142. It should also be noted that for the dispense function to proceed, the frictional force between an outside surface of the distal seal 346 and inside surface of the bore 220 must be greater than the force equal to the pressure of the fluid 121 within the collapsible volume 344 multiplied by the area of the bore 220. The same condition holds true for the spool embodiment 156 discussed above. The pressure within the collapsible volume 344 during a dispense cycle may depend on several factors including the viscosity of the fluid 121, the size and cross sectional area of the various ports 138 and 142, and the speed with which the spool 340 is translated. For some embodiments, these parameters may be selected such that the pressure of the fluid 121 within the collapsible volume 344 may be up to about 20 psi, more specifically, up to about 10 psi, in some cases. If the pressure of the fluid 121 within the collapsible volume 344 exceeds the force of frictional engagement of the distal seal 346 with the surface of the bore 220, the distal seal will be displaced along with the spool 340, at least to some extent. The controller of the pump device may be configured to measure pressure within the volume of the shell 130 as discussed above and detect an increase in pressure during the dispense stroke of the spool 340 or 156. Such a pressure change may be an indication of a clog in the dispense port 142 or fluid lumen of the infusion kit or line disposed and sealed between the dispense port 142 and patient 127. If such a clog is detected, an auditory, vibratory, or visual signal may be generated to warn the patient of the clog. All three types of signals or warnings could be generated as well. The pressure within the shell 130 may be monitored by the controller 168 generally in order to verify the performance of the axial movements of spool 156 or 340.
Referring to
For example, in certain embodiments, the portable infusion device 380 includes a delivery mechanism 384. The delivery mechanism 384 may be any suitable type of mechanism including the delivery mechanisms 90 and 132 discussed above. For some embodiments, the delivery mechanism 384 may include a typical drive mechanism, such as a drive mechanism that includes a drive screw coupled to a motor. In such an instance, the drive mechanism may be configured for being operably coupled to a reservoir, such as a syringe based reservoir, and the housing may be sized to include at least a portion of the drive mechanism and the reservoir. In some instances, the delivery mechanism 384 may include a hydraulics mechanism, pneumatic mechanism, step motor, continuous motor, or the like.
In some embodiments, such as the embodiment depicted in
For certain embodiments, the shuttlecock 410 may be configured such that as it translates forwards and rearwards within the translation chamber, it regulates the flow of a fluid from the reservoir outwards away from the translation chamber outlet 414. The shuttlecock, therefore, can have any suitable shape or size and be of any suitable configuration so long as it is capable of translating within the translation chamber and thereby regulating the flow of a fluid from the device. In certain embodiments, the shuttlecock has an extended body that includes one or more openings, which openings pass through the entire width and/or length of the shuttlecock. The openings may be positioned within the shuttlecock such that they line up with one or more of a corresponding opening in the reservoir and/or the trampoline surface. Hence, as the shuttlecock 410 translates in one direction and at least one opening aligns with a corresponding opening in the reservoir, fluid is expelled inwards through the shuttlecock 410 to contact the surface of the trampoline 412 causing it to extend thereby storing a quantity of fluid thereon, and as the shuttlecock 410 translates in another direction and at least one opening therein aligns with the extended trampoline 412, the stored fluid is expelled away from the trampoline as it moves toward its rest position, through the shuttlecock 410, and out of the translation chamber.
The actuator or drive mechanism 408 may be configured for actuating or otherwise effecting the translation of the shuttlecock 410. The actuator 408 may be any mechanism that is capable of causing the translation of the shuttlecock 410. For instance, the actuator 408 may include an electric coil, a ferrite member, a nitinol member, a lever arm, corresponding magnets or electric magnets or dipoles, and the like.
As shown
In certain embodiments, such as that depicted in
For instance, the reservoir 404 may include a first chamber 416 that is configured for storing a liquid, such as a medicament to be delivered to a body. The second chamber 418 may be configured for storing a gas, such as air, carbon dioxide, or the like. The chambers additionally may be configured to store the fluid under pressure, such as atmospheric or high pressure. The boundary, such as a diaphragm 420, may be made from an elastic material that is substantially impermeable to the fluids in either chamber, but configured for being displaced from a resting position to an extended position, such as in response to an increase in pressure. Accordingly, as the second chamber 418 is filled with the gas, the diaphragm 420 is displaced, which displacement causes the pressure in the first chamber 416 to increase. The chambers may include one or more additional openings for the passage of the fluid into or out of the chamber. For instance, the first chamber 416 may include an opening or egress 426 for allowing the fluid, e.g., a liquid, stored within the chamber 416 to be expelled from the chamber 416 through the egress or dispense port 426.
As indicated above, the egress 426 may be configured so as to communicate with the shuttlecock translation chamber and/or shuttlecock 410 and/or one or more openings therein. The egress 426 may further be configured for opening and closing or otherwise regulating the amount of fluid that is allowed to pass there through. In this manner, the reservoir 404 interacts with the delivery mechanism 384 to effectuate the delivery of a stored fluid from the reservoir 404, through the delivery mechanism 384, and out of the portable infusion device 380, e.g. via infusion set 406.
In further embodiments, a third chamber may also be included. For instance, the third chamber may be in fluid communication or otherwise associated with the second chamber, such as via a solenoid valve. In certain embodiments, the reservoir is configured in such a manner that the amount of fluid delivered by the first chamber is directly calculated by a transfer of an amount of gas, e.g., from one chamber to another, such as by the amount of gas transferred from the third to the second chamber.
For example, the total volume of the second and/or third chambers may be fixed. As gas is transferred from the third chamber to the second chamber, an increase in volume in the second chamber results in a corresponding decrease in volume of the third chamber. This transfer of fluid results in a pressure being exerted on the diaphragm resulting in the expulsion of fluid from the first chamber, wherein the amount of fluid expelled from the first chamber is directly proportional to the increase in volume of the second chamber. Sensors may be included in the second and third chambers so as to determine the pressure transfer of the gas in the second and third chambers.
Specifically, since the volume of the third chamber is known and fixed, the ideal gas law and the principle of conservation of mass may be applied to determine the volume of gas in the second chamber. Since the combined volume of the second and first chambers is known and fixed, the volume of the first chamber is determined from the calculated volume of the second. The flow rate of the fluid from the first chamber is determined by calculating the volume of fluid in the second chamber at two instances in time and dividing the change in volume by the time between measurements. See, for instance, U.S. Pat. No. 7,374,556 incorporated by reference herein in its entirety. The processor may be employed for determining the dispensing of fluid from the first chamber, based upon the pressures sensed by the pressure sensor(s), e.g., in the second and third chambers. See, for instance,
As indicated in
Further, as indicated in
The attachment mechanism may have any shape and configuration, that is capable of removably attaching the housing 428 of the reservoir 404 with the housing 382 of the portable infusion device 380. In certain embodiments, the attachment is a rail system including corresponding grooves that allow the reservoir to be slidably coupled to the portable infusion device. In other embodiments, the attachment is a snap system that includes corresponding male and female parts that allow the reservoir to snap into place in operable contact with the portable infusion device. Hence, in certain instances, the reservoir and/or associated housing form a removable cartridge. Further, in certain embodiments, the reservoir itself is a cartridge that fits into a separate reservoir housing, which housing may then be attached, e.g., removably, to the housing of the portable infusion device.
As shown in
Accordingly, the processor may include programming that it can execute to control the speed of shuttlecock translation, the release of fluid from the reservoir, the data to be displayed by a display, the data to be transmitted via the transmitter, the one or more alarms, etc. The processor may also include programming that allows the processor to receive signals and/or other data from an input device, receiver, various sensors (such as a sensor that may be included as a part of the device or used in conjunction therewith, for instance, a blood glucose monitor and/or a blood glucose sensor, and the like) and to store the same in a memory. The memory can be any type of memory capable of storing data and communicating that data to one or more other components of the device, such as the processor.
For instance, the memory may be one or more of a Flash memory, SRAM, ROM, DRAM, RAM, EPROM, dynamic storage, and the like. For instance, the memory may be coupled to the processor and configured to receive and store input data and/or store one or more template or generated delivery patterns. For example, the memory may be configured to store one or more personalized (e.g., user defined) delivery profiles, such as a profile based on a user's selection and/or grouping of various input factors (as described below); past generated delivery profiles; recommended delivery profiles; one or more traditional delivery profiles, e.g., square wave, dual square wave, basal and bolus rate profiles; and/or the like. The memory may also be configured for storing user information, history of use, compliance, an accessible calendar of events, and the like.
The processor may also include programming to allow the processor to make a recommendation. For instance, the processor may include one or more estimator functionalities 434 that enable the processor 386 to receive data from various sources, parse the data, collate the same, and generate an estimate based on the same. For instance, the processor may be configured to receive user input data and/or data from one or more sensors or other external source, which data the processor can process and thereby use to generate an estimate, such as an estimate of an amount of fluid to deliver to a body, a rate of fluid delivery, and/or a specific fluid delivery profile. For example, the processor may be configured to process data pertinent to a current or predicted condition and to generate an estimate, represented as an amount, rate, profile, etc. of fluid to be delivered based on that data, which estimate may then be displayed to a user, thereby allowing the user to interact with the estimate to accept, decline, and/or otherwise modify the estimate.
Specifically, as shown in
For instance, the processor 386, and other processors discussed herein, may include estimator programming 434, such as estimators A-E (or a larger number as desired), enabling the processor 386 to adjust the amount and/or flow rate, etc. of a fluid from the device 380. For example, the portable infusion device 380 may include an interface that allows a user such as a patient to interact with the programming of the processor to determine an amount of fluid to be delivered, a rate of delivery, a delivery profile, and/or the like. In certain embodiments, the portable infusion device is configured for receiving user information about a users present or predicted conditions. Such information may include the amount of insulin already present in the body, e.g., insulin on board; blood glucose level; trending glucose level; insulin sensitivity/insensitivity; glycemic index; metabolism; metabolic rate; stress level; physiological conditions, e.g., age, health, sickness, diurnal cycles, etc; measurable parameters: hormones, steroids, etc.; pharmacokinetics of the medicament, e.g., age of insulin, decay rate, etc.; food to be ingested, e.g., carbohydrates, proteins, fat; activity; use history; calendared events; environment, e.g., temperature, humidity, pressure, etc.; and the like. One or more of these factors may be entered into the device, for instance, by an input device. The processor 386 includes programming configured for receiving such user input information, such as that discussed above, parsing and collating the information to generate an output, and presenting that output to a user, such as on display 388.
As can be seen with respect to
A unique complication that may be present with respect to diabetic users is that they often build up calluses on the tips of their fingers as a result of blood glucose testing, which may be problematic for capacitive-based touch screen configurations. For example, calluses may prevent or hinder the transfer of energy that the capacitive screens use to receive directions. Accordingly, in certain embodiments, the touch screen may be a resistive based touch screen. The touch screen, or touch sensitive display, may be configured to display screens or pages that allow the user to input data fields, e.g., select variable inputs, so as to allow the program to produce a suggested delivery amount, rate, profile, and/or the like in an intuitive, manipulable, and/or graphic representation, thereby allowing the user to interact with the screen to shape the characteristic/form of the delivery amount, rate, and/or graphic delivery profile, e.g., by manipulating the delivery estimate or pattern displayed on the screen to effectuate the actual delivery. The portable infusion device may additionally include a keyboard or other device known in the art for data entry, which such devices may be separate from the screen and/or display.
Information provided by the portable infusion device may be presented on the display screen as any number of objects, including one or more numerical values, a range, a value or range that is presented in the form of a drop-down menu, a toggle that can be adjusted by the user, a graphical representation or an animated graphic, and the like. For instance, in certain embodiments the value is a range of values that are presented on a screen of the display as a toggle, wherein the toggle may be adjusted upwards or downwards by the user swiping a finger over the screen to select the appropriate value range, e.g. appropriate range of amounts of medicament such as insulin to be delivered and/or the appropriate rate of medicament delivery. In certain instances, the values presented in the range may be adjusted by the processor 170 based on various characteristics of the user, such as age, sex, weight, height, insulin sensitivity, etc.
Additionally, in certain instances, the value estimate may be displayed in graphical form; for instance, as an interactive graphic interface, such as where the value to be displayed is a delivery profile. In some circumstances, a possible advantage of the disclosed portable infusion devices is that the programming of the processor and the touch screen functionality permit the portable infusion device to receive user inputs pertaining to a wide variety of variables, such as those described above. The variables may be used to generate a graphic representation of a delivery profile that may be manipulated by the user to change the delivery profile, with or without various predetermined parameters. This represents a movement away from the static stair step delivery modules that are based more on the limitations of archaic pumping mechanisms and that have a limited ability to correlate with the actual present or future medicament needs of a user. Hence, rather than locking a user into a delivery profile that resembles, for example, a square stair step wave or a dual wave profile, as is commonly employed in the art, the delivery profiles of the present portable infusion device may be represented as a series of adjustable graphs.
For example, where the fluid to be delivered is insulin, a portable infusion device of the present disclosure may be configured to receive user and/or external, e.g., sensor, inputs to calculate current or predicted insulin on board for the user, and may further make calculations to determine a predicted rate of decay for the same. The portable infusion device programming may in turn use this information, along with other information, such as user input information, e.g., current blood glucose level, stress level, or activity level, to generate a delivery profile that more resembles the actual insulin requirements of a user. In this manner, a portable infusion device of the present disclosure generates a delivery profile that models the amount of glucose in the blood, such that a user will have enough insulin to deal with the present blood sugar but not so much of an excess that medical complications arise.
Specifically, in many current infusion pumps, two typical infusion rates are possible: a basal rate, wherein insulin is being delivered at a constant rate; and a bolus rate, wherein prior to ingesting food a bolus of insulin is delivered to account for the amount of sugar to be ingested. In practice, the user enters the amount of carbohydrates they are about to ingest, their carb ratio (the volume of insulin programmed to be delivered for every particular number of carbohydrates predicted to be consumed by the user), and based on this information the infusion pump will generate an estimate of a bolus amount of insulin to be delivered. If accepted by the user, e.g., by depressing a button, the then-current basal delivery mode is suspended and the bolus delivery rate is initiated.
As discussed, there are several shortfalls in such calculations. For instance, the amount of insulin to be delivered should model the amount of glucose in the blood as well as the predicted amount of glucose to be ingested, and/or the insulin sensitivity of the user. These amounts are further affected by factors such as the user's emotional state, activity level, physical conditions, etc; and further, the food to be ingested often include other components, e.g., fat and protein, in addition to carbohydrates, which are generally not of high importance in the calculations performed by current devices. Although the presently disclosed portable infusion devices consider the amount of carbohydrates a user is to ingest as well as their carb ratio, they also may consider a wide variety of other variables that may be input by the user or other external sources, such as by sensors, and the like. That is, the suggested delivery profile that is generated by the processor may include as input values such as amount of carbs, user carb ratio, user's emotional state, activity level, physical conditions, etc. Hence, the suggested delivery profile that is produced by a portable infusion device of the present disclosure more closely represents the amount of insulin to be delivered over time at the time that amount of insulin is expected to be needed, thus more closely matching the amount of insulin on board at any given time with the amount of glucose present in the blood for that time.
Therefore, rather than merely having two basic delivery modes or profiles, such as a basal delivery profile that may be suspended and replaced by a bolus delivery profile, e.g., prior to when a user is about to eat, the delivery profiles of the present portable infusion devices may include a plurality of bolus delivery profiles that may be used in any combination to deliver a series of boluses. These profiles may be adjusted over time to account for a changing variety of variables such as insulin on board, food ingested, decay rates for both the insulin on board and insulin delivered, carb ratio, and the like. The boluses may be of equal size or of different sizes, in accordance with the delivery profile. In this manner, the present portable infusion devices are capable of more closely controlling the level of insulin in the bloodstream, and generating delivery patterns that resemble actual insulin needs rather than delivery patterns that are based on the limitations provided by the pump's mechanical delivery mechanisms.
For instance, due in part to their unique delivery mechanism(s) and/or programming, the portable infusion devices of the disclosure may be configured for delivering a series of multiple reduced size bolus deliveries of a fluid, such as insulin, so as to finely control the amount of that fluid in the blood, e.g., the amount of insulin on board (IOB). Thus the total amount of the fluid, e.g., insulin, delivered is an integrated amount determined by the graphical shape of the delivery profile curve for the series of multiple bolus deliveries. For example, the graphical shape of the delivery profile curve may represent the amount of insulin delivered over a period of time, where the x-axis of the graph represents the time, e.g., hours, minutes, actual time in user's time zone, etc., and the y-axis represents the amount of insulin, e.g., in units. Therefore, the rate of insulin delivery may be easily represented by a graph having a slope defining the delivery rate and the area under the graph totaling generally the amount of fluid delivered, or to be delivered, to the user. Hence, in this manner, the portable infusion device may more closely control the fluid, e.g., the amount of the medicament, such as insulin, in the user's blood stream by generally constantly modulating the boluses of the fluid being delivered. In addition, or alternatively, the modulation of boluses may be done on a non-constant basis, e.g., rapidly, intermittently, periodically, etc., as generally desired by a user.
The mechanisms, processors, and programs employed by current infusion pumps cannot account for the data input and/or to make the calculations and determinations sufficient to enable fine manipulations of the suggested delivery profile(s). Accordingly, although portable infusion devices described herein are capable of generating square or dual wave bolus delivery patterns, because of the dynamics of the systems described herein, such patterns are capable of being manipulated, even in real-time, by a user via, e.g., a touch screen display, so as to be adjusted according to any of a number of variables, as described above. For example, due in part to the programming of the present devices, the portable infusion devices described herein may calculate necessary volumes of insulin to deliver to a user in order to at least attempt to maintain a user's target blood glucose level, which is generated by accounting for various parameters entered by the user or external sources.
In this manner, for instance, with respect to insulin, a desired ideal delivery profile may be generated so as to match the insulin to be delivered with the amount of glucose in the blood given the present or predicted future conditions of the user taking into account such parameters as meals, meal complexities, exercise, absorption/clearance rates, decay rates, and the like. A benefit of the programming described herein may be that it allows for predicted events and provides for real-time corrections to medicament delivery if those predicted events so not correlate with or anticipate current conditions. Thus, the devices disclosed herein allow for generally predictive events so that an appropriate amount of insulin can be available in the blood at the time needed to account for the changing conditions of the user, and/or can be corrected real time. For example, the present devices allow for an estimate of medicament amount, rate, profile, etc. that will be needed in the future so that an appropriate amount of the medicament, e.g., insulin, needed to accomplish a desired function, such as process the now current glucose present in the blood, is generally readily available to the user.
Specifically, in some exemplary situations, the user may input data into the device pertaining to a meal to be consumed. The processor will process that information to generate an insulin delivery pattern, wherein the amount of insulin to be delivered is modeled on the predicted amount of glucose to be present at the time of its entering the bloodstream based on the inputted data and/or data accessed via the memory or remotely via, e.g., a network, for calculating the amount of insulin required. Hence, in such a situation, the portable infusion device system may account for such variables as the type and amount of food to be ingested, the amount of glucose, other sugars and carbohydrates, proteins and fat associated with such food, the decay rate of insulin, as well as the rate at which the food ingested is metabolized by the body for the food ingested. The data to be entered into the system of the device, therefore, may include one or more of the complex composition, as described above, of the meal (e.g., which may be a value range based on low, medium, or high complexity), and/or may include the amounts of carbohydrates, proteins, and fats to be consumed. The users current blood glucose level and/or glycemic index may then be input or may be calculated, the insulin duration and/or food (e.g., carbohydrate, protein, fat) absorption rates may be calculated, current or predicted activity levels, and variables related to present physiological conditions (e.g., stress levels) may be input into the device, any or all of which data may be used by the processor to generate a delivery profile that more closely represents desirable or ideal curve for insulin on board (IOB) over time, which is the amount of insulin remaining in a user's body over time due to any bolus deliveries of insulin to the user. The delivery profile generated may then be accepted and/or manipulated by the user, for instance, in an exemplary situation where the user predicts that he or she will be exercising within a certain period of time but never does. Accordingly, the delivery profile may be represented as a graph, such as a graph that displays the amount of insulin to be delivered over time, which graph may be capable of being graphically manipulated by a user.
For instance, the graphic representation may be a bar graph that indicates an amount of insulin to be delivered over a certain time interval, such as a four minute increment, for a given period of time, e.g., 1 hour, wherein each bars represents an aliquot of insulin to be delivered within the 4 minute time increments, and the height of the bar equals the amount of insulin to be delivered within that time frame, and further wherein the height of the bars may be manipulated by a user in response to present or predicted conditions. For example, in one embodiment, a series of bolus amounts of insulin to be delivered e.g., every four minutes, for a given time period, e.g. 1 hour, may be calculated, wherein the upper limit for the total amount of insulin to be delivered is fixed, but each individual bar, representing an amount of insulin to be delivered in a given 4 minute increment, is adjustable within a given range, so as to allow a user to have greater control of the amount of insulin being delivered over the given time period.
In some instances, a first graph may be displayed wherein the user is notified of the amount of insulin that is presently “on board” and expected to be “on board” over a given time period. A second graph may then be displayed showing a suggested amount of insulin to be delivered over a given time period, e.g. overlaid with the first graph or shown sequentially thereafter. The shape of this second graph may be capable of user manipulation, if desired. In certain embodiments, the systems disclosed herein may allow for complete manipulation of medicament delivery by a user with no limits, or, for safety and/or regulatory reasons may provide a range of data within which the medicament delivery may be so manipulated or altered. The user may, e.g., be prompted before making any or all such changes if they, for instance, calculated by the system to be dangerous, non-optimal, etc., such as with a message prompting the user to select a button before making such change and/or reading a message with information regarding possible effects of such manipulation before making such change. Alternative “lock out” features temporarily disabling the ability for such manipulation may be used as well as alarms or notification functionality for storing and/or transmitting data associated with such user-generated changes to a clinician, parent, etc. In some embodiments, although the shape of the graph is capable of being manipulated so as to change the delivery profile, the total area under the curve, and therefore the total amount of insulin to be delivered over time, is not changed.
In other embodiments, as indicated above, the graph may be a series of bars, wherein the width of each bar represents a time period, the height of each bar represents an amount of insulin to be delivered, and the number of bars represent a given time period for delivery. In such an instance, each individual bar may be capable of being manipulated, and in certain embodiments, the total amount of insulin to be delivered for the overall period could be limited such that an increase in one bar results in an a subsequent decrease in another bar for the given overall period. Additionally, a bar graph could be displayed wherein the insulin on board is represented as a function of activity, wherein the bars represent the amount of suggested insulin to be delivered, e.g., in 4 minute increments, and the bars are capable of being manipulated with respect to the amount of exercise to be engaged in. In such an instance, a decrease in activity level may require an increase in the amount of insulin to be delivered.
In another embodiment, the graphic representation may be a triangle bounded by three points that are variably selected, e.g., food to be ingested, historic blood glucose level, and activity level, wherein the output would be a given amount of glucose to be delivered over a given period of time, and further wherein the shape of the triangle may be modulated by the user to change the delivery profile. In a further embodiment, a delivery rate may be set forth graphically in a series of step, the steps could then be overlaid by a suggested rounded wave, and the user can manipulate the screen so as to configure the steps to model the shape of wave, e.g., rounding out the steps.
It is to be noted that although the above examples have been set forth with respect to the amount of insulin to be delivered in view of certain variables, such as time, activity level, user history, and the like, equivalent graphical representations could be set forth with respect to any of the above described variables. Further, although various graphical representations have been set forth, such as generally wave-from shaped graph, bar graphs, and generally triangular shaped graphs, such graphical representations are not meant to be limited hereby as other graphical representations could be used to convey the relationships between the various factors herein, and thus, the disclosed graphical representations are not meant hereby to be limiting.
As indicated above, the graphical representations are capable of being manipulated, for instance, by a user interacting with the device in such a manner as to produce a change in a characteristic of the graph. For instance, where the screen of the display is a touch screen, or touch sensitive display, the user may interact with the screen, e.g., by use of a finger, stylus, or other such instrument, so as to cause a change in the displayed representation. Hence, in certain embodiments, the display may be configured in any suitable manner that allows for the representation of data, which data may then be acted upon by a user so as to effect a change in the displayed representation. For example, in certain embodiments, the display is configured for displaying various forms of graphs, which graphs may be capable of being manipulated by a user's interaction therewith. Additionally, in certain embodiments, the display is configured for displaying a toggle representing a given quantity, which toggle may be scrolled through for the selection by the user of a determined representation of the quantity to be selected.
For instance, where the display is configured for graphical representation, the graphic representation may be configured for manipulation by a user touching or otherwise “clicking” the representation and dragging the representation in a predefined manner so as to change the form, e.g., height, width, shape, etc. of the representation. For example, where the graphical representation is a bar, the height or width of the bar may be adjusted by clicking on the appropriate dimension and manipulating it to adjust that chosen dimension. Where the graphical representation is a curve or wave, the curve or wave may be clicked and the shape thereof may then be manipulated, for instance, by dragging a finger across the screen in a predetermined manner. As the graphical curve or wave is manipulated by the user, data values corresponding to the curve values are changed.
Some embodiments may include a configuration wherein the graph includes a handle and spline, wherein the graph is capable of being manipulated by tapping the handle and moving the same to effect a change in the spline. Hence, in such manners as these, the graphs of the display, in certain embodiments, are capable of being manipulated, which allows a user to change, e.g., in real time, the delivery pattern of a fluid, for instance, so as to account for present conditions and/or future predictions, such as actual exercise levels and/or actual amounts to be eaten vs. predicted exercise levels and/or amounts actually eaten. In certain embodiments, the graphic representations may also include an auto correct feature, such as a feature that allows for a best-it curve correction, such as, e.g., an auto correct button.
Accordingly, the device may receive information from a user input and/or sensor or monitor input and based on this information may make a calculation of an amount of glucose present or about to be present in the blood. The results of these calculations can then be used generate an amount or rate of insulin to be delivered over a given period of time, which rate may be represented as a graph, such as a graph that can be manipulated by the user. Once the suggested amount, rate, delivery profile, or the like is presented to the user, the system may require the user to take an affirmative action, such as depressing a confirmation screen, before the device will deliver the medicament in response to the user's affirmative action.
For instance, in some exemplary embodiments, as can be seen with respect to
The portable infusion device 380 of the disclosure may also include one or more of a suitably configured power source; wire or wireless communication capability, such as for the remote sending and receiving of data, e.g., a transmitter and/or receiver, WIFI connection, infrared or bluetooth communication device, USB or SD port, flash drive port, or the like; GPS functionality; phone functionality; warning and/or alarm programming; music storage and replay functionality, e.g., an MP3 player; a camera or video mechanism; auto scaling capabilities, and/or one or more video type games. A USB connection may be used to charge the device and may allow the portable infusion device to display information from a program being run by the processor on the device onto the connected computer's monitor. Therefore, this may allow a portable infusion device to interact with any computer having a USB connector for at least downloading data onto the computer for subsequent use of the data, e.g., upload onto the internet, save data in computer's memory, view and/or modify device data using word processing, store the data in various media file formats, etc. This also relieves users from having to load installation software onto a computer prior to at least downloading data from the portable infusion device onto the computer.
The device may also include an accelerometer, for instance, which may be used for changing presented estimates, wherein instead of scrolling through a menu of options or using a numerical keypad, values can be input or changed via the accelerometer, such as by gesturing with or otherwise shaking the device. Further, the processor of the device may include additional programming to allow the processor to learn user preferences and/or user characteristics and/or user history data, for instance, to implement changes in use suggestions based on detected trends, such as weight gain or loss; and may include programming that allows the device to generate reports, such as reports based upon user history, compliance, trending, and/or other such data. Additionally, a device of the disclosure may include a power of or suspend function for suspending one or more functions of the device, such as suspending a delivery protocol, and/or for powering off of the device or the delivery mechanism thereof.
Some embodiments of an infusion system may include a portable infusion device, as described above and a remote commander device. In such an instance, the portable infusion device may include a suitably configured receiver and/or transmitter for communication with an external device such as a remote commander, as well as programming for directing the use of the device; and the remote commander may additionally include a suitably configured receiver and/or transmitter for communication with an external device such as a portable infusion device, as well as programming for directing the use of the device. For instance, the remote commander may include one or more of the functionalities described herein above with respect to the portable infusion device.
For example, the remote commander may include a processor, a memory, a transmitter and/or receiver, an input mechanism, an output mechanism, e.g., a display, a clock, a timer, an alarm, an estimator, and the like. Hence, in certain embodiments, the portable infusion device may include a transmitter that receives commands, e.g., infusion commands, from the processor and transmits the commands (e.g., to a remote commander or vice-versa). Similarly, the remote commander may include a transmitter that receives commands, e.g., infusion commands, from its processor and transmits the commands (e.g., to a portable infusion device or vice-versa). In such an instance, the portable infusion device and/or remote commander may also include a receiver that receives commands, such as remotely/wirelessly generated commands, and communicates the commands to the processor. Accordingly, the remote commander may include the appropriate hardware and software necessary for producing these functionalities in the remote commander, such as that described above with respect to the portable infusion device. The portable infusion device itself or the remote commander may also include programming that includes an initiating command request, whereby the user has to interact with the device, such as by tapping a screen, e.g., on a display of the portable infusion device or remote commander, so as to accept an infusion recommendation before the remote commander signals the portable infusion device and/or before the portable infusion device accepts the command and begins infusion of the fluid.
Some embodiments may be directed to a system for generating an estimate of an amount of fluid to be delivered to a body and for delivering the amount of fluid to the body of a user in accordance with the generated estimate. The system may include a remote commander and a portable infusion device. For instance, the system may include a remote commander configured for generating the estimate of the amount of fluid to be delivered to the body, and for communicating instructions for the delivery of the amount of fluid to the portable infusion device. Accordingly, the remote commander may include one or more of: a processor, for generating an estimate of an amount of fluid to be delivered to a body in response to user input data; a data input interface for communicating with the processor, wherein the data input interface is configured for receiving user input data; a memory coupled to the processor; for receiving and storing user input data; a display for displaying the estimate of an amount of a fluid to be delivered; and a transmitter for transmitting a command to a portable infusion device, wherein the command instructs the portable infusion device to deliver an amount of fluid in accordance with the generated and confirmed estimate.
Further, the system may include a portable infusion device that is configured for delivering the amount of fluid to the body in accordance with the estimate generated by the remote commander. The portable infusion device may include one or more of a reservoir, for storing the fluid; a delivery mechanism, for effecting the delivery of the fluid; a receiver for receiving instructions, e.g., commands, from the transmitter of the remote commander; and a processor, for instructing the reservoir and/or delivery mechanism to deliver the amount of fluid to the body of a user in accordance with the received instructions, e.g., the generated estimate.
Additionally, the housing of the device, e.g., the housing of the portable infusion device and/or reservoir and/or remote commander (if included), may be configured for containing at least a portion of one or more of a stylus, a lancet, and/or glucose sensing strips or other glucose sensing components. Additionally, the device may include a removable skin or other cover configured for protecting the device from the environment and/or breakage due to mishandling. One or more of these may also be included in a kit of the present disclosure.
Some embodiments may be directed to a method for using the above portable infusion device and/or remote commander so as to deliver an amount of a fluid, such as an estimated amount of fluid to a body of a user. The method may include providing an infusion device and/or remote commander, as described above, for instance, where the infusion device includes one or more of a reservoir, for storing the fluid; a delivery mechanism, for delivering the fluid; a processor, for generating an estimate of an amount of fluid to be delivered to the body in response to user input data, and for controlling the delivery mechanism; a data input interface for communicating with the processor, wherein the data input interface is configured for receiving user input data; a transmitter and/or a receiver, for transmitting and receiving commands; and a display for displaying the estimate of an amount of a fluid to be delivered. If a remote commander is provided, the remote commander may include one or more of a processor, for controlling the remote commander and/or generating an estimate of an amount of fluid to be delivered to the body in response to user input data; a data input interface for generating commands and communicating with the processor, wherein the data input interface is configured for receiving user input data, such as a user command; a transmitter and/or a receiver, for transmitting and receiving commands; and a display for displaying the command and/or an estimate of an amount of a fluid to be delivered.
The method may further include inputting externally supplied values into the data input interface, such as a data input interface of the portable infusion device and/or remote commander wherein the data input interface is configured for receiving the user input data and communicating that data to the processor and the processor is configured for receiving the user input data and/or generating an estimate of an amount of a fluid to be delivered to the body of the user, and further configured for communicating the estimate to the display and/or to the portable infusion device or remote commander (if included). For instance, the user input data may include one or more of a blood glucose level, a stress level, a physiological condition, a complexity of a meal to be ingested, an activity level, a user history profile, or the like. The method may additionally include one or more of receiving the generated estimate of an amount of fluid to be delivered on a display of the portable infusion device and/or remote commander; receiving a request for a user input on a display of the device, such as wherein the request requires the user make a selection before delivering the amount of fluid to the body of the user; and making a selection based on the estimate; wherein, once the selection is made (if required) the device delivers the quantity of fluid to the body in response to the selection.
Some embodiments may be directed to a kit which kit may include a device and/or a system for the infusion of a medicament as described herein above. Specifically, the kit may include one or more of a portable infusion device, a reservoir, a remote commander, as well as instructions for using the same, and may include an aliquot of the medicament, e.g., insulin to be delivered, as well as infusion set tubing. The instructions may be in written, audio, or pictorial form and may be included in a written manual and/or on an instruction CD or DVD, MP3 file, or accessible via a network. In certain embodiments, a training video may be included, for instance, on a separate DVD or other medium, may be accessible via a network, or may be included as programming on the portable infusion device and/or remote commander. For instance, in certain embodiments, the portable infusion device and/or remote commander may include a training module. The training module may be included as programming accessible by the processor of the device, wherein the software is configured to instruct a user in the proper use of the device.
In certain embodiments, the programming may be interactive, thus, the software may include steps of tasks (e.g., such as loading a reservoir, entering data, or using an estimator) that must be accomplished to show mastery of the use of the device and/or may include additional programming that prevents a user from moving on to the next step before mastering the present steps, such programming may be automatically erasable after the tasks of the steps have been completed thereby expanding available memory. The programming may include one or more of an automated mascot, an electronic protocol, preloaded or downloadable video training, as well as instructions for how to use the device and/or specific features of the device. Additionally, the remote commander and/or portable infusion device may include one or more indicators and/or alarms, such as an alarm that indicates when a command, e.g., a user input, is being received, has been received, and/or is being or has been implemented by one or both of the remote commander and portable infusion device. The indicator and/or alarm may be a visual indication, auditory indication, tactile indication, and the like.
It should be noted that some or all of the suitable features, dimensions, materials and methods of use of the GUI 166 may be used or incorporated into any other infusion system, or components thereof, discussed herein. As discussed in an embodiment above, the screen of the display 450 may be a touch screen 450. For example, a touch screen 450 may have a 320×240 pixel QVGA display, 16 bit color depth, and a rectangular shaped display area having a diagonal length of 2.5 inches. However, the touch screen 452 display 450 of the portable infusion device 110 may have any variation of display characteristics and configurations, e.g., 128×64 to 1280×1024 pixel resolution, 16 to 32 bit color depth, and a diagonal display 450 length of 1 to 3 inches. The user may interact with the touch screen 452 by touching the touch screen 452 (e.g., by use of finger, stylus, or other such instrument), so as to cause a change in the display representation. The user-interactive touch screen 452 also assists in providing the user with a user-friendly graphical user interface (GUI) 454, which can be used in GUI 166 in the embodiment discussed above. In addition, the GUI 454 may be used in combination with any of the infusion device embodiments described herein for controlling the delivery of one or more fluids to a user, or patient. User-friendly GUI 454 embodiments discussed herein may include any means and/or methods for interacting with the portable infusion device 110, or any device associated with the portable infusion device 110, through direct manipulation or commands.
One possible advantage of some portable infusion device 110 embodiments may be the ability to provide a user with generally improved usability. This has been achieved by integrating a user-centered GUI 454 design that may provide an interface having at least one display screen representation or page 456 that reduces user-error and enhances the efficiency and user satisfaction of the device 110. It may be a benefit for some embodiments to offer generally complex programs in a portable infusion device 110 for assisting in the delivery of insulin that best serve the user's insulin needs. As discussed above, in order to optimize the delivery of insulin to best serve the user's insulin needs, a number of factors must be taken into account for determining the user's present and predicted future insulin needs. Therefore, the GUI 454 of the portable infusion device 110 may provide a user with enhanced usability for interacting with the device 110 in order to customize deliveries of insulin that best meet the insulin needs of the user.
Some embodiments of the portable infusion device 110 may also include multiple other capabilities in addition to delivering one or more medicaments (i.e., insulin). For example, the portable infusion device may be capable of interacting with a personal computer (PC) for uploading and downloading data, various file types (e.g., JPEG, PDF) and programs. The portable infusion device 110 may also access and send information wirelessly to a PC or other electronic device (e.g., printer, memory storage device). These functions, for example, may be particularly beneficial to a user for sending and receiving information to a physician, or uploading new or upgrading current programs onto the portable infusion device 110. Furthermore, the portable infusion device 110 may have instructions, or accessible by the user and/or processor 170 for converting information on the device 110 into various file formats, e.g., portable document format (PDF), word processing documents, JPEG, etc., which may be distributed and shared among various electronic devices. The GUI 454 of the portable infusion device assists in improving the usability of at least these capabilities. In addition, some GUI 454 embodiments may be available to a user by downloading a software application onto the user's cell phone and/or PDA, which would allow the user to use their cell phone or PDA as a remote commander to the portable infusion device 110.
Some GUI 454 embodiments discussed herein, including the GUI 454 shown in
With improved usability, a user may be enticed to interact with the portable infusion device 110 in order to use the device to a greater degree than what is typically experienced with past and present infusion devices. In some cases, there is a need for portable infusion devices with improved usability so that users do not simply “set-it-and forget-it,” as what is often done with other infusion devices because users may find them too difficult, time consuming, and/or confusing to operate. When a user “sets-it and forgets-it,” the user of the infusion devise relies on a small number of generally generic delivery profiles that do not fully represent the user's present and future insulin needs. Therefore, some of the GUI 454 embodiments discussed herein may at least improve upon some of the past and present deficiencies of infusion devices by providing a portable infusion device with improved user friendliness.
In addition, some of the GUI 454 embodiments discussed herein may at least improve a physician and/or clinician's ability to respond to a patient's needs. For example, a user of the portable infusion device may inform a physician of a problem the user has been experiencing, e.g., chronic fatigue, mood swings, large swings in BG levels, etc. The physician may then analyze any of the delivery profiles 458 programmed in the user's device 110 to determine which of the settings to modify in order to try and improve the user's wellbeing. For instance, by viewing the delivery profiles 458, the physician may be able to determine that one of the delivery profile settings is programmed too low, which may have been contributing to not enough insulin being delivered to the user. Therefore, the physician may then directly modify the setting, e.g., increase the setting value, that was determined to be programmed too low. As will be discussed in more detail below, some embodiments of the GUI 454 enable a user, or the user's physician, to view multiple settings across multiple time spans within at least one delivery profile 458, which may be displayed on a single touch screen 452 display 450 (as shown by way of example in
At least a part of the GUI 454 includes an information architecture 460 and a hierarchy of pages (or display representations) 456 that assist the portable infusion device 110 in interacting with the user by collecting and displaying information, as well as guide a user on how to use the device 110. The information architecture 460 may provide a general roadmap for accessing a variety of programs and information accessible by the control unit, or processor 170, of the portable infusion device 110. A user is generally able to interact with the GUI 454 to set up, for example, customizable insulin delivery profiles 458 based on the user's current and predicted future insulin needs. This may be accomplished, at least in part, by a user navigating through one or more infusion workflows, or protocols embedded within a program accessible by the processor 170 of the portable infusion device 110.
An infusion workflow 464, or protocol, may be at least part of a program that, when executed by the processor, assists a user to at least program or control the portable infusion device 110 and/or at least one operation comprising enter, change, confirm, or view various information within the device 110. Any part of a workflow 464 or protocol may include any number of queries for prompting the user to enter, modify, or confirm information, which are typically presented to the user on the display.
For example, a program accessible by the processer that includes an infusion workflow 464 or protocol may enable a user to program the portable infusion device to deliver insulin to the user. In addition, an infusion workflow 464, or protocol, may present the user with a number of understandable queries for allowing the user to enter, confirm or modify information regarding the physiological conditions of the user. For instance, queries presented to a user during the execution of a program may enable a user to set various settings within the portable infusion device (e.g., the time, date, or one or more alarms) and/or enter information about a users present or predicted conditions (e.g., blood glucose level, physiological conditions, food to be ingested, etc).
In some embodiments, the linear approach of a workflow 464, or protocol, for programming the portable infusion device is at least limited. As an alternative approach, the user is instead provided with a virtual form 462 displayed on the touch screen 452 display 450 for the user to complete. A virtual form 462 enables a user to directly select and manipulate one or more parts of a displayed virtual form 462, with each part generally representing a setting. In this way, a user is not required to navigate through a generally linear workflow 464 or protocol and/or prompted with a series of queries. Instead, the user is presented with generally a single page 456 where the user completes the virtual form 462 in order to initiate a programmed delivery of insulin, as will be discussed in greater detail below and shown by way of example in
Some GUI page 456 or screen representation embodiments of the GUI page hierarchy enable a user to easily access and view one or more settings and information within the portable infusion device. A single page 456 may include one or more objects 466 simultaneously presented on the touch screen 452, where an object 466 may be any number of text, numbers, graphs, pictures, video, or combination thereof which display understandable information to a user. The information may have been entered by a user and/or presented by the portable infusion device 110, and may at least be one of information regarding the amount of insulin already present in the body, e.g., insulin on board; blood glucose level; trending glucose level; insulin sensitivity/insensitivity; glycemic index; metabolism; metabolic rate; stress level; physiological conditions, e.g., age, health, sickness, diurnal cycles, etc; measurable parameters: hormones, steroids, etc.; pharmacokinetics of the medicament, e.g., age of insulin, decay rate, etc.; food to be ingested, e.g., carbohydrates, proteins, fat; activity; use history; calendared events; environment, e.g., temperature, humidity, pressure, etc.; and the like. An object 466 may represent any number of information without departing from the scope herein, and may also be in the form of a pictogram to generally intuitively represent, for example, a program, file, user, setting, status, profile, action or other entity discussed herein.
Furthermore, any object 466 may be a soft key so that when the user touches the object soft key, the “selection” of the object 466 is communicated to the processor. How the processor 170 interprets the selection of an object 466 depends, at least in part, on which program is currently executing and what the selected object 466 represents. For instance, selection of an object 466 may be processed by the processor 170 such that the user is given an opportunity to modify displayed information, or the user may be directed to another page 456 within the GUI page hierarchy. Various examples of programs, workflows 464, displayed objects 466, and user selections of objects 466 displayed on the portable infusion device 110 display 450 will be described in more detail below.
By way of one example, an object 466 displayed on the touch screen 452 may represent the number of units of insulin programmed to be delivered to the user. In addition, this object 466 may be a soft key so that when the user selects the object 466, the user is given the opportunity to modify the number of units of insulin programmed to be delivered to the user. The number may be modified by a variety of operations. For example, the display may show a virtual keyboard or keypad 500 for actuation, or may receive input through multi-touch techniques, or may receive input through actuation of a physical button or keypad (not shown). One possible advantage of some embodiments may be that multiple objects 466 may be simultaneously displayed on the touch screen 452 of the portable infusion device 110, including any one of which may be a soft key, so that any one of the multiple modifiable objects 466 simultaneously displayed may be directly manipulated by a user. Moreover, the user can view values of multiple parameters, such as parameters comprising a delivery profile 458, on a single display screen 450 or page 456. Therefore, a user is not limited to having to scroll through more than one page 456 to view, enter, or change, for example, a value, range, graph, or any object 466 representing any number of information entered by the user or presented by the portable infusion device 110.
GUI 454 embodiments of the portable infusion device may serve multiple purposes, including informing the user about various settings, activities, and/or statuses relating to the device, as well as providing a means for the user to enter, confirm, and/or modify displayed settings and/or values. Furthermore, the GUI 454 may also provide the user with video or animated graphics to enhance the ability to instruct or inform a user and improve usability. For example, animated graphics and/or video may be displayed on the touch screen 452 to assist in instructing the user on how to operate the portable infusion device 110, such as load insulin into the device 100.
The GUI 454 of the portable infusion device 110 may also include any number of features for assisting in preventing the user from entering, changing, or accepting any information that may be incorrect. For example, the user may be presented with confirmation pages and/or queries where the user is required to confirm one or more presented information. Some GUI embodiments of the portable infusion device may also prevent the user from selecting one or more objects 466 displayed on the touch screen 452 in order to prevent the user from selecting or entering incorrect information, as will be discussed in more detail below. Some GUI embodiments of the portable infusion device may prevent unauthorized access to accommodate at least privacy, HIPPA regulations, and/or other concerns. For example, passwords, biometric sensors, etc., could be incorporated in the portable infusion device system as well as encrypted processors and data transmission to assist in added security and/or privacy of the device.
GUI 454 embodiments may also interact with a variety of pre-programmed or user programmed alarms integrated in the portable infusion device 110 for at least assisting in alerting the user and/or preventing user error. For instance, the portable infusion device may utilize the GUI 454 to present important information to the user as to the status of the device (e.g., battery life, remaining medicament in the cartridge, occlusion in the fluid line, etc). For example, the portable infusion device 110 may warn the user by changing one or more colors on the display screen 450 of the portable infusion device 110 to alert the user. Alternatively, or in combination, the portable infusion device 110 may alert the user by sounding an alarm (e.g., a beeping noise) or vibrating the device. The user may program the portable infusion device 110 to alert the user for various reasons relating to at least one of a physiological measurement and/or a portable infusion device status. For example, in the context of insulin delivery, a user may program the portable infusion device to alert the user when a predetermined amount of insulin, e.g., one hundred units, fifty units, twenty-five units, or any number of units of insulin remain in the portable infusion device for dispensing.
Turning now to the figures,
The “home” 472 location of the
In addition, once a bolus delivery has been setup, a bolus object 482 may also include a bolus status indicator 492 that provides feedback to the user regarding the programmed bolus delivery of insulin. For example, the status indicator 492 may provide feedback as to how much of the bolus has been delivered to the user. The bolus status indicator 492 may display the total bolus volume of insulin to be delivered (shown by way of example as 0.7 units). The bolus status indicator may also provide animated feedback, such as an animated indicator line 494 or bar that moves in a generally intuitive manner such that the status of the bolus delivery is generally understood by the user. Furthermore, feedback may be provided to a user for any number of reasons and may be portrayed to a user in various configurations, e.g., one or more blinking lights, color changes on the display 450, etc.
For example, the animated indicator line 494 may travel from one side to the other of the bolus status indicator 492 as the bolus is delivered to the user. By way of further example, as the animated indicator line 494 moves, the color on one side of the animated indicator line 494 may be a different color than the other side such that it is generally intuitive to a user as to the status of the bolus delivery. Therefore, the bolus status indicator 492 may provide efficient and user-friendly information that is easily accessible for a user to view and understand the status of a insulin being delivered.
A user may enter the amount of carbs or volume of insulin in order to assist in programming the portable infusion device to deliver generally an appropriate bolus of insulin based on the amount of food the user has predicted to consume, which may also be referred to as the food or meal bolus. If the device 110 is programmed for the user to enter the number of carbs, the processor 170 may use a carb ratio (the amount of insulin delivered for every X number of carbohydrates consumed) to determine the food bolus of insulin to deliver to the user. In addition, a user may program the device 110 to prompt the user to enter any one or more of a variety of information to determine an appropriate food bolus, which may generally depend on the type of information the user wants to enter. For example, the user may program the device 110 to prompt the user to enter a blood glucose level and the number of carbs predicted to be consumed for programming a food bolus. Therefore, the portable infusion device 110 enables a user to customize the device 110 regarding what type of information the user will be prompted to enter for programming at least a bolus of insulin.
Additionally, and shown by way of example in
For instance, a virtual keypad 500 may be presented with queries in the text entry field 504 (such as the “enter insulin” query presented in the test field in
Although the virtual keypad 500 illustrated in
As illustrated in
Alternatively, the portable infusion device 110 may include a feature that either continuously or selectively reads the user's blood glucose level directly. If the portable infusion device 110 includes such a feature, the user would not have to enter a blood glucose level and would not be presented with the third query 516. Instead, the blood glucose monitoring feature would input the user's blood glucose level automatically into a workflow or protocol, as necessary, or simply require the user to confirm a blood glucose level gathered from the blood glucose monitoring feature.
The fourth query 518 of the bolus workflow, may ask the user whether the user would like a correction bolus. A correction bolus may be used to deliver additional insulin in order to reach the user's programmed target BG level (the BG level the user would generally optimally like to have). If the user chooses not to have a correction bolus, the user is directed to a bolus confirmation page 514, as shown in
Once the user has either skipped or entered information for at least one of the first five queries 498, 512, 516, 518, 520 of the bolus workflow 490, the user is presented with a bolus confirmation page 514.
One benefit of embodiments discussed herein may be that any one of the objects presented on the bolus confirmation page 514 may be a soft key for allowing a user to modify any one of the objects as well as decide whether a standard or extended bolus is the appropriate delivery profile. For example, the total units object 530 displayed on the bolus confirmation page 514 may be a soft key so that when a user touches, or selects, the total units object 530, the user is then able to modify the total units of insulin programmed to be delivered.
By way of further example, if the user touches the total units object 530, the user may be directed to a new page 456 displaying a virtual keypad 500 to enable a user to enter an appropriate number. Once the user enters an appropriate number, the user would then be directed back to the bolus confirmation page 514. Alternatively, the user may not be directed away from the bolus confirmation page 514 to modify an object. For example, a user may touch either the total units object 530 on the bolus confirmation page 514 and be given a visual or audible indicator (e.g., flashing total units object, a color change of the total units object, and/or an audible indicator) to inform the user that the total units of insulin may be altered. The user may then touch the “plus” object 532 or “minus” object 534 (as shown in
By way of another example, a user may select the edit object 536 soft key on the bolus confirmation page 514 which allows the user to alter one or more subsequently touched objects 466 displayed on the bolus confirmation page 514. An edit object 536 soft key may be displayed on any page 456 in the GUI page hierarchy for modifying one or more modifiable objects 466, as described above. Furthermore, any modifiable object displayed on the touch screen 452 display 450 of the portable infusion device 110 may be selected and modified by a user using any method and/or means described herein.
As discussed above, the bolus confirmation page 514 displays more than one modifiable object generally related to the programmed delivery of a bolus of insulin to a user. One possible advantage of some GUI embodiments of the portable infusion pump may be the ability to view and directly modify more than one modifiable object displayed on the touch screen 452. Because GUI 454 embodiments may be able to display multiple settings that may be directly manipulated by the user, the user is not required to memorize stored entries and navigate through multiple pages 456 to at least view or modify a setting. The ability of the GUI 454 of the portable infusion device 110 to provide this feature may improve the usability of the device and reduce user error.
In addition, the bolus confirmation page 514 also offers the user the option to select a standard or extended bolus by touching either the standard bolus object 522 or extended bolus object 524, respectively. As illustrated in the bolus workflow 490 example
If the user chooses a standard bolus (e.g., by selecting the standard bolus object 522 followed by the deliver object 540), the user may then be presented with a bolus delivery confirmation page where the total units of insulin to be delivered to the user is displayed along with a countdown timer 542 and a cancel object. The countdown timer 542 may begin at any time duration, either set by the user or pre-programmed in the portable infusion device 110, to allow the user some time to cancel the delivery of the bolus, e.g., by selecting the cancel object. The countdown timer appears on the display 450 and begins to countdown to zero at about the same time the bolus delivery confirmation page appears on the touch screen 452. By way of further example, the countdown timer 542 may begin at five seconds, thus giving the user about five seconds to decide whether to select the cancel object to cancel the programmed bolus delivery of insulin.
Once the countdown timer 542 counts down to zero time, the processor 170 instructs the delivery mechanism 384 or 132 of the portable infusion device 110 to deliver the programmed bolus of insulin to the user. If an emergency exists, for example, and the user wants to attempt to stop the insulin being delivered to the user after the countdown timer reaches zero, the user may hard-stop the portable infusion device by powering off the device. The countdown timer 542, along with the displayed total volume of insulin to be delivered and a cancel object 544, may provide a user with a further opportunity, in addition to the bolus confirmation page, to generally ensure a proper amount of insulin is being delivered to the user. A countdown timer 542, along with a cancel object 544, may be displayed to a user on the touch screen 452 display 450 prior to any delivery of insulin to a user and is not limited to only prior to the delivery of a standard bolus. It may be a benefit of some embodiments to provide the user with multiple opportunities to view and modify insulin delivery settings in order to at least improve the usability and reduce user error of the portable infusion device 110.
Alternatively, to the standard bolus, the user may choose to have an extended bolus delivered (e.g., by sequentially selecting the extended bolus object 524 followed by the deliver object 540 on the bolus confirmation page 514). The user may then be directed to an extended bolus setup page 546 where the user is presented with multiple modifiable objects representing settings relating to the delivery of an extended bolus.
A user who decides to have an extended bolus of insulin delivered may define a number of units to be delivered immediately upon completion of the extended bolus delivery setup, as well as a defined number of units delivered over a defined duration. This customizable delivery profile may benefit the user by delivering insulin generally more equivalent to the user's insulin needs over a period of time, which may be due to any one of the various factors influencing a body's insulin needs, as described above.
One advantage of a portable infusion pump 110 for medicament delivery in general and specifically in the context of insulin is the ability to deliver such complex and customizable insulin delivery profiles 458 to a user that would be extraordinarily difficult, if not impossible, to achieve with standard syringe delivery methods currently used by a significant number of diabetics. As the complexity and customization of insulin delivery devices increase in order to provide users with improved delivery profiles, so may the user errors. Again, it may be a benefit of some embodiments to provide a GUI 454 with improved usability, which include the ability to simultaneously present multiple modifiable settings for a user to either view or modify. Therefore, this may allow embodiments of the portable infusion device 110 to provide the user with complex insulin delivery profiles 458 that generally better serve the user's insulin needs, while also reducing user error by providing the user with condensed and easily modifiable information pertinent to the delivery profiles 458.
Similar to the standard bolus setup described in the example above, once a user has completed viewing and modifying any information presented on the extended bolus setup page 546, the user may select the deliver object 540 to initiate the delivery of the extended bolus. As illustrated in
Another feature of the portable infusion device 110 for assisting in preventing an undesired volume of insulin delivered to a user is referred to herein as the dynamic error prevention feature 560. The dynamic error prevention feature 560 of embodiments may assist in preventing a user from incorrectly selecting one or more objects 466 displayed on the touch screen 452 display 450. For example, and illustrated in the insulin delivery example of
For instance, in the context of insulin delivery, the user may have programmed the portable infusion device 110 to limit the allowable volume of insulin to be delivered over a specified duration. Therefore, if the user programmed the portable infusion device 110 not to allow more than twenty-five units of insulin to be delivered over the period of an hour, the virtual keyboard 500 would not allow the user to initially select any of the virtual keys 502 corresponding to a value greater than two. If the user selected a virtual key 502 displaying a one or a two, the number would appear, for example, in the text field 504 on the display 450. However, if the user attempted to select an object 466 displaying a number three, or greater than three, either no number would appear in the test field 504 and/or a warning may be displayed on the display 450 for informing the user that the selection is not acceptable. Because this feature is dynamic, after the user selects an acceptable entry, the deactivated and activated objects may change. Therefore, if the user selects an object 466 displaying a one or a two, as described above, any object 466 displaying a number less than or equal to five would be activated for user selection while any object 466 displaying a number greater than five would be deactivated. Therefore the user would be prevented from entering a value greater than twenty-five, as previously defined by the user. Furthermore, after the user selects a second acceptable entry, at least all of the numeric virtual keys 502 would be deactivated such that the user would only be able to select the delete 508, enter 506, back 510 or skip 510 objects in order to prevent the user from selecting an entry greater than twenty-five. Therefore, the dynamic error prevention feature 560 assists in preventing the user from entering an undesired value, and may be used to generally limit a user's available selections on the touch screen 452 display 450. In addition, the dynamic error prevention feature 560 advantageously assists in relieving the user from having to read an error message and then go back and re-enter a new setting value. This may benefit the user by eliminating time wasted due to entering values that are programmed to be unacceptable.
The dynamic error prevention feature 560 may also improve usability by relieving the user from having to recall what had been previously determined to be appropriate limits of various settings, for example, while being consulted by a physician. Therefore, a physician, physician's assistant, nurse, certified diabetes educator, etc., may assist a user of the portable infusion device to store acceptable parameters to any number of settings modifiable by a user so that a user does not later attempt to program a user modifiable setting that is out of the user's appropriate range.
In addition, some GUI 454 embodiments may display the activated and deactivated objects such that they are visually distinct from each other to a user viewing the display. For example, the deactivated objects 562 may appear darker in color and/or less illuminated than the objects acceptable for selection. The visual distinction may assist in preventing a user from wasting time attempting to select objects that are deactivated and unable to select this may improve the efficiency and user satisfaction of the portable infusion device 110.
A delivery profile object 488 may display one or more items of information relating to the history, current status, and/or programmed future status of the delivery of insulin from the portable infusion device 110. In addition, the one or more items of information displayed within a delivery profile object 488 may be presented in numerical, textual, graphical and/or symbolic form. Additionally, as described above, where at least a part of the display 450 is configured for graphical representation 570, the graphic representation 570 may be configured for manipulation by a user touching or otherwise “clicking” the representation 570 and dragging the representation 570 in a predefined manner so as to change the form, e.g., height, width, shape, etc. of the representation.
A delivery profile object 488 may display information relating to the status of the pump, where the user is informed that all deliveries have been stopped, or what name or type of delivery profile 458, or personal profile, is currently being delivered to the user. As illustrated by way of example for insulin delivery in
In general, a user may select among different home screen page representations and configurations for displaying various information in a variety of forms, e.g., graphical, numerical, textual, symbolical. This feature enables the user to customize the home screen page 474, 564, 566, 568 so that it generally displays information that is of particular interest to the user. Additionally, it allows the user some freedom to select what information the user would like to view in combination on the display screen 450. As discussed above, it may be a benefit of some embodiments to provide the user with the ability to view multiple selectable and/or modifiable objects 466 simultaneously displayed on the display screen 450 for comparing and directly manipulating one or more of the displayed information. A user may access a setup screen or initiate an administrative process that provides the user with options 572 for setup, as indicated in the hierarchy of
For instance, when the portable infusion device 110 is generally fully charged, all four of the indicator bars 576 may be a particular color and/or illuminated such that it is generally intuitive to a user that the portable infusion device 110 is fully charged. As the portable infusion device 110 consumes power, one or more indicator bars 576 may change in appearance, such as its color, brightness, or it may no longer illuminate. This change in appearance allows the user intuitively to understand that the portable infusion pump is no longer fully charged, as well as approximately how much battery life remains (e.g., percentage of full charge or time remaining) in the device. In addition to symbolic identifiers, such as indicator bars 576, any number of numerical, textual, symbolic and/or graphical representations may be displayed in the delivery status indicator for informing a user as to the status of any number of conditions of the portable infusion device.
Some portable infusion device embodiments may also alert a user (e.g., sound a noise, vibrate the device, flash the display screen) when the status of any number of device conditions reach a pre-programmed or user-defined condition level, or condition state. For example, the user may program the portable infusion device 110 to alert the user when the cartridge contains less than fifty units of insulin. By way of further example, the portable infusion device may also alert a user by any means described herein to inform the user when a programmed delivery of insulin is interrupted for any reason; that the maximum allowable delivery of insulin for a user has been reached, that a user profile and/or insulin delivery profile setup information is incomplete, that the insulin cartridge was not correctly loaded into the housing, that the insulin cartridge is empty, that there is an occlusion preventing delivery, that the system is malfunctioning, and/or any condition appropriate for alerting a user as to the status of the portable infusion device 110. Any one of the alerts may be customized by the user to alert at user-defined condition levels, or conditional states, in generally any way that the user prefers (e.g., vibrate the device, sound a noise, flashing display, etc.). As broadly illustrated by way of example in the information architecture 460 in
In addition, a selectable help object 466 may appear on any page within the GUI page 456 hierarchy that, when selected by a user, directs a user to a help page. The help page may be a generic help page, which may describe general instructions on how to use the device 110. Additionally, a help page may be tailored to the page 456 from which the help object 466 appeared on. For example, a user who selects a help object 466 on a bolus confirmation page 514 would be directed to a help page displaying at least information regarding how to set up the device 110 to deliver a bolus of insulin. Furthermore, one or more help objects 466 may be displayed on a single page being displayed on the touch screen 452 display 450, with each help object 466 relating to various help information, e.g., definitions of settings, instructions on how to execute a function, etc.
The options page 588 may also include a history object 592 that, when selected by a user, directs a user to be able to view one or more history profiles that may include any number of information relating to a delivery of insulin that was made to a user (e.g., time and duration insulin was delivered, units of insulin delivered, physiological conditions recorded, etc.). Generally, any information entered by the user, processed by the processor 170, or sensed by the device 110 may be stored in memory 172 and recalled by the user in one or more history profiles.
Additionally, the options page 588 may list a load object 594 that, when selected by a user, may direct a user on how to load and unload a cartridge into a housing of the portable infusion device 110; fill the infusion tubing with fluid to be delivered to a user; and fill a cannula with fluid to be delivered to a user. Generally, selection of the load object 594 by a user allows a user to prepare the device 110 for proper delivery of insulin after loading a cartridge into the housing of the portable infusion device 110. As mentioned above, video and or animation 584 may be displayed on the touch screen 452 display 450 for assisting in informing and instructing a user on how to do any of the aforementioned tasks, with or without audio accompaniment.
A user may also select the temp rate object 596 on the options page 588 to allow a user to set a percentage of the current basal rate to be delivered for a temporary period of time. For example, a user may want to program a temp rate of eighty percent for a period of two hours because the user is planning to exercise for an hour. After the defined period of time is over, the portable infusion device 110 returns to the basal rate that was set prior to activation of the temp rate.
The options page 588 also allows a user to initiate the programming of one or more delivery profiles 458. Depictions of various delivery profile setup pages 598 are shown in
By way of example, and broadly shown in
In some embodiments, the max basal may be programmed in the device 110 to be a factor of the programmed standard basal rate. For example, once a standard basal rate has been programmed in the device 110 for a particular user, the device would generally automatically determine a max basal based on the programmed basal rate. By way of further example, the max basal may be calculated to be 1.5 to 3 times the standard basal rate, or profile basal rate. This may provide an additional safety feature by preventing a user from delivering too large of a bolus from the device 110.
As illustrated in
As illustrated in
As illustrated in the personal delivery profile workflow 600 in
The final steps of setting up a new personal delivery profile 604 include defining an insulin duration and a bolus delivery value, as illustrated in the personal delivery profile workflow 600 in
The user may then be directed to a food bolus setup page 640, as illustrated in
The final steps a user may make in setting up a new personal delivery profile 604, for some embodiments, such as those illustrated here in the insulin delivery context, may be to select to have the quick bolus feature “on” or “off,” which may also be the tenth query 650 in the personal profile delivery workflow 600. If the user chooses to turn the quick bolus feature “on,” the user must define the increment of a quick bolus (either in grams of carbohydrates, or units of insulin). A quick bolus, as will be discussed in more detail below, allows a user efficiently to deliver a bolus quickly defined by the user. By way of example, the portable infusion device 110 may include a hard button (not shown) positioned at a convenient location for the user to simply press at least once to activate the delivery of a quick bolus to the user. Once the user has defined the quick bolus increment, the user has generally completed setting up the new personal delivery profile 604 and is able to save the personal delivery profile 604 for either immediate use or to be activated at a later time. By way of example, the portable infusion device 110 may be able to save any number of different personal delivery profiles 604 for a user to save and select for activating at any time. In one embodiment, the portable infusion device may be able to save up to 10 or more different delivery profiles. In another embodiment, the portable infusion device may be able to save up to 8 different delivery profiles. In yet another embodiment, the portable infusion device may be able to save up to six different delivery profiles.
As mentioned above, the portable infusion device 110 may include a quick bolus delivery function which allows a user to quickly deliver a bolus of insulin to a user. Depictions of various quick bolus delivery configuration pages 652 are shown in
Once the user presses and holds the hard button, a quick bolus delivery configuration page 652 is displayed on the touch screen 452 display, as illustrated in
For example, a user may have defined a quick bolus increment to be five grams, and a carb ratio of 0.5 units of insulin for every five grams of carbs. Therefore, each time the user presses the hard button in response to the first query 654 of the quick bolus workflow 651, the grams of carbohydrate increase by five grams and the units of insulin increase by 0.5 units. Therefore, if the user presses the hard button three times in response to the first query 654 of the quick bolus workflow 651, the quick bolus programmed to be delivered to the user would be 1.5 units of insulin, as shown by way of example in
Once the user has completed defining the number of units to be delivered in the quick bolus, the user is prompted with a second query 656, as illustrated in
Alternatively, a user may define a quick bolus increment in terms of units of insulin so that each time a user presses the hard button in response to the first query of the quick bolus workflow 654, the quick bolus volume is increased by the defined units of insulin. Therefore, a user may define a quick bolus increment to be one unit, so that each press of the hard button in response to the first query 654 in the quick bolus workflow 651 increases the quick bolus by one unit. Although described by way of example as pressing a hard button, any number of user interactions with the portable infusion device 110 may be completed by the user to define and initiate a quick bolus. A quick bolus may be defined while programming one or more personal delivery profiles 604 so that when a particular personal delivery profile 604 is activated, the volume of a quick bolus depends on what the user programmed the volume of a quick bolus to be for that particular personal delivery profile 604. Alternatively, the device 110 may have a universal quick bolus volume that may be defined by the user, which is not dependent upon the currently activated personal delivery profile 604. Instead, when the user activates the delivery of a universal quick bolus, the volume of the quick bolus will always be the same, regardless of which personal delivery profile 604 is activated. This may be an additional safety feature of the portable infusion device 110, because it generally relieves the user from having to at least be aware and recall what personal delivery profile 604 is currently active and what the volume for the quick bolus was programmed for the active personal delivery profile 604. For example, with a universal quick bolus, the user may be able to know that each time the user presses the hard button while setting up a quick bolus, the volume increases by five units, regardless of which personal delivery profile 604 is currently active.
An additional feature of the portable infusion device 110 includes a bolus delivery delay feature, which allows a user to at least define a bolus delivery volume, as well as define a delay in time before the bolus is delivered. For example, once a user has defined the bolus delivery (either by way of entering predicted carb intake or directly entering units of insulin), a user may either define a later time to start the bolus delivery (e.g., bolus delivery starts at 2:00 pm), or a time delay (e.g., bolus delivery starts in one hour). This feature may be particularly beneficial to children who may be more sensitive to bolus deliveries and may need an adult to assist in the setup of a bolus delivery, which may be more appropriately delivered at a later time (e.g., while the child is at school).
Another feature of some embodiments allows a user to set up a personal delivery profile 604, as was described and illustrated in
Furthermore, and shown by way of example in
One embodiment of the virtual keypad 500 may include one or more mathematical symbol virtual keys 502, e.g., plus sign, minus sign, multiplication sign, division sign, etc., to enable the virtual keypad 500 and processor 170 to function as a virtual calculator. For example, a virtual keypad 500 with one or more mathematical symbols displayed on the display screen 450 may enable a user to enter more than one entry and instruct the processor 170 to, for example, add, subtract, multiply, and/or divide the user entries. For instance, a user may be presented with a virtual calculator for enabling a user to enter and add more than one amount of carbs making up at least a part of a meal the user intends to consume. This feature may improve usability of the device 110 and reduce user error by simplifying the means by which a user determines the total number of carbs that make up a meal the user intends to consume, in addition to generally relieving the user from having to perform the calculations that may be necessary to determine the total number of carbs. As mentioned above, a virtual keyboard 500 including one or more mathematical virtual key 502 symbols may be presented to a user for various reasons and opportunities for a user to instruct the processor 170 to perform one or more calculations.
In addition, from the bolus delivery setup page 676 a user may choose to program an extended bolus, as illustrated in
As described above, once the user completes setting up an extended bolus on the extended bolus setup page 682, the user may select the done object 506 on the extended bolus setup page 682 to be directed back to the bolus delivery setup page 676. Once the user is directed back to the bolus delivery setup page 676, the user may either modify any of the settings displayed on the touch screen 452, select the back object 510 to be directed to a previous page, or select the done object 506 to initiate delivery of the extended bolus.
Alternatively, a user may not have selected to setup an extended bolus, e.g. by positing the virtual slide button 680 to allow the “off” to be displayed as shown in
Therefore, the embodiment of the bolus delivery setup page 676 illustrated in
Once the user has completed setting up either a standard or extended bolus and has confirmed delivery of the bolus, the user may be directed back to a home screen page 674.
Additionally, and shown by way of example in
As discussed above, the GUI 454 may display various information in graphical form, and the graphic representation 570 may be configured for manipulation by a user touching or otherwise “clicking” the representation and dragging the representation in a predefined manner so as to change the form, e.g., height, width, shape, etc. of the representation. For example, where the graphical representation 570 is a bar, the height or width of the bar may be adjusted by clicking on the appropriate dimension and manipulating it to adjust that chosen dimension. Where the graphical representation 570 is a curve or wave, the curve or wave may be clicked and the shape thereof may then be manipulated, for instance, by dragging a finger across the screen in a predetermined manner.
In addition, the information represented by at least one of the graphs 570 may be used to calculate and determine additional settings. For instance, the high BG graph 686 may display the range of a user's acceptable high BG levels over a period of time, the low BG graph 688 may display the range of acceptable low BG levels over a period of time, and the optimal BG graph 690 may display the range of optimal BG levels over a period of time. For example, a user's high BG level range may influence the occurrence and amount of correction boluses delivered to a user. Therefore, a user may modify, for example, the programmed high BG level range in order to modify the occurrence and amount of correction boluses programmed to be delivered to the user.
Furthermore, any one of the graphs 570 may be configured for manipulation by a user, such that a user may modify the range of any one of the graphs 570. For example, a user may want to modify the high BG range, e.g., by selecting and dragging a part of the high BG graph 686, in order to decrease the percentage of correction bolus comprising the total amount of insulin delivered to a user over a period of time. Therefore, modification of one graph 570 may generally cause modification to one or more additional graphs 570, which may result in improved usability of the portable infusion device 110 for a user to at least manage their insulin therapy.
With regard to the above detailed description, like reference numerals used therein may refer to like elements that may have the same or similar dimensions, materials and configurations. While particular forms of embodiments have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the embodiments herein. Accordingly, it is not intended that the invention be limited by the forgoing detailed description.
The entirety of each patent, patent application, publication and document referenced herein is hereby incorporated by reference. Citation of the above patents, patent applications, publications and documents is not an admission that any of the foregoing is pertinent prior art, nor does it constitute any admission as to the contents or date of these documents.
Modifications may be made to the foregoing embodiments without departing from the basic aspects of the technology. Although the technology may have been described in substantial detail with reference to one or more specific embodiments, changes may be made to the embodiments specifically disclosed in this application, yet these modifications and improvements are within the scope and spirit of the technology. The technology illustratively described herein suitably may be practiced in the absence of any element(s) not specifically disclosed herein. Thus, for example, in each instance herein any of the terms “comprising,” “consisting essentially of,” and “consisting of” may be replaced with either of the other two terms. The terms and expressions which have been employed are used as terms of description and not of limitation, and use of such terms and expressions do not exclude any equivalents of the features shown and described or portions thereof, and various modifications are possible within the scope of the technology claimed. The term “a” or “an” may refer to one of or a plurality of the elements it modifies (e.g., “a reagent” can mean one or more reagents) unless it is contextually clear either one of the elements or more than one of the elements is described. Although the present technology has been specifically disclosed by representative embodiments and optional features, modification and variation of the concepts herein disclosed may be made, and such modifications and variations may be considered within the scope of this technology.
Certain embodiments of the technology are set forth in the claim(s) that follow(s).
This application is a continuation of U.S. application Ser. No. 17/478,530 filed Sep. 17, 2021, and a continuation of U.S. application Ser. No. 16/580,573 filed Sep. 24, 2019, which is a continuation of U.S. application Ser. No. 16/502,248 filed Jul. 3, 2019, now issued U.S. Pat. No. 11,135,362, which in turn is a continuation of U.S. application Ser. No. 15/340,417 filed Nov. 1, 2016, now U.S. Pat. No. 10,434,253, which in turn is a continuation of U.S. application Ser. No. 12/846,688 filed Jul. 29, 2010, now abandoned, which claims the benefit of U.S. Provisional Patent Application No. 61/230,061, titled Infusion System and Methods for Using Same, filed Jul. 30, 2009, by P. DiPerna et al., each of which is hereby incorporated herein by reference in its entirety. This application is also related to U.S. patent application Ser. No. 12/846,706, titled Infusion Pump System with Disposable Cartridge Having Pressure Venting and Pressure Feedback, filed Jul. 29, 2010, by G. Kruse, et al., U.S. patent application Ser. No. 12/846,720, titled Infusion Pump System with Disposable Cartridge Having Pressure Venting and Pressure Feedback, filed Jul. 29, 2010, by D. Brown, et al., U.S. patent application Ser. No. 12/846,733, titled Infusion Pump System with Disposable Cartridge Having Pressure Venting and Pressure Feedback, filed Jul. 29, 2010, by M. Michaud, et al., U.S. patent application Ser. No. 12/846,734, titled Infusion Pump System with Disposable Cartridge Having Pressure Venting and Pressure Feedback, filed Jul. 29, 2010, by P. DiPerna, et al., and PCT Patent Application No. PCT/US2010/043789, titled Infusion Pump System with Disposable Cartridge Having Pressure Venting and Pressure Feedback, filed Jul. 29, 2010, by P. DiPerna, et al., all of which are incorporated by reference herein in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 318856 | Bilz | May 1885 | A |
| 329881 | Benton | Nov 1885 | A |
| 332402 | Leadley | Dec 1885 | A |
| 596062 | Firey | Dec 1897 | A |
| 722431 | Packard et al. | Mar 1903 | A |
| 818938 | Crane | Apr 1906 | A |
| 926092 | Bright | Jun 1909 | A |
| 1079522 | Smith | Nov 1913 | A |
| 1274884 | Hudson et al. | Aug 1918 | A |
| 1304036 | Eshielby | May 1919 | A |
| 1314987 | Smith | Sep 1919 | A |
| 1643021 | Ridder et al. | Sep 1927 | A |
| 1657663 | Devereux | Jan 1928 | A |
| 1866061 | Schoel et al. | Jul 1932 | A |
| 1910032 | Mills | May 1933 | A |
| 2018316 | Owings | Oct 1935 | A |
| 2029630 | McMichael | Feb 1936 | A |
| 2147164 | Kent | Feb 1939 | A |
| 2398234 | Long | Apr 1946 | A |
| 2412397 | Harper et al. | Dec 1946 | A |
| 2444677 | Rosenblum | Jul 1948 | A |
| 2454929 | Kempton | Nov 1948 | A |
| 2462596 | Bent et al. | Feb 1949 | A |
| 2495693 | Byrd, Jr. et al. | Jan 1950 | A |
| 2497020 | Singer | Feb 1950 | A |
| 2568519 | Smith | Sep 1951 | A |
| 2599325 | Fritzberg | Jun 1952 | A |
| 2629376 | Pierre et al. | Feb 1953 | A |
| 2629402 | Cook | Feb 1953 | A |
| 2667900 | Cantalupo | Feb 1954 | A |
| 2674262 | Bradshaw | Apr 1954 | A |
| 2679954 | Barnes | Jun 1954 | A |
| 2691542 | Chenoweth et al. | Oct 1954 | A |
| 2701583 | Rux | Feb 1955 | A |
| 2706612 | Ratelband | Apr 1955 | A |
| 2728355 | Dahl | Dec 1955 | A |
| 2735642 | Norman | Feb 1956 | A |
| 2736463 | Levine | Feb 1956 | A |
| 2746709 | Minor | May 1956 | A |
| 2764183 | Gollehon | Sep 1956 | A |
| 2781058 | Warhus | Feb 1957 | A |
| 2834379 | Fields | May 1958 | A |
| 2841237 | Slayter | Jul 1958 | A |
| 2852033 | Orser | Sep 1958 | A |
| 2878836 | Binks | Mar 1959 | A |
| 2891578 | Dahl et al. | Jun 1959 | A |
| 2898078 | Stephenson et al. | Aug 1959 | A |
| 2898088 | Alder | Aug 1959 | A |
| 2899979 | Dahl et al. | Aug 1959 | A |
| 2936788 | Dahl et al. | May 1960 | A |
| 2939487 | Fraser et al. | Jun 1960 | A |
| 2960109 | Wilson | Nov 1960 | A |
| 2968318 | Bauman | Jan 1961 | A |
| 2971466 | Corbett et al. | Feb 1961 | A |
| 2989096 | Dahl | Jun 1961 | A |
| 3017903 | Steffens | Jan 1962 | A |
| 3023750 | Baron | Mar 1962 | A |
| 3035613 | Beatty | May 1962 | A |
| 3059639 | Blackman et al. | Oct 1962 | A |
| 3060966 | Ratelband | Oct 1962 | A |
| 3061039 | Peters | Oct 1962 | A |
| 3070132 | Sheridan | Dec 1962 | A |
| 3072151 | Quercia | Jan 1963 | A |
| 3077903 | George et al. | Feb 1963 | A |
| 3095120 | Steiner et al. | Jun 1963 | A |
| 3095175 | Iketani | Jun 1963 | A |
| 3118646 | Markey | Jan 1964 | A |
| 3121445 | Wisniewski | Feb 1964 | A |
| 3123900 | Millar | Mar 1964 | A |
| 3133678 | Marwell et al. | May 1964 | A |
| 3143861 | Dumas | Aug 1964 | A |
| 3153414 | Beall et al. | Oct 1964 | A |
| 3174694 | Kitbayashi | Mar 1965 | A |
| 3187562 | Rolfson | Jun 1965 | A |
| 3189125 | Windsor et al. | Jun 1965 | A |
| 3195586 | Vogt | Jul 1965 | A |
| 3202178 | Wolfe | Aug 1965 | A |
| 3203662 | Lau | Aug 1965 | A |
| 3214903 | Cochran | Nov 1965 | A |
| 3216451 | Smallpiece | Nov 1965 | A |
| 3227311 | Rowell | Jan 1966 | A |
| 3298394 | Chorkey | Jan 1967 | A |
| 3302578 | Anderson et al. | Feb 1967 | A |
| 3318138 | Rolfson | May 1967 | A |
| 3338049 | Fernberger | Aug 1967 | A |
| 3347418 | Fefferman | Oct 1967 | A |
| 3376625 | McCulloch | Apr 1968 | A |
| 3409050 | Weese | Nov 1968 | A |
| 3428223 | Edward et al. | Feb 1969 | A |
| 3430659 | Homer | Mar 1969 | A |
| 3455247 | Adrian et al. | Jul 1969 | A |
| 3464359 | King et al. | Sep 1969 | A |
| 3471079 | Myers et al. | Oct 1969 | A |
| 3479002 | Gene | Nov 1969 | A |
| 3493496 | Bray et al. | Feb 1970 | A |
| 3508587 | Mauch | Apr 1970 | A |
| 3532125 | Everett et al. | Oct 1970 | A |
| 3556159 | Bleasdale | Jan 1971 | A |
| 3568847 | Carr | Mar 1971 | A |
| 3583603 | Freckmann et al. | Jun 1971 | A |
| 3586040 | Urback | Jun 1971 | A |
| 3586129 | Cass et al. | Jun 1971 | A |
| 3596939 | Gibson | Aug 1971 | A |
| 3620500 | Santomieri | Nov 1971 | A |
| 3621882 | Kupiec | Nov 1971 | A |
| 3648694 | Mogos et al. | Mar 1972 | A |
| 3654959 | Kassel | Apr 1972 | A |
| 3665967 | Kachnik | May 1972 | A |
| 3673853 | Griswold et al. | Jul 1972 | A |
| 3675672 | Freeman | Jul 1972 | A |
| 3693484 | Anderson, Jr. | Sep 1972 | A |
| 3696958 | Lee | Oct 1972 | A |
| 3699812 | Masnik | Oct 1972 | A |
| 3717174 | Dewall | Feb 1973 | A |
| 3724234 | Garavelli | Apr 1973 | A |
| 3756459 | Bannister et al. | Sep 1973 | A |
| 3833019 | Diggs | Sep 1974 | A |
| 3836113 | Johnson | Sep 1974 | A |
| 3837363 | Meronek | Sep 1974 | A |
| 3838794 | Cogley et al. | Oct 1974 | A |
| 3847178 | Keppel | Nov 1974 | A |
| 3860353 | Lukasik et al. | Jan 1975 | A |
| 3894538 | Richter et al. | Jul 1975 | A |
| 3899135 | O'Brian | Aug 1975 | A |
| 3918674 | Sutter | Nov 1975 | A |
| 3946761 | Thompson et al. | Mar 1976 | A |
| RE28890 | Ingram et al. | Jul 1976 | E |
| 3970105 | Peton et al. | Jul 1976 | A |
| 3985133 | Jenkins et al. | Oct 1976 | A |
| 3991972 | Eaton | Nov 1976 | A |
| 4000857 | Moen | Jan 1977 | A |
| 4003398 | Duveau | Jan 1977 | A |
| 4023772 | Ratelband | May 1977 | A |
| 4028931 | Bisera et al. | Jun 1977 | A |
| 4032265 | Miller | Jun 1977 | A |
| 4042153 | Callahan et al. | Aug 1977 | A |
| 4076872 | Lewicki et al. | Feb 1978 | A |
| 4087301 | Steadman | May 1978 | A |
| 4089206 | Raffel et al. | May 1978 | A |
| 4103689 | Leighton | Aug 1978 | A |
| 4105050 | Hendrickson et al. | Aug 1978 | A |
| 4106510 | Hakim et al. | Aug 1978 | A |
| 4111391 | Pilolla | Sep 1978 | A |
| 4137913 | Georgi | Feb 1979 | A |
| 4156127 | Honda et al. | May 1979 | A |
| 4178938 | Au | Dec 1979 | A |
| 4191184 | Carlisle | Mar 1980 | A |
| 4191204 | Nehring | Mar 1980 | A |
| 4191358 | Ferri | Mar 1980 | A |
| 4193552 | Ishikawa | Mar 1980 | A |
| 4195810 | Lavin | Apr 1980 | A |
| 4215726 | Tagami | Aug 1980 | A |
| 4228956 | Varner | Oct 1980 | A |
| 4248270 | Ostrowski | Feb 1981 | A |
| 4259872 | Tamari | Feb 1981 | A |
| 4254791 | Bron | Mar 1981 | A |
| 4265241 | Portner et al. | May 1981 | A |
| 4271989 | O'Neill et al. | Jun 1981 | A |
| 4275727 | Keeri-Szanto | Jun 1981 | A |
| 4306556 | Zelman | Dec 1981 | A |
| 4313979 | Deabriges et al. | Feb 1982 | A |
| 4314621 | Hansen | Feb 1982 | A |
| 4327845 | Keyes et al. | May 1982 | A |
| 4330071 | Ohlson | May 1982 | A |
| 4344459 | Nelson | Aug 1982 | A |
| 4356935 | Kamin | Aug 1982 | A |
| 4367786 | Haefner et al. | Jan 1983 | A |
| 4382453 | Bujan et al. | May 1983 | A |
| 4403984 | Ash et al. | Sep 1983 | A |
| 4405294 | Albarda et al. | Sep 1983 | A |
| 4406656 | Hattler et al. | Sep 1983 | A |
| 4411651 | Schulman et al. | Oct 1983 | A |
| 4416596 | Lichtenstein et al. | Nov 1983 | A |
| 4432468 | Siff et al. | Feb 1984 | A |
| 4440154 | Bellows | Apr 1984 | A |
| 4440323 | Benson | Apr 1984 | A |
| 4443218 | Decant, Jr. et al. | Apr 1984 | A |
| 4444546 | Pazemenas | Apr 1984 | A |
| 4445885 | Kifune | Apr 1984 | A |
| 4448538 | Mantel | May 1984 | A |
| 4457343 | Zukausky | Jul 1984 | A |
| 4469481 | Kobayashi | Sep 1984 | A |
| 4481808 | Sakata et al. | Nov 1984 | A |
| 4492339 | Kreitzberg | Jan 1985 | A |
| 4498843 | Schneider et al. | Feb 1985 | A |
| 4508144 | Bernett | May 1985 | A |
| 4520948 | Hampel et al. | Jun 1985 | A |
| 4527595 | Jorgensen et al. | Jul 1985 | A |
| 4529106 | Broadfoot et al. | Jul 1985 | A |
| 4529401 | Leslie et al. | Jul 1985 | A |
| 4538616 | Rogoff | Sep 1985 | A |
| 4557726 | Reinicke | Dec 1985 | A |
| 4559036 | Wunsch | Dec 1985 | A |
| 4559038 | Berg et al. | Dec 1985 | A |
| 4562751 | Nason et al. | Jan 1986 | A |
| 4562960 | Marty et al. | Jan 1986 | A |
| 4565542 | Berg | Jan 1986 | A |
| 4570745 | Sparks et al. | Feb 1986 | A |
| 4573994 | Fischell et al. | Mar 1986 | A |
| 4592390 | Boyd | Jun 1986 | A |
| 4609014 | Jurjevic et al. | Sep 1986 | A |
| 4620648 | Schwartzman | Nov 1986 | A |
| 4624661 | Arimond | Nov 1986 | A |
| 4627573 | Havens et al. | Dec 1986 | A |
| 4628928 | Lowell et al. | Dec 1986 | A |
| 4636226 | Canfora et al. | Jan 1987 | A |
| 4646945 | Steiner et al. | Mar 1987 | A |
| 4649959 | Wadleigh | Mar 1987 | A |
| 4650469 | Berg et al. | Mar 1987 | A |
| 4650471 | Tamari | Mar 1987 | A |
| 4651781 | Kandelman | Mar 1987 | A |
| 4657486 | Stempfle et al. | Apr 1987 | A |
| 4666430 | Brown et al. | May 1987 | A |
| 4667700 | Buzzi | May 1987 | A |
| 4673415 | Stanford et al. | Jun 1987 | A |
| 4678408 | Nason et al. | Jul 1987 | A |
| 4678460 | Rosner et al. | Jul 1987 | A |
| 4684367 | Schaffer et al. | Aug 1987 | A |
| 4687423 | Maget et al. | Aug 1987 | A |
| 4694364 | Sawyer et al. | Aug 1987 | A |
| 4699415 | Fischell et al. | Oct 1987 | A |
| 4713063 | Krumme | Dec 1987 | A |
| 4718430 | Holzer et al. | Jan 1988 | A |
| 4718893 | Dorman et al. | Jan 1988 | A |
| 4723947 | Konopka | Feb 1988 | A |
| 4741736 | Brown | May 1988 | A |
| 4770211 | Olsson | Sep 1988 | A |
| 4773448 | Francis | Sep 1988 | A |
| 4776842 | Franetzki et al. | Oct 1988 | A |
| 4779451 | Kamen | Oct 1988 | A |
| 4779762 | Klein et al. | Oct 1988 | A |
| 4787408 | Twerdochlib | Nov 1988 | A |
| 4793486 | Konopka et al. | Dec 1988 | A |
| 4808167 | Mann et al. | Feb 1989 | A |
| 4810243 | Howson | Mar 1989 | A |
| 4823844 | Bartholomew | Apr 1989 | A |
| 4826482 | Kamen | May 1989 | A |
| 4840191 | Gausman et al. | Jun 1989 | A |
| 4850972 | Schulman et al. | Jul 1989 | A |
| 4869431 | Jubert et al. | Sep 1989 | A |
| 4871093 | Burshtain et al. | Oct 1989 | A |
| 4878896 | Garrison et al. | Nov 1989 | A |
| 4883093 | Miles et al. | Nov 1989 | A |
| 4886499 | Cirelli et al. | Dec 1989 | A |
| 4886514 | Maget et al. | Dec 1989 | A |
| 4893966 | Roehl | Jan 1990 | A |
| 4897906 | Bartholomew | Feb 1990 | A |
| 4902278 | Maget et al. | Feb 1990 | A |
| 4919596 | Slate et al. | Apr 1990 | A |
| 4931050 | Idriss et al. | Jun 1990 | A |
| 4936832 | Vaillancourt | Jun 1990 | A |
| 4938259 | Schmidt | Jul 1990 | A |
| 4955860 | Ruano | Sep 1990 | A |
| 4969884 | Yum | Nov 1990 | A |
| 4973402 | Johnson et al. | Nov 1990 | A |
| 4976162 | Kamen et al. | Dec 1990 | A |
| 4985015 | Obermann et al. | Jan 1991 | A |
| 4986312 | Gute | Jan 1991 | A |
| 4989456 | Stupecky | Feb 1991 | A |
| 4995258 | Frank | Feb 1991 | A |
| 5000739 | Kulisz et al. | Mar 1991 | A |
| 5002527 | Reller et al. | Mar 1991 | A |
| 5005403 | Steudle et al. | Apr 1991 | A |
| 5006997 | Reich | Apr 1991 | A |
| 5011477 | Winchell et al. | Apr 1991 | A |
| 5020562 | Richmond et al. | Jun 1991 | A |
| 5027861 | Gute | Jul 1991 | A |
| 5035865 | Inaba et al. | Jul 1991 | A |
| 5038821 | Maget | Aug 1991 | A |
| 5041086 | Koenig et al. | Aug 1991 | A |
| 5044900 | Cavallaro | Sep 1991 | A |
| 5047044 | Smith et al. | Sep 1991 | A |
| 5049141 | Olive | Sep 1991 | A |
| 5050612 | Matsumura | Sep 1991 | A |
| 5053001 | Reller et al. | Oct 1991 | A |
| 5053189 | Chrise et al. | Oct 1991 | A |
| 5059171 | Bridge et al. | Oct 1991 | A |
| 5059182 | Laing | Oct 1991 | A |
| 5062834 | Gross et al. | Nov 1991 | A |
| 5062841 | Siegel | Nov 1991 | A |
| 5076911 | Brown et al. | Dec 1991 | A |
| 5078683 | Sancoff et al. | Jan 1992 | A |
| 5080652 | Voss et al. | Jan 1992 | A |
| 5082240 | Richmod | Jan 1992 | A |
| 5082503 | Sluga et al. | Jan 1992 | A |
| 5083908 | Gagnebin et al. | Jan 1992 | A |
| 5084021 | Baldwin et al. | Jan 1992 | A |
| 5085644 | Watson et al. | Feb 1992 | A |
| 5087245 | Doan | Feb 1992 | A |
| 5090963 | Gross et al. | Feb 1992 | A |
| 5091091 | Terman | Feb 1992 | A |
| 5091094 | Veech | Feb 1992 | A |
| 5096385 | Georgi et al. | Mar 1992 | A |
| 5097122 | Colman et al. | Mar 1992 | A |
| 5103211 | Daoud et al. | Apr 1992 | A |
| 5104374 | Bishko | Apr 1992 | A |
| 5104526 | Brown et al. | Apr 1992 | A |
| 5104813 | Besemer et al. | Apr 1992 | A |
| 5108363 | Tuttle et al. | Apr 1992 | A |
| 5125781 | Breunig et al. | Jun 1992 | A |
| 5126324 | Clark et al. | Jun 1992 | A |
| 5127258 | Brown et al. | Jul 1992 | A |
| 5128145 | Edgren et al. | Jul 1992 | A |
| 5131816 | Brown et al. | Jul 1992 | A |
| 5135491 | Baldwin | Aug 1992 | A |
| 5135498 | Kam et al. | Aug 1992 | A |
| 5135499 | Tafani et al. | Aug 1992 | A |
| 5148154 | MacKay et al. | Sep 1992 | A |
| 5149413 | Maget | Sep 1992 | A |
| 5156591 | Gross et al. | Oct 1992 | A |
| 5156598 | Skakoon et al. | Oct 1992 | A |
| 5157960 | Brehm et al. | Oct 1992 | A |
| 5158230 | Curran | Oct 1992 | A |
| 5167633 | Mann et al. | Dec 1992 | A |
| 5170912 | Du et al. | Dec 1992 | A |
| 5170986 | Zelczer et al. | Dec 1992 | A |
| 5173302 | Holmblad et al. | Dec 1992 | A |
| 5176502 | Sanderson et al. | Jan 1993 | A |
| 5176644 | Srisathapat et al. | Jan 1993 | A |
| 5176662 | Bartholomew et al. | Jan 1993 | A |
| 5178603 | Prince | Jan 1993 | A |
| 5181910 | Scanlon | Jan 1993 | A |
| 5182258 | Chiou | Jan 1993 | A |
| 5184359 | Tsukamura et al. | Feb 1993 | A |
| 5186431 | Tamari et al. | Feb 1993 | A |
| 5186805 | Gross et al. | Feb 1993 | A |
| 5188258 | Iwashita | Feb 1993 | A |
| 5190522 | Wojcicki et al. | Mar 1993 | A |
| 5191719 | Kitt | Mar 1993 | A |
| 5192264 | Fossel | Mar 1993 | A |
| 5192272 | Faure et al. | Mar 1993 | A |
| 5197322 | Indravudh | Mar 1993 | A |
| 5203506 | Gross et al. | Apr 1993 | A |
| 5207642 | Orkin et al. | May 1993 | A |
| 5207645 | Ross et al. | May 1993 | A |
| 5207666 | Idriss et al. | May 1993 | A |
| 5209265 | Taguri et al. | May 1993 | A |
| 5215450 | Tamari et al. | Jun 1993 | A |
| 5217440 | Frassica | Jun 1993 | A |
| 5217442 | Davis | Jun 1993 | A |
| 5218987 | Heil et al. | Jun 1993 | A |
| 5220515 | Freerks et al. | Jun 1993 | A |
| 5224796 | Zeman | Jul 1993 | A |
| 5226446 | Cooper | Jul 1993 | A |
| 5228291 | Meyering | Jul 1993 | A |
| 5228842 | Guebeli et al. | Jul 1993 | A |
| 5231616 | Oliver et al. | Jul 1993 | A |
| 5232437 | Lysaght et al. | Aug 1993 | A |
| 5232449 | Stern et al. | Aug 1993 | A |
| 5240603 | Frank et al. | Aug 1993 | A |
| 5241935 | Beck et al. | Sep 1993 | A |
| 5242406 | Gross et al. | Sep 1993 | A |
| 5242408 | Jhuboo et al. | Sep 1993 | A |
| 5243983 | Tarr et al. | Sep 1993 | A |
| 5246147 | Gross | Sep 1993 | A |
| 5247434 | Peterson et al. | Sep 1993 | A |
| 5254096 | Rondelet et al. | Oct 1993 | A |
| 5256157 | Samiotes et al. | Oct 1993 | A |
| 5257971 | Lord et al. | Nov 1993 | A |
| 5257980 | Van Antwerp et al. | Nov 1993 | A |
| 5259399 | Brown | Nov 1993 | A |
| 5259732 | Stern | Nov 1993 | A |
| 5261459 | Atkinson et al. | Nov 1993 | A |
| 5261884 | Stern et al. | Nov 1993 | A |
| 5266265 | Raible | Nov 1993 | A |
| 5270005 | Raible | Dec 1993 | A |
| 5271724 | Van Lintel | Dec 1993 | A |
| 5272294 | Charboneau et al. | Dec 1993 | A |
| 5272909 | Nguyen et al. | Dec 1993 | A |
| 5273406 | Feygin | Dec 1993 | A |
| 5273518 | Lee et al. | Dec 1993 | A |
| 5278142 | Chiou | Jan 1994 | A |
| 5279543 | Glikfeld et al. | Jan 1994 | A |
| 5279565 | Goi et al. | Jan 1994 | A |
| 5279585 | Balkwill | Jan 1994 | A |
| 5279586 | Balkwill | Jan 1994 | A |
| 5290684 | Kelly | Mar 1994 | A |
| 5291086 | Shekalim | Mar 1994 | A |
| 5294133 | Dutta | Mar 1994 | A |
| 5295966 | Stern et al. | Mar 1994 | A |
| 5295967 | Rondelet et al. | Mar 1994 | A |
| 5295976 | Harris et al. | Mar 1994 | A |
| 5303843 | Zink et al. | Apr 1994 | A |
| 5304126 | Epstein et al. | Apr 1994 | A |
| 5304163 | Bonnici et al. | Apr 1994 | A |
| 5308340 | Harris | May 1994 | A |
| 5312233 | Tanny et al. | May 1994 | A |
| 5320250 | La et al. | Jun 1994 | A |
| 5321392 | Skakoon et al. | Jun 1994 | A |
| 5322418 | Comer et al. | Jun 1994 | A |
| 5322620 | Brown et al. | Jun 1994 | A |
| 5322626 | Frank et al. | Jun 1994 | A |
| 5327777 | Kaye et al. | Jul 1994 | A |
| 5328460 | Lord et al. | Jul 1994 | A |
| 5328464 | Kriesel et al. | Jul 1994 | A |
| 5334144 | Alchas et al. | Aug 1994 | A |
| 5334162 | Harris | Aug 1994 | A |
| 5335705 | Morishita et al. | Aug 1994 | A |
| 5335852 | Muntean et al. | Aug 1994 | A |
| 5336051 | Tamari et al. | Aug 1994 | A |
| 5336174 | Daoud et al. | Aug 1994 | A |
| 5336180 | Kriesel et al. | Aug 1994 | A |
| 5336188 | Kriesel et al. | Aug 1994 | A |
| 5337747 | Neftel | Aug 1994 | A |
| 5338157 | Blomquist | Aug 1994 | A |
| 5339393 | Duffy et al. | Aug 1994 | A |
| 5339865 | Asghar et al. | Aug 1994 | A |
| 5341783 | Beck et al. | Aug 1994 | A |
| 5342180 | Daoud | Aug 1994 | A |
| 5345273 | Sun | Sep 1994 | A |
| 5345488 | Skipper et al. | Sep 1994 | A |
| 5348197 | Mizzi et al. | Sep 1994 | A |
| 5348548 | Meyer et al. | Sep 1994 | A |
| 5349933 | Hasegawa et al. | Sep 1994 | A |
| 5350224 | Nell et al. | Sep 1994 | A |
| 5352201 | Jemmott | Oct 1994 | A |
| 5354273 | Hagen | Oct 1994 | A |
| 5356375 | Higley et al. | Oct 1994 | A |
| 5356378 | Doan | Oct 1994 | A |
| 5356632 | Gross et al. | Oct 1994 | A |
| 5358489 | Wyrick | Oct 1994 | A |
| 5358635 | Frank et al. | Oct 1994 | A |
| 5360062 | White | Nov 1994 | A |
| 5362213 | Chapman et al. | Nov 1994 | A |
| 5362307 | Guy et al. | Nov 1994 | A |
| 5364242 | Olsen et al. | Nov 1994 | A |
| 5364387 | Sweeney | Nov 1994 | A |
| 5366904 | Qureshi et al. | Nov 1994 | A |
| 5367910 | Woodward et al. | Nov 1994 | A |
| 5368555 | Sussman et al. | Nov 1994 | A |
| 5368562 | Blomquist et al. | Nov 1994 | A |
| 5369976 | Ratton | Dec 1994 | A |
| 5370622 | Livingston et al. | Dec 1994 | A |
| 5370870 | Wong | Dec 1994 | A |
| 5373865 | Jung et al. | Dec 1994 | A |
| 5376070 | Purvis et al. | Dec 1994 | A |
| 5381823 | Dibartolo | Jan 1995 | A |
| 5384709 | Seder et al. | Jan 1995 | A |
| 5387192 | Glantz et al. | Feb 1995 | A |
| 5387327 | Khan | Feb 1995 | A |
| 5388453 | Ratton et al. | Feb 1995 | A |
| 5389071 | Kawahara et al. | Feb 1995 | A |
| 5389078 | Zalesky et al. | Feb 1995 | A |
| 5389091 | Moorehead | Feb 1995 | A |
| 5390671 | Lord et al. | Feb 1995 | A |
| 5391250 | Cheney, II et al. | Feb 1995 | A |
| 5395320 | Padda et al. | Mar 1995 | A |
| 5395326 | Haber et al. | Mar 1995 | A |
| 5399166 | Laing | Mar 1995 | A |
| 5403551 | Galloway et al. | Apr 1995 | A |
| 5407444 | Kroll | Apr 1995 | A |
| 5410908 | Erichsen | May 1995 | A |
| 5411685 | Burgis | May 1995 | A |
| 5415024 | Proffitt et al. | May 1995 | A |
| 5418154 | Aebischer et al. | May 1995 | A |
| 5421208 | Packard et al. | Jun 1995 | A |
| 5423743 | Butterfield | Jun 1995 | A |
| 5425374 | Ueda et al. | Jun 1995 | A |
| 5425706 | Gross et al. | Jun 1995 | A |
| 5425742 | Joy | Jun 1995 | A |
| 5427870 | Joshi et al. | Jun 1995 | A |
| 5429483 | Tamari | Jul 1995 | A |
| 5429601 | Conley et al. | Jul 1995 | A |
| 5431171 | Harrison et al. | Jul 1995 | A |
| 5431206 | Aoki et al. | Jul 1995 | A |
| 5431627 | Pastrone et al. | Jul 1995 | A |
| 5433710 | Vanantwerp et al. | Jul 1995 | A |
| 5435465 | El-Amin | Jul 1995 | A |
| 5435697 | Guebeli et al. | Jul 1995 | A |
| 5435797 | Harris | Jul 1995 | A |
| 5438510 | Bryant et al. | Aug 1995 | A |
| 5441027 | Buchanon et al. | Aug 1995 | A |
| 5442948 | Cowing | Aug 1995 | A |
| 5442950 | Unalmiser et al. | Aug 1995 | A |
| 5443450 | Kratoska et al. | Aug 1995 | A |
| 5445506 | Afflerbaugh et al. | Aug 1995 | A |
| 5445616 | Kratoska et al. | Aug 1995 | A |
| 5447509 | Mills et al. | Sep 1995 | A |
| 5447863 | Langley | Sep 1995 | A |
| 5448034 | Skipper et al. | Sep 1995 | A |
| 5448978 | Hasegawa et al. | Sep 1995 | A |
| 5450750 | Abler | Sep 1995 | A |
| 5454922 | Joshi | Oct 1995 | A |
| 5458469 | Hauser | Oct 1995 | A |
| 5460030 | Bloxsom et al. | Oct 1995 | A |
| 5460381 | Smith et al. | Oct 1995 | A |
| 5460405 | Tuttle et al. | Oct 1995 | A |
| 5460618 | Harreld | Oct 1995 | A |
| 5460945 | Springer et al. | Oct 1995 | A |
| 5462417 | Chapman | Oct 1995 | A |
| 5462525 | Srisathapat et al. | Oct 1995 | A |
| 5462535 | Bonnichsen et al. | Oct 1995 | A |
| 5464392 | Epstein et al. | Nov 1995 | A |
| 5464398 | Haindl | Nov 1995 | A |
| 5466218 | Srisathapat et al. | Nov 1995 | A |
| 5466229 | Elson et al. | Nov 1995 | A |
| 5469846 | Khan | Nov 1995 | A |
| 5470318 | Griffith, III et al. | Nov 1995 | A |
| 5472577 | Porter et al. | Dec 1995 | A |
| 5476444 | Keeling et al. | Dec 1995 | A |
| 5476449 | Richmond | Dec 1995 | A |
| 5476460 | Montalvo | Dec 1995 | A |
| 5478316 | Bitdinger et al. | Dec 1995 | A |
| 5478751 | Oosta et al. | Dec 1995 | A |
| 5480294 | Diperna et al. | Jan 1996 | A |
| 5482446 | Williamson et al. | Jan 1996 | A |
| 5482745 | Cuellar et al. | Jan 1996 | A |
| 5483930 | Moriya et al. | Jan 1996 | A |
| 5485408 | Blomquist | Jan 1996 | A |
| 5487528 | Richmond | Jan 1996 | A |
| 5489265 | Montalvo et al. | Feb 1996 | A |
| 5492534 | Athayde et al. | Feb 1996 | A |
| 5494578 | Brown et al. | Feb 1996 | A |
| 5497772 | Schulman et al. | Mar 1996 | A |
| 5498421 | Grinstaff et al. | Mar 1996 | A |
| 5503538 | Wiernicki et al. | Apr 1996 | A |
| 5505709 | Funderburk et al. | Apr 1996 | A |
| 5505777 | Ciardella et al. | Apr 1996 | A |
| 5509294 | Gowing | Apr 1996 | A |
| 5510336 | Saven et al. | Apr 1996 | A |
| 5514103 | Srisathapat et al. | May 1996 | A |
| 5518730 | Fuisz | May 1996 | A |
| 5522798 | Johnson et al. | Jun 1996 | A |
| 5526675 | Ratton | Jun 1996 | A |
| 5527288 | Gross et al. | Jun 1996 | A |
| 5527307 | Srisathapat et al. | Jun 1996 | A |
| 5527704 | Wolf, Jr. et al. | Jun 1996 | A |
| 5528624 | Kaku et al. | Jun 1996 | A |
| 5531697 | Olsen et al. | Jul 1996 | A |
| 5531698 | Olsen | Jul 1996 | A |
| 5533876 | Nelson, II | Jul 1996 | A |
| 5533981 | Mandro et al. | Jul 1996 | A |
| 5536249 | Castellano et al. | Jul 1996 | A |
| 5538002 | Boussignac et al. | Jul 1996 | A |
| 5538043 | Salazar | Jul 1996 | A |
| 5538399 | Johnson | Jul 1996 | A |
| 5540562 | Giter | Jul 1996 | A |
| 5544519 | Hammarberg et al. | Aug 1996 | A |
| 5545140 | Conero et al. | Aug 1996 | A |
| 5545252 | Hinshaw et al. | Aug 1996 | A |
| 5549458 | Chapman et al. | Aug 1996 | A |
| 5551391 | Beck et al. | Sep 1996 | A |
| 5551850 | Williamson et al. | Sep 1996 | A |
| 5554177 | Kieval et al. | Sep 1996 | A |
| 5556421 | Prutchi et al. | Sep 1996 | A |
| 5558638 | Evers et al. | Sep 1996 | A |
| 5562079 | Gray, Jr. | Oct 1996 | A |
| 5562618 | Cai et al. | Oct 1996 | A |
| 5563347 | Martin et al. | Oct 1996 | A |
| 5564915 | Johnson | Oct 1996 | A |
| 5566865 | Jouillat et al. | Oct 1996 | A |
| 5567136 | Johnson | Oct 1996 | A |
| 5567287 | Joshi et al. | Oct 1996 | A |
| 5568036 | Tatsumi | Oct 1996 | A |
| 5568806 | Cheney et al. | Oct 1996 | A |
| 5568884 | Bruna | Oct 1996 | A |
| 5569186 | Lord et al. | Oct 1996 | A |
| 5575310 | Kamen et al. | Nov 1996 | A |
| 5575632 | Morris et al. | Nov 1996 | A |
| 5575770 | Melsky et al. | Nov 1996 | A |
| 5578005 | Sancoff et al. | Nov 1996 | A |
| 5578014 | Erez et al. | Nov 1996 | A |
| 5578832 | Trulson et al. | Nov 1996 | A |
| 5582168 | Samuels et al. | Dec 1996 | A |
| 5584667 | Davis | Dec 1996 | A |
| 5584815 | Pawelka et al. | Dec 1996 | A |
| 5586553 | Halili et al. | Dec 1996 | A |
| 5586727 | Shekalim | Dec 1996 | A |
| 5590648 | Mitchell et al. | Jan 1997 | A |
| 5593551 | Joshi et al. | Jan 1997 | A |
| 5602040 | May et al. | Feb 1997 | A |
| 5603729 | Brown et al. | Feb 1997 | A |
| 5605152 | Slate et al. | Feb 1997 | A |
| 5605701 | Bymaster et al. | Feb 1997 | A |
| 5606131 | Pope | Feb 1997 | A |
| 5607418 | Arzbaecher | Mar 1997 | A |
| 5613945 | Cai et al. | Mar 1997 | A |
| 5615671 | Schoonen et al. | Apr 1997 | A |
| 5616123 | Cheikh | Apr 1997 | A |
| 5616132 | Newman | Apr 1997 | A |
| 5617650 | Grim | Apr 1997 | A |
| 5621797 | Rosen | Apr 1997 | A |
| RE35501 | Ross et al. | May 1997 | E |
| 5626566 | Petersen et al. | May 1997 | A |
| 5628324 | Sarbach | May 1997 | A |
| 5628349 | Diggins et al. | May 1997 | A |
| 5628922 | Chen | May 1997 | A |
| 5634491 | Benedict | Jun 1997 | A |
| 5634779 | Eysymontt | Jun 1997 | A |
| 5634896 | Bryant et al. | Jun 1997 | A |
| 5637092 | Shaw | Jun 1997 | A |
| 5637095 | Nason et al. | Jun 1997 | A |
| 5639220 | Hayakawa | Jun 1997 | A |
| 5639441 | Sievers et al. | Jun 1997 | A |
| 5639473 | Grinstaff et al. | Jun 1997 | A |
| 5641405 | Keshaviah et al. | Jun 1997 | A |
| 5660163 | Schulman et al. | Jun 1997 | A |
| 5643773 | Aebischer et al. | Jul 1997 | A |
| 5645526 | Flower | Jul 1997 | A |
| 5647853 | Feldmann et al. | Jul 1997 | A |
| 5647854 | Olsen et al. | Jul 1997 | A |
| 5651980 | Lanza et al. | Jul 1997 | A |
| 5656032 | Kriesel et al. | Aug 1997 | A |
| 5656501 | Yedgar et al. | Aug 1997 | A |
| 5656503 | May et al. | Aug 1997 | A |
| 5658250 | Blomquist et al. | Aug 1997 | A |
| 5658252 | Johnson | Aug 1997 | A |
| 5659126 | Farber | Aug 1997 | A |
| 5660150 | Andersen et al. | Aug 1997 | A |
| 5665065 | Colman et al. | Sep 1997 | A |
| 5665070 | McPhee et al. | Sep 1997 | A |
| 5669877 | Blomquist | Sep 1997 | A |
| 5671874 | Behar et al. | Sep 1997 | A |
| 5676651 | Larson, Jr. et al. | Oct 1997 | A |
| 5681285 | Ford et al. | Oct 1997 | A |
| 5681435 | Joshi et al. | Oct 1997 | A |
| 5693018 | Kriesel et al. | Oct 1997 | A |
| 5685844 | Marttila | Nov 1997 | A |
| 5688113 | Bareiss et al. | Nov 1997 | A |
| 5688225 | Walker | Nov 1997 | A |
| 5688232 | Flower | Nov 1997 | A |
| 5694961 | Begemann et al. | Dec 1997 | A |
| 5695464 | Viallet | Dec 1997 | A |
| 5695472 | Wyrick | Dec 1997 | A |
| 5695473 | Olsen | Dec 1997 | A |
| 5700244 | Kriesel | Dec 1997 | A |
| 5702384 | Umeyama et al. | Dec 1997 | A |
| 5704366 | Tacklind et al. | Jan 1998 | A |
| 5704520 | Gross | Jan 1998 | A |
| 5707212 | Matthews | Jan 1998 | A |
| 5707361 | Slettenmark | Jan 1998 | A |
| 5711989 | Ciardella et al. | Jan 1998 | A |
| 5712795 | Layman et al. | Jan 1998 | A |
| 5713856 | Eggers et al. | Feb 1998 | A |
| 5713858 | Heruth et al. | Feb 1998 | A |
| 5718562 | Lawless et al. | Feb 1998 | A |
| 5719761 | Gatti et al. | Feb 1998 | A |
| 5720241 | Gail | Feb 1998 | A |
| 5720921 | Meserol | Feb 1998 | A |
| 5722367 | Izydorek et al. | Mar 1998 | A |
| 5730149 | Nakayama et al. | Mar 1998 | A |
| 5730723 | Castellano et al. | Mar 1998 | A |
| 5735618 | Kriesel et al. | Apr 1998 | A |
| 5738650 | Gregg | Apr 1998 | A |
| 5740718 | Rathweg | Apr 1998 | A |
| 5741211 | Renirie et al. | Apr 1998 | A |
| 5741242 | Kriesel et al. | Apr 1998 | A |
| 5743291 | Nehm et al. | Apr 1998 | A |
| 5743873 | Cai et al. | Apr 1998 | A |
| 5746733 | Capaccio et al. | May 1998 | A |
| 5755683 | Houle et al. | May 1998 | A |
| 5755696 | Caizza | May 1998 | A |
| 5759018 | Thanscheidt | Jun 1998 | A |
| 5759199 | Snell et al. | Jun 1998 | A |
| 5763267 | Kurjan et al. | Jun 1998 | A |
| 5763398 | Bengtsson | Jun 1998 | A |
| 5765464 | Morita | Jun 1998 | A |
| 5765729 | Miller et al. | Jun 1998 | A |
| 5769615 | Giter | Jun 1998 | A |
| 5770149 | Raible | Jun 1998 | A |
| 5770160 | Smith et al. | Jun 1998 | A |
| 5771770 | Mueller | Jun 1998 | A |
| 5772409 | Johnson | Jun 1998 | A |
| 5772635 | Dastur et al. | Jun 1998 | A |
| 5762931 | Yang et al. | Jul 1998 | A |
| 5782805 | Meinzer et al. | Jul 1998 | A |
| 5785681 | Indravudh | Jul 1998 | A |
| 5785688 | Joshi et al. | Jul 1998 | A |
| 5788642 | Hamatake et al. | Aug 1998 | A |
| 5788669 | Peterson | Aug 1998 | A |
| 5788671 | Johnson | Aug 1998 | A |
| 5788682 | Maget | Aug 1998 | A |
| 5792603 | Dunkelman et al. | Aug 1998 | A |
| 5794505 | Fischer et al. | Aug 1998 | A |
| 5794515 | Bethke | Aug 1998 | A |
| 5795327 | Wilson et al. | Aug 1998 | A |
| 5797867 | Guerrera et al. | Aug 1998 | A |
| 5798114 | Elsberry et al. | Aug 1998 | A |
| 5800387 | Duffy et al. | Sep 1998 | A |
| 5800420 | Gross et al. | Sep 1998 | A |
| 5803319 | Smith et al. | Sep 1998 | A |
| 5803917 | Butterfield et al. | Sep 1998 | A |
| 5807315 | Van Antwerp et al. | Sep 1998 | A |
| 5807335 | Kriesel et al. | Sep 1998 | A |
| 5807336 | Russo et al. | Sep 1998 | A |
| 5807374 | Ciazza et al. | Sep 1998 | A |
| 5807375 | Gross et al. | Sep 1998 | A |
| 5810737 | Dardik | Sep 1998 | A |
| 5810771 | Blomquist | Sep 1998 | A |
| 5810783 | Claro et al. | Sep 1998 | A |
| 5814020 | Gross | Sep 1998 | A |
| 5814100 | Carpenter et al. | Sep 1998 | A |
| 5820587 | Place | Oct 1998 | A |
| 5820622 | Gross et al. | Oct 1998 | A |
| 5822715 | Worthington et al. | Oct 1998 | A |
| 5823388 | Green | Oct 1998 | A |
| 5823746 | Johnson et al. | Oct 1998 | A |
| 5823998 | Yamagata | Oct 1998 | A |
| 5826621 | Jemmott | Oct 1998 | A |
| 5830175 | Flower et al. | Nov 1998 | A |
| 5830187 | Kriesel et al. | Nov 1998 | A |
| 5837220 | Blake et al. | Nov 1998 | A |
| 5837444 | Shah | Nov 1998 | A |
| 5840069 | Robinson | Nov 1998 | A |
| 5840071 | Kriesel et al. | Nov 1998 | A |
| 5840770 | Hill | Nov 1998 | A |
| 5848593 | McGrady et al. | Dec 1998 | A |
| 5848880 | Helmig | Dec 1998 | A |
| 5848990 | Cirelli et al. | Dec 1998 | A |
| 5848991 | Gross et al. | Dec 1998 | A |
| 5849031 | Martinez et al. | Dec 1998 | A |
| 5849737 | Chaplan et al. | Dec 1998 | A |
| 5851197 | Marano et al. | Dec 1998 | A |
| 5851198 | Castellano et al. | Dec 1998 | A |
| 5851549 | Svec | Dec 1998 | A |
| 5851985 | Tepic et al. | Dec 1998 | A |
| 5853386 | Davis et al. | Dec 1998 | A |
| 5854074 | Charlton et al. | Dec 1998 | A |
| 5854719 | Ginosar et al. | Dec 1998 | A |
| 5858001 | Tsals et al. | Jan 1999 | A |
| 5858201 | Otsuka et al. | Jan 1999 | A |
| 5858388 | Grossman et al. | Jan 1999 | A |
| 5858393 | Bymaster et al. | Jan 1999 | A |
| 5859365 | Kataoka et al. | Jan 1999 | A |
| 5860957 | Jacobsen et al. | Jan 1999 | A |
| 5863187 | Bensley et al. | Jan 1999 | A |
| 5865603 | Francart, Jr. | Feb 1999 | A |
| 5871125 | Gross | Feb 1999 | A |
| 5871515 | Wiklund et al. | Feb 1999 | A |
| 5876189 | Lukas et al. | Mar 1999 | A |
| 5876368 | Flower | Mar 1999 | A |
| 5876370 | Blomquist | Mar 1999 | A |
| 5877146 | McKenzie et al. | Mar 1999 | A |
| 5878991 | Edwards et al. | Mar 1999 | A |
| 5879143 | Cote et al. | Mar 1999 | A |
| 5879144 | Johnson | Mar 1999 | A |
| 5882494 | Van Antwerp | Mar 1999 | A |
| 5883138 | Hershkowitz et al. | Mar 1999 | A |
| 5885211 | Eppstein et al. | Mar 1999 | A |
| 5885250 | Kriesel et al. | Mar 1999 | A |
| 5885614 | Hirsch | Mar 1999 | A |
| 5886056 | Hershkowitz et al. | Mar 1999 | A |
| 5887793 | Kieffer | Mar 1999 | A |
| 5890413 | Bayer et al. | Apr 1999 | A |
| 5891097 | Saito et al. | Apr 1999 | A |
| 5893708 | Nelson, II | Apr 1999 | A |
| 5894992 | Liu et al. | Apr 1999 | A |
| 5895369 | Flower | Apr 1999 | A |
| 5897530 | Jackson | Apr 1999 | A |
| 5902336 | Mishkin et al. | May 1999 | A |
| 5903710 | Wefler et al. | May 1999 | A |
| 5912005 | Lanza et al. | Jun 1999 | A |
| 5916191 | Plunkett et al. | Jun 1999 | A |
| 5919156 | Stropkay et al. | Jul 1999 | A |
| 5919209 | Schouten | Jul 1999 | A |
| 5919216 | Houben et al. | Jul 1999 | A |
| 5924448 | West et al. | Jul 1999 | A |
| 5924456 | Simon | Jul 1999 | A |
| 5925629 | Place | Jul 1999 | A |
| 5928194 | Maget et al. | Jul 1999 | A |
| 5928196 | Johnson et al. | Jul 1999 | A |
| 5928201 | Poulsen et al. | Jul 1999 | A |
| 5928281 | Huynh et al. | Jul 1999 | A |
| 5931814 | Alex et al. | Aug 1999 | A |
| 5933287 | Mueller | Aug 1999 | A |
| 5935099 | Peterson et al. | Aug 1999 | A |
| 5935106 | Olsen | Aug 1999 | A |
| 5935168 | Yang et al. | Aug 1999 | A |
| 5935598 | Sage et al. | Aug 1999 | A |
| 5938636 | Kramer et al. | Aug 1999 | A |
| 5938640 | Maget et al. | Aug 1999 | A |
| 5938642 | Burroughs et al. | Aug 1999 | A |
| 5941846 | Duffy et al. | Aug 1999 | A |
| 5944694 | Hitchins et al. | Aug 1999 | A |
| 5948267 | Gmeiner et al. | Sep 1999 | A |
| 5950879 | Ritsche | Sep 1999 | A |
| 5951521 | Mastrototaro et al. | Sep 1999 | A |
| 5951523 | Oesterlind et al. | Sep 1999 | A |
| 5954485 | Johnson et al. | Sep 1999 | A |
| 5954643 | Vanantwerp et al. | Sep 1999 | A |
| 5954685 | Tierney et al. | Sep 1999 | A |
| 5954696 | Ryan et al. | Sep 1999 | A |
| 5954697 | Srisathapat et al. | Sep 1999 | A |
| 5954700 | Kovelman | Sep 1999 | A |
| 5954752 | Mongeon et al. | Sep 1999 | A |
| 5957861 | Combs et al. | Sep 1999 | A |
| 5957885 | Bollish et al. | Sep 1999 | A |
| 5957889 | Poulsen et al. | Sep 1999 | A |
| 5957890 | Mann et al. | Sep 1999 | A |
| 5957895 | Sage et al. | Sep 1999 | A |
| 5958760 | Freeman | Sep 1999 | A |
| 5961305 | Eek et al. | Oct 1999 | A |
| 5961483 | Sage et al. | Oct 1999 | A |
| 5962566 | Grandfils et al. | Oct 1999 | A |
| 5962794 | Kriesel et al. | Oct 1999 | A |
| 5964377 | Demarest et al. | Oct 1999 | A |
| 5964724 | Rivera et al. | Oct 1999 | A |
| 5971722 | Maget et al. | Oct 1999 | A |
| 5973012 | Behrmann et al. | Oct 1999 | A |
| 5976109 | Heruth et al. | Nov 1999 | A |
| 5980489 | Kriesel | Nov 1999 | A |
| 5980596 | Herskowitz et al. | Nov 1999 | A |
| 5983976 | Kono | Nov 1999 | A |
| 5984894 | Poulsen et al. | Nov 1999 | A |
| 5984897 | Petersen et al. | Nov 1999 | A |
| 5984906 | Bonnichsen et al. | Nov 1999 | A |
| 5985305 | Peery et al. | Nov 1999 | A |
| 5988165 | Richey et al. | Nov 1999 | A |
| 5988851 | Gent | Nov 1999 | A |
| 5988998 | Glover | Nov 1999 | A |
| 5989216 | Johnson et al. | Nov 1999 | A |
| 5989222 | Cole et al. | Nov 1999 | A |
| 5989238 | Ginsburg | Nov 1999 | A |
| 5989409 | Kurnik et al. | Nov 1999 | A |
| 5992695 | Start | Nov 1999 | A |
| 5993421 | Kriesel | Nov 1999 | A |
| 5993425 | Kriesel | Nov 1999 | A |
| 5995860 | Sun et al. | Nov 1999 | A |
| 5997475 | Bortz | Dec 1999 | A |
| 5997501 | Gross et al. | Dec 1999 | A |
| 5997518 | Laibovitz et al. | Dec 1999 | A |
| 6001089 | Burroughs et al. | Dec 1999 | A |
| 6001585 | Gramer | Dec 1999 | A |
| 6003566 | Thibault et al. | Dec 1999 | A |
| 6003736 | Ljunggren | Dec 1999 | A |
| 6006800 | Nakano | Dec 1999 | A |
| 6007314 | Nelson, II | Dec 1999 | A |
| 6007518 | Kriesel et al. | Dec 1999 | A |
| 6012034 | Hamparian et al. | Jan 2000 | A |
| 6012492 | Kozyuk | Jan 2000 | A |
| 6013020 | Meloul et al. | Jan 2000 | A |
| 6016044 | Holdaway | Jan 2000 | A |
| 6017318 | Gauthier et al. | Jan 2000 | A |
| 6017545 | Modi | Jan 2000 | A |
| 6019747 | McPhee | Feb 2000 | A |
| 6023629 | Tamada | Feb 2000 | A |
| 6023641 | Thompson | Feb 2000 | A |
| 6024009 | Morita | Feb 2000 | A |
| 6024539 | Blomwuist | Feb 2000 | A |
| 6024699 | Surwit et al. | Feb 2000 | A |
| 6030358 | Odland | Feb 2000 | A |
| 6030363 | Kriesel | Feb 2000 | A |
| 6033377 | Rasmussen et al. | Mar 2000 | A |
| 6034054 | Defelippis et al. | Mar 2000 | A |
| 6035639 | Kolmanovsky et al. | Mar 2000 | A |
| 6037346 | Doherty, Jr. et al. | Mar 2000 | A |
| 6038960 | Fukushima et al. | Mar 2000 | A |
| 6040834 | Jain et al. | Mar 2000 | A |
| 6042461 | Ash et al. | Mar 2000 | A |
| 6045537 | Kiltmose | Apr 2000 | A |
| 6048337 | Svedman et al. | Apr 2000 | A |
| 6051256 | Platz et al. | Apr 2000 | A |
| 6053887 | Levitas et al. | Apr 2000 | A |
| 6056522 | Johnson | May 2000 | A |
| 6056718 | Funderburk et al. | May 2000 | A |
| 6059507 | Adams | May 2000 | A |
| 6059753 | Faust et al. | May 2000 | A |
| 6062022 | Folsom et al. | May 2000 | A |
| 6062531 | Rapp et al. | May 2000 | A |
| 6063053 | Castellano et al. | May 2000 | A |
| 6063059 | Kriesel | May 2000 | A |
| 6065279 | Kuromitsu et al. | May 2000 | A |
| 6065289 | Phillips | May 2000 | A |
| 6065941 | Gray et al. | May 2000 | A |
| 6070761 | Bloom et al. | Jun 2000 | A |
| 6071423 | Brown et al. | Jun 2000 | A |
| 6073048 | Kieval et al. | Jun 2000 | A |
| 6074359 | Keshaviah et al. | Jun 2000 | A |
| 6077055 | Vilks | Jun 2000 | A |
| 6077246 | Kullas et al. | Jun 2000 | A |
| 6080130 | Castellano | Jun 2000 | A |
| 6083602 | Caldwell et al. | Jul 2000 | A |
| 6083710 | Heller et al. | Jul 2000 | A |
| 6086561 | Kriesel et al. | Jul 2000 | A |
| 6086562 | Jacobsen et al. | Jul 2000 | A |
| 6093167 | Houben et al. | Jul 2000 | A |
| 6093172 | Funderburk et al. | Jul 2000 | A |
| 6093312 | Boulter et al. | Jul 2000 | A |
| 6095134 | Sievers et al. | Aug 2000 | A |
| 6096216 | Shanbrom et al. | Aug 2000 | A |
| 6099293 | Kern et al. | Aug 2000 | A |
| 6099495 | Kinghorn et al. | Aug 2000 | A |
| 6099504 | Gross et al. | Aug 2000 | A |
| 6102127 | Pierce | Aug 2000 | A |
| 6103033 | Say et al. | Aug 2000 | A |
| 6103275 | Seitz et al. | Aug 2000 | A |
| 6105442 | Kriesel et al. | Aug 2000 | A |
| 6106477 | Miesel et al. | Aug 2000 | A |
| 6109896 | Schuller et al. | Aug 2000 | A |
| 6110148 | Brown et al. | Aug 2000 | A |
| 6110149 | Klitgaard et al. | Aug 2000 | A |
| 6110152 | Kovelman | Aug 2000 | A |
| 6110427 | Uffenheimer | Aug 2000 | A |
| RE36871 | Epstein et al. | Sep 2000 | E |
| 6113782 | Leonard | Sep 2000 | A |
| 6117122 | Din et al. | Sep 2000 | A |
| 6120460 | Abreu | Sep 2000 | A |
| 6122536 | Sun et al. | Sep 2000 | A |
| 6123175 | Fett | Sep 2000 | A |
| 6123686 | Olsen et al. | Sep 2000 | A |
| 6126642 | Kriesel et al. | Oct 2000 | A |
| 6126956 | Grossman et al. | Oct 2000 | A |
| 6127363 | Doherty, Jr. et al. | Oct 2000 | A |
| 6132686 | Gallup et al. | Oct 2000 | A |
| 6135196 | Kono | Oct 2000 | A |
| 6135978 | Houben et al. | Oct 2000 | A |
| D433755 | Mastrototaro et al. | Nov 2000 | S |
| 6135625 | Prokop et al. | Nov 2000 | A |
| 6142939 | Eppstein et al. | Nov 2000 | A |
| 6143238 | Konishi et al. | Nov 2000 | A |
| 6143252 | Haxo, Jr. et al. | Nov 2000 | A |
| 6144866 | Miesel et al. | Nov 2000 | A |
| 6144869 | Berner et al. | Nov 2000 | A |
| 6146361 | Dibiasi et al. | Nov 2000 | A |
| 6147070 | Facchini | Nov 2000 | A |
| 6147109 | Liao et al. | Nov 2000 | A |
| 6152898 | Olsen et al. | Nov 2000 | A |
| 6155748 | Allen et al. | Dec 2000 | A |
| 6156753 | Doherty, Jr. et al. | Dec 2000 | A |
| 6158431 | Poole | Dec 2000 | A |
| 6158965 | Butterfield et al. | Dec 2000 | A |
| 6163721 | Thompson | Dec 2000 | A |
| 6164924 | Gruett et al. | Dec 2000 | A |
| 6165155 | Jacobsen et al. | Dec 2000 | A |
| 6167290 | Yang et al. | Dec 2000 | A |
| 6168575 | Soltanpour | Jan 2001 | B1 |
| 6175752 | Rienarts et al. | Jan 2001 | B1 |
| 6178996 | Suzuki | Jan 2001 | B1 |
| 6179583 | Weston | Jan 2001 | B1 |
| 6180416 | Kurnik et al. | Jan 2001 | B1 |
| 6180597 | Liao | Jan 2001 | B1 |
| 6224347 | Clark et al. | Jan 2001 | B1 |
| 6185460 | Thompson | Feb 2001 | B1 |
| 6186982 | Gross et al. | Feb 2001 | B1 |
| 6190359 | Heruth et al. | Feb 2001 | B1 |
| 6198383 | Sekura et al. | Mar 2001 | B1 |
| 6202708 | Bynum et al. | Mar 2001 | B1 |
| 6205961 | Bailey et al. | Mar 2001 | B1 |
| 6210135 | Rassin et al. | Apr 2001 | B1 |
| 6210361 | Kamen et al. | Apr 2001 | B1 |
| 6210368 | Rogers et al. | Apr 2001 | B1 |
| 6210957 | Carpentier et al. | Apr 2001 | B1 |
| 6211147 | Unemori | Apr 2001 | B1 |
| 6211426 | Abrams | Apr 2001 | B1 |
| 6212948 | Ekdahl et al. | Apr 2001 | B1 |
| 6213120 | Block et al. | Apr 2001 | B1 |
| 6213408 | Shekalim | Apr 2001 | B1 |
| 6217826 | Reeder et al. | Apr 2001 | B1 |
| 6218666 | Lukica et al. | Apr 2001 | B1 |
| 6221378 | Modi | Apr 2001 | B1 |
| 6223080 | Thompson | Apr 2001 | B1 |
| 6223703 | Galvin | May 2001 | B1 |
| 6223746 | Jewett et al. | May 2001 | B1 |
| 6224352 | Hauser et al. | May 2001 | B1 |
| 6225999 | Jain et al. | May 2001 | B1 |
| 6227818 | Falk et al. | May 2001 | B1 |
| 6228044 | Jensen et al. | May 2001 | B1 |
| 6229584 | Chou et al. | May 2001 | B1 |
| 6231545 | Kriesel et al. | May 2001 | B1 |
| 6231560 | Bui et al. | May 2001 | B1 |
| 6231882 | Modi | May 2001 | B1 |
| 6232609 | Snyder et al. | May 2001 | B1 |
| 6233471 | Berner et al. | May 2001 | B1 |
| 6236887 | Ben-Haim et al. | May 2001 | B1 |
| 6238423 | Bardy | May 2001 | B1 |
| 6241704 | Peterson et al. | Jun 2001 | B1 |
| 6241743 | Levin et al. | Jun 2001 | B1 |
| 6245347 | Zhang et al. | Jun 2001 | B1 |
| 6247493 | Henderson | Jun 2001 | B1 |
| 6248067 | Causey, III et al. | Jun 2001 | B1 |
| 6248093 | Moberg et al. | Jun 2001 | B1 |
| 6248280 | Kern et al. | Jun 2001 | B1 |
| 6251098 | Rake et al. | Jun 2001 | B1 |
| 6251293 | Snodgrass et al. | Jun 2001 | B1 |
| 6251932 | Reichelt et al. | Jun 2001 | B1 |
| 6254355 | Gharib | Jul 2001 | B1 |
| 6254569 | O'Donell et al. | Jul 2001 | B1 |
| 6254576 | Shekalim | Jul 2001 | B1 |
| 6254586 | Mann et al. | Jul 2001 | B1 |
| 6256533 | Yuzhakov et al. | Jul 2001 | B1 |
| 6257178 | Laimboeck | Jul 2001 | B1 |
| 6257191 | Kutlucinar | Jul 2001 | B1 |
| 6261272 | Gross et al. | Jul 2001 | B1 |
| 6261280 | Houben et al. | Jul 2001 | B1 |
| 6264429 | Falk et al. | Jul 2001 | B1 |
| 6264680 | Ash | Jul 2001 | B1 |
| 6266564 | Hill et al. | Jul 2001 | B1 |
| 6267564 | Rapheal | Jul 2001 | B1 |
| 6269340 | Ford et al. | Jul 2001 | B1 |
| 6270478 | Mernoee | Aug 2001 | B1 |
| 6272364 | Kurnik et al. | Aug 2001 | B1 |
| 6275717 | Gross et al. | Aug 2001 | B1 |
| 6276434 | Kono | Aug 2001 | B1 |
| 6277095 | Kriesel et al. | Aug 2001 | B1 |
| 6277097 | Mikkelsen et al. | Aug 2001 | B1 |
| 6277819 | Effendic | Aug 2001 | B1 |
| 6280408 | Sipin et al. | Aug 2001 | B1 |
| 6280409 | Stone et al. | Aug 2001 | B1 |
| 6280416 | Van Antwerp et al. | Aug 2001 | B1 |
| 6283197 | Kono | Sep 2001 | B1 |
| 6283680 | Mdal | Sep 2001 | B1 |
| 6283943 | Dy et al. | Sep 2001 | B1 |
| 6283944 | McMullen et al. | Sep 2001 | B1 |
| 6283949 | Roorda et al. | Sep 2001 | B1 |
| 6284725 | Coolidge et al. | Sep 2001 | B1 |
| 6288518 | Yang et al. | Sep 2001 | B1 |
| 6289248 | Conley et al. | Sep 2001 | B1 |
| 6290683 | Erez et al. | Sep 2001 | B1 |
| 6293159 | Kriesel et al. | Sep 2001 | B1 |
| 6293242 | Kutlucinar | Sep 2001 | B1 |
| 6293429 | Sadler et al. | Sep 2001 | B2 |
| 6293756 | Andersson | Sep 2001 | B1 |
| 6294550 | Place et al. | Sep 2001 | B1 |
| 6296456 | Thronelow et al. | Oct 2001 | B1 |
| 6296623 | Spinello | Oct 2001 | B2 |
| 6298254 | Tamada | Oct 2001 | B2 |
| 6298760 | Truttmann et al. | Oct 2001 | B1 |
| 6298941 | Spadafora | Oct 2001 | B1 |
| 6299415 | Bahrton | Oct 2001 | B1 |
| 6299578 | Kurnik et al. | Oct 2001 | B1 |
| 6302107 | Richey, II et al. | Oct 2001 | B1 |
| 6302653 | Bryant et al. | Oct 2001 | B1 |
| 6302855 | Lav et al. | Oct 2001 | B1 |
| 6304911 | Brcich et al. | Oct 2001 | B1 |
| 6306420 | Cheikh | Oct 2001 | B1 |
| 6306841 | Place et al. | Oct 2001 | B1 |
| 6309351 | Kurnik et al. | Oct 2001 | B1 |
| 6309371 | Deboer et al. | Oct 2001 | B1 |
| 6310270 | Huang et al. | Oct 2001 | B1 |
| 6312409 | Gross | Nov 2001 | B1 |
| 6314317 | Willis et al. | Nov 2001 | B1 |
| 6315769 | Peer et al. | Nov 2001 | B1 |
| 6319215 | Manor et al. | Nov 2001 | B1 |
| 6319245 | Berrigan | Nov 2001 | B1 |
| 6323022 | Chang et al. | Nov 2001 | B1 |
| 6325999 | Bellgrau et al. | Dec 2001 | B1 |
| 6327964 | Schuller et al. | Dec 2001 | B1 |
| 6328004 | Rynhart | Dec 2001 | B1 |
| 6331172 | Epstein et al. | Dec 2001 | B1 |
| 6334761 | Tai et al. | Jan 2002 | B1 |
| 6338942 | Kraus et al. | Jan 2002 | B2 |
| 6340357 | Poulsen et al. | Jan 2002 | B1 |
| 6340421 | Vachon et al. | Jan 2002 | B1 |
| 6340783 | Snow | Jan 2002 | B1 |
| 6341232 | Conn et al. | Jan 2002 | B1 |
| 6342037 | Roe et al. | Jan 2002 | B1 |
| 6342484 | Kulkarni et al. | Jan 2002 | B1 |
| 6344457 | Jeanpitit et al. | Feb 2002 | B1 |
| 6346095 | Gross et al. | Feb 2002 | B1 |
| 6359589 | Morris et al. | Feb 2002 | B1 |
| 6355030 | Aldrich et al. | Mar 2002 | B1 |
| 6358225 | Butterfield | Mar 2002 | B1 |
| 6358519 | Waterman | Mar 2002 | B1 |
| 6360888 | McIvor et al. | Mar 2002 | B1 |
| 6362591 | Moberg | Mar 2002 | B1 |
| 6364865 | Lavi et al. | Apr 2002 | B1 |
| 6365285 | Ritschel et al. | Apr 2002 | B1 |
| 6365628 | Berge | Apr 2002 | B1 |
| 6366808 | Schroeppel et al. | Apr 2002 | B1 |
| 6368272 | Porbumbescu | Apr 2002 | B1 |
| 6368314 | Kipfer et al. | Apr 2002 | B1 |
| 6371732 | Moubayed et al. | Apr 2002 | B1 |
| 6372182 | Mauro et al. | Apr 2002 | B1 |
| 6372508 | Shnizer et al. | Apr 2002 | B1 |
| 6374683 | Hunicke-Smith et al. | Apr 2002 | B1 |
| 6374876 | Bynum et al. | Apr 2002 | B2 |
| 6375638 | Nason et al. | Apr 2002 | B2 |
| 6381493 | Stadler et al. | Apr 2002 | B1 |
| 6382923 | Gray | May 2002 | B1 |
| 6393318 | Conn et al. | May 2002 | B1 |
| 6393893 | Fetz et al. | May 2002 | B1 |
| 6394981 | Heruth et al. | May 2002 | B2 |
| 6395292 | Peery et al. | May 2002 | B2 |
| 6395536 | Freeman | May 2002 | B2 |
| 6397199 | Goodwini, III | May 2002 | B1 |
| 6398718 | Yachia et al. | Jun 2002 | B1 |
| 6398760 | Danby et al. | Jun 2002 | B1 |
| 6399024 | Bevirt et al. | Jun 2002 | B1 |
| 6402689 | Scarantino et al. | Jun 2002 | B1 |
| 6406455 | Willis et al. | Jun 2002 | B1 |
| 6409698 | Robinson et al. | Jun 2002 | B1 |
| 6412273 | Rohs | Jul 2002 | B1 |
| 6413238 | Maget | Jul 2002 | B1 |
| 6413254 | Hissong et al. | Jul 2002 | B1 |
| 6415961 | Bonningue | Jul 2002 | B2 |
| 6416215 | Terentiev | Jul 2002 | B1 |
| 6416293 | Bouchard et al. | Jul 2002 | B1 |
| 6420169 | Read et al. | Jul 2002 | B1 |
| 6422057 | Anderson | Jul 2002 | B1 |
| 6422256 | Balazy et al. | Jul 2002 | B1 |
| 6423029 | Elsberry | Jul 2002 | B1 |
| 6423035 | Das et al. | Jul 2002 | B1 |
| 6423344 | Platz et al. | Jul 2002 | B1 |
| 6424847 | Mastrototaro et al. | Jul 2002 | B1 |
| 6425878 | Shekalim | Jul 2002 | B1 |
| 6427088 | Bowman, IV et al. | Jul 2002 | B1 |
| 6428491 | Weiss | Aug 2002 | B1 |
| 6429197 | Coolidge et al. | Aug 2002 | B1 |
| 6429230 | Cavazza | Aug 2002 | B1 |
| 6429232 | Kinsella et al. | Aug 2002 | B1 |
| 6433040 | Dellamary et al. | Aug 2002 | B1 |
| 6436072 | Kullas et al. | Aug 2002 | B1 |
| 6436078 | Svedman et al. | Aug 2002 | B1 |
| 6438408 | Svedman et al. | Aug 2002 | B1 |
| 6438414 | Conn et al. | Aug 2002 | B1 |
| 6440096 | Lastovich et al. | Aug 2002 | B1 |
| 6441036 | Berge | Aug 2002 | B1 |
| 6442433 | Linberg | Aug 2002 | B1 |
| 6443097 | Zohar et al. | Sep 2002 | B1 |
| 6443942 | Van Antwerp et al. | Sep 2002 | B2 |
| 6446513 | Henderson | Sep 2002 | B1 |
| 6447443 | Keogh et al. | Sep 2002 | B1 |
| 6447446 | Smith et al. | Sep 2002 | B1 |
| 6447475 | Castellano | Sep 2002 | B1 |
| 6447522 | Gambale et al. | Sep 2002 | B2 |
| 6450942 | Lapanashvili et al. | Sep 2002 | B1 |
| 6450953 | Place et al. | Sep 2002 | B1 |
| 6454707 | Casscells, III et al. | Sep 2002 | B1 |
| 6454785 | De Hoyos Garza | Sep 2002 | B2 |
| 6457956 | Hauser et al. | Oct 2002 | B1 |
| 6458102 | Mann et al. | Oct 2002 | B1 |
| 6458109 | Henley et al. | Oct 2002 | B1 |
| 6458256 | Zhong | Oct 2002 | B1 |
| 6458762 | McKenzie et al. | Oct 2002 | B1 |
| 6461329 | Van Antwerp et al. | Oct 2002 | B1 |
| 6461331 | Van Antwerp | Oct 2002 | B1 |
| 6461334 | Buch-Rasmussen et al. | Oct 2002 | B1 |
| 6461828 | Stanton et al. | Oct 2002 | B1 |
| 6463794 | Moshe et al. | Oct 2002 | B1 |
| 6464667 | Kamen et al. | Oct 2002 | B1 |
| 6467267 | Kanazawa et al. | Oct 2002 | B2 |
| 6468200 | Fischi | Oct 2002 | B1 |
| 6468242 | Wilson et al. | Oct 2002 | B1 |
| 6469016 | Place et al. | Oct 2002 | B1 |
| 6470234 | McGrady | Oct 2002 | B1 |
| 6471496 | Merklein et al. | Oct 2002 | B1 |
| 6471689 | Joseph et al. | Oct 2002 | B1 |
| 6471855 | Odak et al. | Oct 2002 | B1 |
| 6472434 | Place et al. | Oct 2002 | B1 |
| 6474219 | Klitmose et al. | Nov 2002 | B2 |
| 6475180 | Peterson et al. | Nov 2002 | B2 |
| 6475750 | Han et al. | Nov 2002 | B1 |
| 6477774 | Marando et al. | Nov 2002 | B1 |
| 6478385 | Nishii et al. | Nov 2002 | B2 |
| 6478771 | Lavi et al. | Nov 2002 | B1 |
| 6482186 | Douglas et al. | Nov 2002 | B1 |
| 6484906 | Bonnigue | Nov 2002 | B2 |
| 6485263 | Brant et al. | Nov 2002 | B1 |
| 6485452 | French et al. | Nov 2002 | B1 |
| 6485461 | Mason et al. | Nov 2002 | B1 |
| 6485463 | Yeh | Nov 2002 | B1 |
| 6485464 | Christenson et al. | Nov 2002 | B1 |
| 6485465 | Moberg et al. | Nov 2002 | B2 |
| 6485471 | Zivitz et al. | Nov 2002 | B1 |
| 6488652 | Weijand et al. | Dec 2002 | B1 |
| 6488697 | Ariura et al. | Dec 2002 | B1 |
| 6489346 | Phillips | Dec 2002 | B1 |
| 6490483 | Willis et al. | Dec 2002 | B2 |
| 6494865 | Alchas et al. | Dec 2002 | B1 |
| 6500150 | Gross et al. | Dec 2002 | B1 |
| 6505059 | Kollias et al. | Jan 2003 | B1 |
| 6506594 | Barany et al. | Jan 2003 | B1 |
| 6508788 | Prethun | Jan 2003 | B2 |
| 6511435 | Bluth et al. | Jan 2003 | B1 |
| 6512949 | Combs et al. | Jan 2003 | B1 |
| 6522980 | Arnold | Jan 2003 | B1 |
| 6514689 | Han et al. | Feb 2003 | B2 |
| 6517482 | Elden et al. | Feb 2003 | B1 |
| 6520936 | Mann et al. | Feb 2003 | B1 |
| 6520938 | Funderburk et al. | Feb 2003 | B1 |
| 6530900 | Daily et al. | Mar 2003 | B1 |
| 6533183 | Aasmul et al. | Mar 2003 | B2 |
| 6535714 | Melker et al. | Mar 2003 | B2 |
| 6537241 | Odland | Mar 2003 | B1 |
| 6537251 | Klitmose | Mar 2003 | B2 |
| 6537268 | Gibson et al. | Mar 2003 | B1 |
| 6537272 | Christopherson et al. | Mar 2003 | B2 |
| 6540006 | Kono | Apr 2003 | B2 |
| 6540161 | Gordon | Apr 2003 | B1 |
| 6540727 | Harper et al. | Apr 2003 | B2 |
| 6540996 | Zwaal et al. | Apr 2003 | B1 |
| 6541021 | Johnson et al. | Apr 2003 | B1 |
| 6542774 | Hill et al. | Apr 2003 | B2 |
| 6544212 | Galley et al. | Apr 2003 | B2 |
| 6544233 | Danby et al. | Apr 2003 | B1 |
| 6546269 | Kurnik | Apr 2003 | B1 |
| 6547775 | Blyakhman | Apr 2003 | B1 |
| 6550245 | Nishii et al. | Apr 2003 | B2 |
| 6551276 | Mann et al. | Apr 2003 | B1 |
| 6551277 | Ford | Apr 2003 | B1 |
| 6551992 | Defelippis et al. | Apr 2003 | B1 |
| 6553244 | Lesho et al. | Apr 2003 | B2 |
| 6553245 | Grace et al. | Apr 2003 | B1 |
| 6554798 | Mann et al. | Apr 2003 | B1 |
| 6555986 | Moberg | Apr 2003 | B2 |
| 6557454 | Miyazawa | Apr 2003 | B2 |
| 6558320 | Causey et al. | May 2003 | B1 |
| 6558345 | Houben et al. | May 2003 | B1 |
| 6558351 | Steil et al. | May 2003 | B1 |
| 6558665 | Cohen et al. | May 2003 | B1 |
| 6558902 | Hillenkamp | May 2003 | B1 |
| 6560478 | Alfano et al. | May 2003 | B1 |
| 6561978 | Conn et al. | May 2003 | B1 |
| 6562001 | Lebel et al. | May 2003 | B2 |
| 6562011 | Buch-Rasmussen et al. | May 2003 | B1 |
| 6564093 | Ostrow et al. | May 2003 | B1 |
| 6564104 | Nelson et al. | May 2003 | B2 |
| 6564105 | Starkweather et al. | May 2003 | B2 |
| 6565802 | Hanley et al. | May 2003 | B1 |
| 6565872 | Wu et al. | May 2003 | B2 |
| 6568898 | Nishimura et al. | May 2003 | B2 |
| 6568922 | Winsel | May 2003 | B1 |
| 6569123 | Alchas et al. | May 2003 | B2 |
| 6569143 | Alchas et al. | May 2003 | B2 |
| 6569456 | Faour et al. | May 2003 | B2 |
| 6571128 | Lebel et al. | May 2003 | B2 |
| 6571931 | Hart | Jun 2003 | B2 |
| 6572542 | Houben et al. | Jun 2003 | B1 |
| 6572566 | Effenhauser et al. | Jun 2003 | B2 |
| 6572586 | Wojick | Jun 2003 | B1 |
| 6572787 | Huisman et al. | Jun 2003 | B1 |
| 6575935 | Oliver et al. | Jun 2003 | B1 |
| 6577899 | Lebel et al. | Jun 2003 | B2 |
| 6579496 | Fausset et al. | Jun 2003 | B1 |
| 6582366 | Porumbescu | Jun 2003 | B1 |
| 6582393 | Sage | Jun 2003 | B2 |
| 6582418 | Verbeek et al. | Jun 2003 | B1 |
| 6583111 | DiMarchi et al. | Jun 2003 | B1 |
| 6585644 | Lebel et al. | Jul 2003 | B2 |
| 6585695 | Adair et al. | Jul 2003 | B1 |
| 6585707 | Cabiri et al. | Jul 2003 | B2 |
| 6587705 | Kim et al. | Jul 2003 | B1 |
| 6589158 | Winkler et al. | Jul 2003 | B2 |
| 6589229 | Connelly et al. | Jul 2003 | B1 |
| 6592544 | Mooney et al. | Jul 2003 | B1 |
| 6592571 | Verbeek et al. | Jul 2003 | B1 |
| 6592860 | Levy et al. | Jul 2003 | B1 |
| 6592904 | Platz et al. | Jul 2003 | B2 |
| 6593313 | Place et al. | Jul 2003 | B2 |
| 6594514 | Berner et al. | Jul 2003 | B2 |
| 6594634 | Hampton et al. | Jul 2003 | B1 |
| 6595648 | Suzuki et al. | Jul 2003 | B1 |
| 6595756 | Gray et al. | Jul 2003 | B2 |
| 6595919 | Berner et al. | Jul 2003 | B2 |
| 6595956 | Gross et al. | Jul 2003 | B1 |
| 6599281 | Struys et al. | Jul 2003 | B1 |
| 6602241 | Makower et al. | Aug 2003 | B2 |
| 6604908 | Bryant et al. | Aug 2003 | B1 |
| 6605072 | Struys et al. | Aug 2003 | B2 |
| 6607513 | Down et al. | Aug 2003 | B1 |
| 6607658 | Heller et al. | Aug 2003 | B1 |
| 6607739 | Wallo | Aug 2003 | B1 |
| 6610003 | Meloul et al. | Aug 2003 | B1 |
| 6612535 | Tai et al. | Sep 2003 | B1 |
| 6613019 | Munk | Sep 2003 | B2 |
| 6616196 | Weh et al. | Sep 2003 | B1 |
| 6616627 | Willis et al. | Sep 2003 | B2 |
| 6618603 | Varalli et al. | Sep 2003 | B2 |
| 6620140 | Metzger | Sep 2003 | B1 |
| 6620379 | Piuk et al. | Sep 2003 | B1 |
| 6623698 | Kuo | Sep 2003 | B2 |
| 6625479 | Weber et al. | Sep 2003 | B1 |
| 6626644 | Ozaki | Sep 2003 | B2 |
| 6629934 | Mault et al. | Oct 2003 | B2 |
| 6629938 | Engvall et al. | Oct 2003 | B1 |
| 6629949 | Douglas | Oct 2003 | B1 |
| 6629954 | Heruth et al. | Oct 2003 | B1 |
| 6634939 | Johnson et al. | Oct 2003 | B2 |
| 6635014 | Starkweather et al. | Oct 2003 | B2 |
| 6635048 | Ullestad et al. | Oct 2003 | B1 |
| 6636796 | Kolmanovsky et al. | Oct 2003 | B2 |
| 6639381 | Tamura et al. | Oct 2003 | B2 |
| 6641533 | Causey, III et al. | Nov 2003 | B2 |
| 6641562 | Peterson et al. | Nov 2003 | B1 |
| 6641565 | Lavi et al. | Nov 2003 | B1 |
| 6641566 | Douglas et al. | Nov 2003 | B2 |
| 6642019 | Anderson et al. | Nov 2003 | B1 |
| 6645176 | Christenson et al. | Nov 2003 | B1 |
| 6645181 | Lavi et al. | Nov 2003 | B1 |
| 6645448 | Cho et al. | Nov 2003 | B2 |
| 6648821 | Lebel et al. | Nov 2003 | B2 |
| 6648859 | Bitdinger et al. | Nov 2003 | B2 |
| 6648861 | Platt et al. | Nov 2003 | B2 |
| 6649403 | McDevitt et al. | Nov 2003 | B1 |
| 6650919 | Edelberg et al. | Nov 2003 | B2 |
| 6650951 | Jones et al. | Nov 2003 | B1 |
| 6651546 | Sandlin et al. | Nov 2003 | B2 |
| 6652493 | Das | Nov 2003 | B1 |
| 6652510 | Lord et al. | Nov 2003 | B2 |
| 6653091 | Dunn et al. | Nov 2003 | B1 |
| 6656114 | Poulsen et al. | Dec 2003 | B1 |
| 6656148 | Das et al. | Dec 2003 | B2 |
| 6656158 | Mahoney et al. | Dec 2003 | B2 |
| 6656159 | Flaherty et al. | Dec 2003 | B2 |
| 6659948 | Lebel et al. | Dec 2003 | B2 |
| 6659978 | Kasuga et al. | Dec 2003 | B1 |
| 6659980 | Moberg et al. | Dec 2003 | B2 |
| 6663359 | Gray et al. | Dec 2003 | B2 |
| 6663602 | Moller et al. | Dec 2003 | B2 |
| 6666621 | Keimel | Dec 2003 | B1 |
| 6666665 | Nguyen et al. | Dec 2003 | B1 |
| 6668196 | Villegas et al. | Dec 2003 | B1 |
| 6668701 | Everitt | Dec 2003 | B1 |
| 6669663 | Thompson | Dec 2003 | B1 |
| 6669669 | Flaherty et al. | Dec 2003 | B2 |
| 6673033 | Sciulli et al. | Jan 2004 | B1 |
| 6676387 | Penn et al. | Jan 2004 | B1 |
| 6677320 | Diederich et al. | Jan 2004 | B2 |
| 6679865 | Shekalim | Jan 2004 | B2 |
| 6682497 | Jensen et al. | Jan 2004 | B2 |
| 6683690 | Tobias | Jan 2004 | B1 |
| 6687522 | Tamada | Feb 2004 | B2 |
| 6687546 | Lebel et al. | Feb 2004 | B2 |
| 6689100 | Connelly et al. | Feb 2004 | B2 |
| 6689108 | Lavi et al. | Feb 2004 | B2 |
| 6689118 | Alchas et al. | Feb 2004 | B2 |
| 6689373 | Johnson et al. | Feb 2004 | B2 |
| 6692456 | Eppstein et al. | Feb 2004 | B1 |
| 6692457 | Flaherty | Feb 2004 | B2 |
| 6692472 | Hansen et al. | Feb 2004 | B2 |
| 6692473 | St. Cyr et al. | Feb 2004 | B2 |
| 6694191 | Starkweaather | Feb 2004 | B2 |
| 6695011 | Sochtig | Feb 2004 | B2 |
| 6696090 | Nilsson et al. | Feb 2004 | B1 |
| 6696493 | Cavazza | Feb 2004 | B2 |
| 6699218 | Flaherty et al. | Mar 2004 | B2 |
| 6699234 | Yeh et al. | Mar 2004 | B2 |
| 6699885 | Phillips | Mar 2004 | B2 |
| 6702779 | Connelly et al. | Mar 2004 | B2 |
| 6702857 | Brauker et al. | Mar 2004 | B2 |
| 6705845 | Krieger et al. | Mar 2004 | B2 |
| 6706008 | Vishnoi et al. | Mar 2004 | B2 |
| 6706009 | Diermann et al. | Mar 2004 | B2 |
| 6706689 | Coolidge et al. | Mar 2004 | B2 |
| 6710051 | Trier | Mar 2004 | B1 |
| 6711489 | Haskara et al. | Mar 2004 | B2 |
| 6712095 | Marttila et al. | Mar 2004 | B2 |
| 6715516 | Ohms et al. | Apr 2004 | B2 |
| 6716190 | Glines et al. | Apr 2004 | B1 |
| 6716198 | Larsen | Apr 2004 | B2 |
| 6718206 | Casavant | Apr 2004 | B2 |
| 6719302 | Andrick | Apr 2004 | B2 |
| 6723068 | Lavi et al. | Apr 2004 | B2 |
| 6723072 | Flaherty et al. | Apr 2004 | B2 |
| 6726920 | Theeuwes et al. | Apr 2004 | B1 |
| 6732573 | Shin et al. | May 2004 | B2 |
| 6733446 | Lebel et al. | May 2004 | B2 |
| 6734186 | Maw et al. | May 2004 | B1 |
| 6736796 | Shekalim | May 2004 | B2 |
| 6738052 | Manke et al. | May 2004 | B1 |
| 6738663 | Schroeppel et al. | May 2004 | B2 |
| 6738707 | Kotwicki et al. | May 2004 | B2 |
| 6740059 | Flaherty | May 2004 | B2 |
| 6740072 | Starkweather et al. | May 2004 | B2 |
| 6740075 | Lebel et al. | May 2004 | B2 |
| 6743201 | Doenig et al. | Jun 2004 | B1 |
| 6743202 | Hirschman et al. | Jun 2004 | B2 |
| 6744152 | Kroll | Jun 2004 | B2 |
| 6745079 | King | Jun 2004 | B2 |
| 6746438 | Arnissolle | Jun 2004 | B1 |
| 6748930 | Bofinger et al. | Jun 2004 | B2 |
| 6749403 | Bryant et al. | Jun 2004 | B2 |
| 6749587 | Flaherty | Jun 2004 | B2 |
| 6752785 | Van Antwerp et al. | Jun 2004 | B2 |
| 6755628 | Howell | Jun 2004 | B1 |
| 6755810 | Buch-Rasmussen et al. | Jun 2004 | B1 |
| 6758593 | Terentiev | Jul 2004 | B1 |
| 6758810 | Lebel et al. | Jul 2004 | B2 |
| 6759386 | Franco | Jul 2004 | B2 |
| 6767188 | Vrane et al. | Jul 2004 | B2 |
| 6767896 | McIntosh et al. | Jul 2004 | B1 |
| 6768425 | Flaherty et al. | Jul 2004 | B2 |
| 6769384 | Dougherty | Aug 2004 | B2 |
| 6770054 | Smolyarov et al. | Aug 2004 | B1 |
| 6770067 | Lorenzen et al. | Aug 2004 | B2 |
| 6773669 | Holaday et al. | Aug 2004 | B1 |
| 6773739 | Hauck et al. | Aug 2004 | B2 |
| 6775577 | Crnkovich et al. | Aug 2004 | B2 |
| 6776776 | Alchas et al. | Aug 2004 | B2 |
| 6780156 | Haueter et al. | Aug 2004 | B2 |
| 6780171 | Gabel et al. | Aug 2004 | B2 |
| 6780426 | Zhang et al. | Aug 2004 | B2 |
| 6780770 | Larson | Aug 2004 | B2 |
| 6780836 | Unemori | Aug 2004 | B2 |
| 6783107 | Chtufale | Aug 2004 | B2 |
| 6783328 | Lucke et al. | Aug 2004 | B2 |
| 6790670 | Munagavalasa | Sep 2004 | B2 |
| 6796956 | Hartlaub et al. | Sep 2004 | B2 |
| 6801420 | Talbot et al. | Oct 2004 | B2 |
| 6804002 | Fine et al. | Oct 2004 | B2 |
| 6804555 | Warkentin | Oct 2004 | B2 |
| 6805122 | Richey et al. | Oct 2004 | B2 |
| 6805687 | Dextradeur et al. | Oct 2004 | B2 |
| 6808506 | Lastovich et al. | Oct 2004 | B2 |
| 6809653 | Mann et al. | Oct 2004 | B1 |
| 6810290 | Lebel et al. | Oct 2004 | B2 |
| RE38654 | Hill et al. | Nov 2004 | E |
| 6811533 | Lebel et al. | Nov 2004 | B2 |
| 6811534 | Bowman et al. | Nov 2004 | B2 |
| 6811792 | Roser et al. | Nov 2004 | B2 |
| 6813519 | Lebel et al. | Nov 2004 | B2 |
| 6813964 | Clark et al. | Nov 2004 | B1 |
| 6814547 | Childers et al. | Nov 2004 | B2 |
| 6821249 | Casscells et al. | Nov 2004 | B2 |
| 6821484 | Gregersen | Nov 2004 | B1 |
| 6824529 | Gross et al. | Nov 2004 | B2 |
| 6827524 | Starry et al. | Dec 2004 | B2 |
| 6827702 | Lebel et al. | Dec 2004 | B2 |
| 6827710 | Mooney et al. | Dec 2004 | B1 |
| 6827898 | Fausset et al. | Dec 2004 | B1 |
| 6828552 | Hartley | Dec 2004 | B2 |
| 6830558 | Flaherty et al. | Dec 2004 | B2 |
| 6830580 | Gross et al. | Dec 2004 | B2 |
| 6835175 | Porumbescu | Dec 2004 | B1 |
| 6835194 | Johnson et al. | Dec 2004 | B2 |
| 6842642 | Vanhout | Jan 2005 | B2 |
| 6843782 | Gorss et al. | Jan 2005 | B2 |
| 6844350 | Kobayashi | Jan 2005 | B2 |
| 6847898 | Chen et al. | Jan 2005 | B1 |
| 6851449 | Kleibrink | Feb 2005 | B2 |
| 6852104 | Blomquist | Feb 2005 | B2 |
| 6852487 | Barany et al. | Feb 2005 | B1 |
| 6854432 | Hirano et al. | Feb 2005 | B2 |
| 6854620 | Ramey | Feb 2005 | B2 |
| 6858011 | Sehgal | Feb 2005 | B2 |
| 6858403 | Han et al. | Feb 2005 | B2 |
| 6859673 | Steffen | Feb 2005 | B2 |
| 6862466 | Ackerman | Mar 2005 | B2 |
| 6864101 | Wikler et al. | Mar 2005 | B1 |
| 6867196 | Wolff et al. | Mar 2005 | B1 |
| 6868358 | Brown et al. | Mar 2005 | B2 |
| 6872200 | Mann et al. | Mar 2005 | B2 |
| 6873268 | Lebel et al. | Mar 2005 | B2 |
| 6876885 | Swoyer et al. | Apr 2005 | B2 |
| 6877713 | Gray et al. | Apr 2005 | B1 |
| 6880564 | Erickson | Apr 2005 | B2 |
| 6882940 | Potts et al. | Apr 2005 | B2 |
| 6884122 | Robinson et al. | Apr 2005 | B2 |
| 6884228 | Brown et al. | Apr 2005 | B2 |
| 6885881 | Leonhardt | Apr 2005 | B2 |
| 6885888 | Rezai | Apr 2005 | B2 |
| 6886556 | Fuchs | May 2005 | B2 |
| 6892755 | Black et al. | May 2005 | B2 |
| 6892900 | Drechsel | May 2005 | B2 |
| 6893415 | Madsen et al. | May 2005 | B2 |
| 6894024 | Coolidge et al. | May 2005 | B2 |
| 6895263 | Shin et al. | May 2005 | B2 |
| 6896666 | Kochamba | May 2005 | B2 |
| 6899699 | Enggaard | May 2005 | B2 |
| RE38749 | Dardik | Jun 2005 | E |
| 6902905 | Burson et al. | Jun 2005 | B2 |
| 6905314 | Danby | Jun 2005 | B2 |
| 6905479 | Bouchard et al. | Jun 2005 | B1 |
| 6906028 | Defelippis et al. | Jun 2005 | B2 |
| 6908591 | MacPhee et al. | Jun 2005 | B2 |
| 6909840 | Harwig | Jun 2005 | B2 |
| 6912425 | Nova et al. | Jun 2005 | B2 |
| 6913933 | Jacobs et al. | Jul 2005 | B2 |
| 6914076 | Cavazza | Jul 2005 | B2 |
| 6916010 | Beck et al. | Jul 2005 | B2 |
| 6916159 | Rush et al. | Jul 2005 | B2 |
| 6918542 | Silverbrook et al. | Jul 2005 | B2 |
| 6923006 | Walton et al. | Jul 2005 | B2 |
| 6923180 | Richey, II et al. | Aug 2005 | B2 |
| 6923764 | Aceti et al. | Aug 2005 | B2 |
| 6926694 | Marano-Ford et al. | Aug 2005 | B2 |
| 6928338 | Buchser et al. | Aug 2005 | B1 |
| 6930093 | Brantl | Aug 2005 | B2 |
| 6931845 | Schaeffer | Aug 2005 | B2 |
| 6931925 | Huemer et al. | Aug 2005 | B2 |
| 6932114 | Sparks | Aug 2005 | B2 |
| 6932584 | Gray et al. | Aug 2005 | B2 |
| 6935531 | Sage et al. | Aug 2005 | B1 |
| 6935539 | Krieger et al. | Aug 2005 | B2 |
| 6936026 | Diermann et al. | Aug 2005 | B2 |
| 6936029 | Mann et al. | Aug 2005 | B2 |
| 6936035 | Rake et al. | Aug 2005 | B2 |
| 6936046 | Hissong et al. | Aug 2005 | B2 |
| 6939323 | Angel et al. | Aug 2005 | B2 |
| 6939324 | Gonnelli et al. | Sep 2005 | B2 |
| 6942636 | Holst et al. | Sep 2005 | B2 |
| 6943034 | Winkler et al. | Sep 2005 | B1 |
| 6945760 | Gray et al. | Sep 2005 | B2 |
| 6946117 | Schutt et al. | Sep 2005 | B1 |
| 6948918 | Hansen et al. | Sep 2005 | B2 |
| 6949081 | Chance | Sep 2005 | B1 |
| 6950708 | Bowman et al. | Sep 2005 | B2 |
| 6951165 | Kun et al. | Oct 2005 | B2 |
| 6951553 | Bubb et al. | Oct 2005 | B2 |
| 6952604 | Denuzzio et al. | Oct 2005 | B2 |
| 6952963 | Delnevo | Oct 2005 | B2 |
| 6953323 | Childers et al. | Oct 2005 | B2 |
| 6955819 | Zhang et al. | Oct 2005 | B2 |
| 6955915 | Fodor et al. | Oct 2005 | B2 |
| 6956204 | Dong et al. | Oct 2005 | B2 |
| 6957655 | Erickson et al. | Oct 2005 | B2 |
| 6957924 | McMeekin et al. | Oct 2005 | B1 |
| 6958073 | Rogers et al. | Oct 2005 | B2 |
| 6958691 | Anderson et al. | Oct 2005 | B1 |
| 6958705 | Lebel et al. | Oct 2005 | B2 |
| 6960184 | Willis et al. | Nov 2005 | B2 |
| 6960192 | Flaherty et al. | Nov 2005 | B1 |
| 6962103 | Sandlin | Nov 2005 | B2 |
| 6962151 | Knoch et al. | Nov 2005 | B1 |
| 6963770 | Scarantino et al. | Nov 2005 | B2 |
| 6966325 | Erickson | Nov 2005 | B2 |
| 6966895 | Tribe | Nov 2005 | B2 |
| 6969369 | Struble et al. | Nov 2005 | B2 |
| 6970741 | Whitehurst et al. | Nov 2005 | B1 |
| 6970742 | Mann et al. | Nov 2005 | B2 |
| 6971999 | Py et al. | Dec 2005 | B2 |
| 6973374 | Ader | Dec 2005 | B2 |
| 6974055 | Moore et al. | Dec 2005 | B2 |
| 6974115 | Silva et al. | Dec 2005 | B2 |
| 6974437 | Lebel et al. | Dec 2005 | B2 |
| 6974438 | Shekalim | Dec 2005 | B2 |
| 6974588 | Miranda et al. | Dec 2005 | B1 |
| 6979308 | MacDonald et al. | Dec 2005 | B1 |
| 6979315 | Rogers et al. | Dec 2005 | B2 |
| 6979316 | Rubin et al. | Dec 2005 | B1 |
| 6979326 | Mann et al. | Dec 2005 | B2 |
| 6980855 | Cho | Dec 2005 | B2 |
| 6981499 | Anderson et al. | Jan 2006 | B2 |
| 6981967 | Massengale et al. | Jan 2006 | B2 |
| 6982248 | Coolidge et al. | Jan 2006 | B2 |
| 6983209 | Jaynes | Jan 2006 | B2 |
| 6985770 | Nyhart et al. | Jan 2006 | B2 |
| 6985771 | Fischell et al. | Jan 2006 | B2 |
| 6986867 | Hanley et al. | Jan 2006 | B2 |
| 6987129 | Abouraphael | Jan 2006 | B2 |
| 6991619 | Marano-Ford et al. | Jan 2006 | B2 |
| 6991620 | Marano-Ford et al. | Jan 2006 | B2 |
| 6993795 | Prineppi et al. | Feb 2006 | B2 |
| 6994691 | Ejlersen | Feb 2006 | B2 |
| 6994700 | Elkins et al. | Feb 2006 | B2 |
| 6997202 | Olander | Feb 2006 | B2 |
| 6997905 | Gillespie et al. | Feb 2006 | B2 |
| 6997911 | Klitmose | Feb 2006 | B2 |
| 6997916 | Simas, Jr. et al. | Feb 2006 | B2 |
| 6997920 | Mann et al. | Feb 2006 | B2 |
| 6997921 | Gray et al. | Feb 2006 | B2 |
| 6998387 | Goke et al. | Feb 2006 | B1 |
| 6998404 | Moskowitz | Feb 2006 | B2 |
| 6999810 | Berner et al. | Feb 2006 | B2 |
| 6999854 | Roth | Feb 2006 | B2 |
| 7003336 | Holker et al. | Feb 2006 | B2 |
| 7004928 | Aceti et al. | Feb 2006 | B2 |
| 7008399 | Larsen et al. | Mar 2006 | B2 |
| 7008403 | Mallett et al. | Mar 2006 | B1 |
| 7008413 | Kovach et al. | Mar 2006 | B2 |
| 7010340 | Scarantino et al. | Mar 2006 | B2 |
| 7011630 | Desai et al. | Mar 2006 | B2 |
| 7011647 | Purdy et al. | Mar 2006 | B2 |
| 7011682 | Lashinski et al. | Mar 2006 | B2 |
| 7013727 | Delnevo | Mar 2006 | B2 |
| 7015782 | Kincaid et al. | Mar 2006 | B2 |
| 7018336 | Enegren et al. | Mar 2006 | B2 |
| 7018360 | Flaherty et al. | Mar 2006 | B2 |
| 7018361 | Gillespie et al. | Mar 2006 | B2 |
| 7018630 | Takaoka | Mar 2006 | B2 |
| 7022071 | Schaupp et al. | Apr 2006 | B2 |
| 7022072 | Fox et al. | Apr 2006 | B2 |
| 7022087 | Dempster et al. | Apr 2006 | B2 |
| 7022108 | Marano-Ford et al. | Apr 2006 | B2 |
| 7024244 | Muhlenberg et al. | Apr 2006 | B2 |
| 7024245 | Lebel et al. | Apr 2006 | B2 |
| 7025716 | Meloul et al. | Apr 2006 | B1 |
| 7025743 | Mann et al. | Apr 2006 | B2 |
| 7027478 | Ackley | Apr 2006 | B2 |
| 7027871 | Burnes et al. | Apr 2006 | B2 |
| 7029455 | Flaherty | Apr 2006 | B2 |
| 7031772 | Condie et al. | Apr 2006 | B2 |
| 7033338 | Vilks et al. | Apr 2006 | B2 |
| 7033539 | Krensky et al. | Apr 2006 | B2 |
| 7033843 | Hasegawa et al. | Apr 2006 | B2 |
| 7041082 | Blomquist et al. | May 2006 | B2 |
| 7047070 | Wilkinson et al. | May 2006 | B2 |
| 7048193 | Tsukada et al. | May 2006 | B2 |
| 7048951 | Seitz et al. | May 2006 | B1 |
| 7052251 | Nason et al. | May 2006 | B2 |
| 7052483 | Wojcik | May 2006 | B2 |
| 7053761 | Schofield et al. | May 2006 | B2 |
| 7056179 | Courtney | Jun 2006 | B2 |
| 7056302 | Douglas | Jun 2006 | B2 |
| 7056494 | Adjei et al. | Jun 2006 | B2 |
| 7056887 | Coolidge et al. | Jun 2006 | B2 |
| 7058438 | Grace et al. | Jun 2006 | B2 |
| 7059348 | Nat et al. | Jun 2006 | B2 |
| 7060856 | Macikenas et al. | Jun 2006 | B2 |
| 7063684 | Moberg et al. | Jun 2006 | B2 |
| 7064472 | Pelrine et al. | Jun 2006 | B2 |
| 7066359 | Greiner-Perth | Jun 2006 | B2 |
| 7066910 | Bauhahn et al. | Jun 2006 | B2 |
| 7066915 | Olsen | Jun 2006 | B2 |
| 7066922 | Angel et al. | Jun 2006 | B2 |
| 7069075 | Olson | Jun 2006 | B2 |
| 7070577 | Haller et al. | Jul 2006 | B1 |
| 7072802 | Hartlaub | Jul 2006 | B2 |
| 7073485 | Truscott et al. | Jul 2006 | B2 |
| 7073713 | Silverbrook et al. | Jul 2006 | B2 |
| 7074200 | Lewis | Jul 2006 | B1 |
| 7077822 | Howard, III et al. | Jul 2006 | B1 |
| 7078163 | Torrianni | Jul 2006 | B2 |
| 7081105 | Reilly et al. | Jul 2006 | B2 |
| 7082333 | Bauhahn et al. | Jul 2006 | B1 |
| 7082812 | Lenormand et al. | Aug 2006 | B2 |
| 7083108 | Silverbrook et al. | Aug 2006 | B2 |
| 7083592 | Lastovich et al. | Aug 2006 | B2 |
| 7083599 | Alchas et al. | Aug 2006 | B2 |
| 7089608 | Erb et al. | Aug 2006 | B2 |
| 7090648 | Sackner et al. | Aug 2006 | B2 |
| 7091179 | Franco | Aug 2006 | B2 |
| 7092011 | Silverbrook et al. | Aug 2006 | B2 |
| 7092796 | Vanderveen | Aug 2006 | B2 |
| 7095210 | Tamura et al. | Aug 2006 | B2 |
| 7096889 | Roys | Aug 2006 | B1 |
| 7097104 | Silverbrook et al. | Aug 2006 | B2 |
| 7098803 | Mann et al. | Aug 2006 | B2 |
| 7104973 | Woolston et al. | Sep 2006 | B2 |
| 7104981 | Elkins et al. | Sep 2006 | B2 |
| 7107706 | Bailey, Sr. et al. | Sep 2006 | B1 |
| 7107837 | Lauman et al. | Sep 2006 | B2 |
| 7108491 | Ganser | Sep 2006 | B2 |
| 7108679 | Alchas | Sep 2006 | B2 |
| 7109878 | Mann et al. | Sep 2006 | B2 |
| 7111346 | Inman et al. | Sep 2006 | B2 |
| 7115108 | Wilkinson et al. | Oct 2006 | B2 |
| 7118351 | Effenhauser et al. | Oct 2006 | B2 |
| 7118676 | Mueth et al. | Oct 2006 | B2 |
| 7122151 | Reeder et al. | Oct 2006 | B2 |
| 7127292 | Warman et al. | Oct 2006 | B2 |
| 7128727 | Flaherty et al. | Oct 2006 | B2 |
| 7128730 | Marano-Ford et al. | Oct 2006 | B2 |
| 7131967 | Gray et al. | Nov 2006 | B2 |
| 7133329 | Skyggebjerg et al. | Nov 2006 | B2 |
| 7136701 | Greatbatch et al. | Nov 2006 | B2 |
| 7137951 | Pilarski | Nov 2006 | B2 |
| 7137964 | Flaherty | Nov 2006 | B2 |
| 7138141 | Platz et al. | Nov 2006 | B2 |
| 7140332 | Klein et al. | Nov 2006 | B2 |
| 7141425 | Dzekunov et al. | Nov 2006 | B2 |
| 7141812 | Appleby et al. | Nov 2006 | B2 |
| 7144384 | Gorman et al. | Dec 2006 | B2 |
| 7144729 | Rolland et al. | Dec 2006 | B2 |
| 7147386 | Zhang et al. | Dec 2006 | B2 |
| 7147839 | Sampath et al. | Dec 2006 | B2 |
| 7150409 | Gonnelli et al. | Dec 2006 | B2 |
| 7150724 | Morris et al. | Dec 2006 | B2 |
| 7150726 | Dalton | Dec 2006 | B2 |
| 7150737 | Purdy et al. | Dec 2006 | B2 |
| 7150741 | Erickson et al. | Dec 2006 | B2 |
| 7152673 | Lobeck | Dec 2006 | B2 |
| 7153286 | Busby et al. | Dec 2006 | B2 |
| 7153823 | Franco | Dec 2006 | B2 |
| 7156808 | Quy | Jan 2007 | B2 |
| 7156838 | Gabel | Jan 2007 | B2 |
| 7159271 | Sepke et al. | Jan 2007 | B2 |
| 7162303 | Levin et al. | Jan 2007 | B2 |
| 7163385 | Gharib | Jan 2007 | B2 |
| 7163520 | Bernard et al. | Jan 2007 | B2 |
| 7166280 | Franco | Jan 2007 | B2 |
| 7171274 | Starkweather et al. | Jan 2007 | B2 |
| 7174199 | Berner et al. | Feb 2007 | B2 |
| 7179226 | Crothall et al. | Feb 2007 | B2 |
| 7181505 | Haller et al. | Feb 2007 | B2 |
| 7183066 | Burson et al. | Feb 2007 | B2 |
| 7186236 | Gibson et al. | Mar 2007 | B2 |
| 7187404 | Silverbrook et al. | Mar 2007 | B2 |
| 7187528 | Talbot et al. | Mar 2007 | B2 |
| 7187969 | Willis et al. | Mar 2007 | B2 |
| 7189352 | Carpenter et al. | Mar 2007 | B2 |
| 7193521 | Moberg et al. | Mar 2007 | B2 |
| 7194890 | Tanaka et al. | Mar 2007 | B2 |
| 7195616 | Atterbury et al. | Mar 2007 | B2 |
| 7198603 | Penner et al. | Apr 2007 | B2 |
| 7198637 | Deshmukh et al. | Apr 2007 | B2 |
| 7198751 | Carpenter et al. | Apr 2007 | B2 |
| 7198940 | Vellinger et al. | Apr 2007 | B2 |
| 7201319 | Silverbrook et al. | Apr 2007 | B2 |
| 7201730 | Davidner et al. | Apr 2007 | B2 |
| 7204823 | Estes et al. | Apr 2007 | B2 |
| 7204958 | Olsen et al. | Apr 2007 | B2 |
| 7207952 | Takinami et al. | Apr 2007 | B2 |
| 7207964 | Davidner et al. | Apr 2007 | B2 |
| 7208119 | Kurtock et al. | Apr 2007 | B1 |
| 7208120 | Bitensky et al. | Apr 2007 | B2 |
| 7214207 | Lynch et al. | May 2007 | B2 |
| 7214221 | Fentress et al. | May 2007 | B2 |
| 7214658 | Tobinick et al. | May 2007 | B2 |
| 7217699 | Yakubov | May 2007 | B2 |
| 7217796 | Wang et al. | May 2007 | B2 |
| 7220109 | Kultgen | May 2007 | B2 |
| 7220236 | Pan | May 2007 | B2 |
| 7220248 | Mernoe et al. | May 2007 | B2 |
| 7220365 | Qu et al. | May 2007 | B2 |
| 7224815 | Maltan et al. | May 2007 | B2 |
| 7225807 | Papania et al. | Jun 2007 | B2 |
| 7226278 | Nason et al. | Jun 2007 | B2 |
| 7226910 | Wilson et al. | Jun 2007 | B2 |
| 7229288 | Stuart et al. | Jun 2007 | B2 |
| 7229430 | Hickle et al. | Jun 2007 | B2 |
| 7231263 | Choi | Jun 2007 | B2 |
| 7232423 | Mernoe et al. | Jun 2007 | B2 |
| 7232430 | Carlisle et al. | Jun 2007 | B2 |
| 7232435 | Hildebrand et al. | Jun 2007 | B2 |
| 7234645 | Silverbrook et al. | Jun 2007 | B2 |
| 7235164 | Anex et al. | Jun 2007 | B2 |
| 7235583 | Webb et al. | Jun 2007 | B1 |
| 7237694 | Freudinger | Jul 2007 | B2 |
| 7238165 | Vincent et al. | Jul 2007 | B2 |
| 7239941 | Mori et al. | Jul 2007 | B2 |
| 7244225 | Loeb et al. | Jul 2007 | B2 |
| 7244354 | Burris et al. | Jul 2007 | B2 |
| 7247138 | Reghabi et al. | Jul 2007 | B2 |
| 7247428 | Makrigiorgos | Jul 2007 | B2 |
| 7247702 | Gardner et al. | Jul 2007 | B2 |
| 7250037 | Shermer et al. | Jul 2007 | B2 |
| 7251516 | Walker et al. | Jul 2007 | B2 |
| 7252014 | Mayer et al. | Aug 2007 | B1 |
| 7252651 | Haider et al. | Aug 2007 | B2 |
| 7254782 | Sherer | Aug 2007 | B1 |
| 7255690 | Gray et al. | Aug 2007 | B2 |
| 7256771 | Novak et al. | Aug 2007 | B2 |
| 7256824 | Silverbrook et al. | Aug 2007 | B2 |
| 7256888 | Staehr et al. | Aug 2007 | B2 |
| 7258864 | Clark | Aug 2007 | B2 |
| RE39816 | Stanton et al. | Sep 2007 | E |
| 7264730 | Connell et al. | Sep 2007 | B2 |
| 7265091 | Lue et al. | Sep 2007 | B2 |
| 7267665 | Steil et al. | Sep 2007 | B2 |
| 7267753 | Anex et al. | Sep 2007 | B2 |
| 7267771 | Gorsuch et al. | Sep 2007 | B2 |
| 7268859 | Sage et al. | Sep 2007 | B2 |
| 7272544 | Gopal et al. | Sep 2007 | B2 |
| 7276027 | Haar et al. | Oct 2007 | B2 |
| 7276028 | Ellingsen et al. | Oct 2007 | B2 |
| 7276057 | Gerber et al. | Oct 2007 | B2 |
| 7278983 | Ireland et al. | Oct 2007 | B2 |
| 7281519 | Schroeder et al. | Oct 2007 | B2 |
| 7282029 | Poulsen et al. | Oct 2007 | B1 |
| 7285293 | Castillo et al. | Oct 2007 | B2 |
| 7287289 | Hagopian | Oct 2007 | B1 |
| 7287485 | Petrakis | Oct 2007 | B2 |
| 7288085 | Olsen | Oct 2007 | B2 |
| 7288760 | Weitz | Oct 2007 | B2 |
| 7289142 | Silverbrook | Oct 2007 | B2 |
| 7291126 | Shekalim et al. | Nov 2007 | B2 |
| 7291132 | Deruntz et al. | Nov 2007 | B2 |
| 7291133 | Kindler et al. | Nov 2007 | B1 |
| 7295867 | Berner et al. | Nov 2007 | B2 |
| 7297151 | Boecker et al. | Nov 2007 | B2 |
| 7302295 | Stahmann et al. | Nov 2007 | B2 |
| 7303543 | Maule et al. | Dec 2007 | B1 |
| 7303549 | Flaherty et al. | Dec 2007 | B2 |
| 7303680 | Connell et al. | Dec 2007 | B2 |
| 7304033 | Larsen et al. | Dec 2007 | B2 |
| 7305975 | Reddy | Dec 2007 | B2 |
| 7306555 | Dolecek et al. | Dec 2007 | B2 |
| 7306578 | Gray et al. | Dec 2007 | B2 |
| 7311693 | Shekalim et al. | Dec 2007 | B2 |
| 7316700 | Alden et al. | Jan 2008 | B2 |
| 7316899 | McDevitt et al. | Jan 2008 | B2 |
| 7318892 | Connell et al. | Jan 2008 | B2 |
| 7320675 | Pastore et al. | Jan 2008 | B2 |
| 7320677 | Brouillette et al. | Jan 2008 | B2 |
| 7322321 | Robinson et al. | Jan 2008 | B2 |
| 7323141 | Kirchhevel et al. | Jan 2008 | B2 |
| 7323543 | Van Antwerp et al. | Jan 2008 | B2 |
| 7324012 | Mann et al. | Jan 2008 | B2 |
| 7324949 | Bristol | Jan 2008 | B2 |
| 7334556 | Wachigai et al. | Feb 2008 | B2 |
| 7335377 | Stern et al. | Feb 2008 | B2 |
| 7338464 | Blischak et al. | Mar 2008 | B2 |
| 7341577 | Gill | Mar 2008 | B2 |
| 7341581 | Mallett et al. | Mar 2008 | B2 |
| 7344500 | Talbot et al. | Mar 2008 | B2 |
| 7344507 | Briggs et al. | Mar 2008 | B2 |
| 7344894 | Greenstien et al. | Mar 2008 | B2 |
| 7347836 | Peterson et al. | Mar 2008 | B2 |
| 7347854 | Shelton et al. | Mar 2008 | B2 |
| 7348176 | Dimilla et al. | Mar 2008 | B2 |
| 7350190 | Torres et al. | Mar 2008 | B2 |
| 7351239 | Gill et al. | Apr 2008 | B2 |
| 7351340 | Connell et al. | Apr 2008 | B2 |
| 7351695 | Almarssoo et al. | Apr 2008 | B2 |
| 7354420 | Steil et al. | Apr 2008 | B2 |
| 7356382 | Vanderveen | Apr 2008 | B2 |
| 7357794 | Makower et al. | Apr 2008 | B2 |
| 7357899 | Gaillard et al. | Apr 2008 | B2 |
| 7358091 | Phillps et al. | Apr 2008 | B2 |
| 7361155 | Sage et al. | Apr 2008 | B2 |
| 7362971 | Silverbrook et al. | Apr 2008 | B2 |
| 7363072 | Movahed | Apr 2008 | B2 |
| 7363075 | Stern et al. | Apr 2008 | B2 |
| 7364566 | Elkins et al. | Apr 2008 | B2 |
| 7364568 | Angel et al. | Apr 2008 | B2 |
| 7366925 | Keely et al. | Apr 2008 | B2 |
| 7368003 | Crasper et al. | May 2008 | B2 |
| 7371418 | Sheabar et al. | May 2008 | B2 |
| 7373083 | Silverbrook et al. | May 2008 | B2 |
| 7373690 | Sepke et al. | May 2008 | B2 |
| 7373826 | Weber et al. | May 2008 | B2 |
| 7374544 | Boecker et al. | May 2008 | B2 |
| 7374556 | Mallett et al. | May 2008 | B2 |
| 7377706 | Silverbrook et al. | May 2008 | B2 |
| 7377907 | Shekalim | May 2008 | B2 |
| 7378270 | Azarnia et al. | May 2008 | B2 |
| 7378443 | Berge | May 2008 | B2 |
| 7380447 | Rollinger et al. | Jun 2008 | B2 |
| 7384397 | Zhang et al. | Jun 2008 | B2 |
| 7384410 | Eggers et al. | Jun 2008 | B2 |
| 7384413 | Gross et al. | Jun 2008 | B2 |
| 7384912 | Stewart | Jun 2008 | B2 |
| 7385443 | Denison | Jun 2008 | B1 |
| 7386346 | Struble et al. | Jun 2008 | B2 |
| 7390311 | Hildebrand et al. | Jun 2008 | B2 |
| 7390314 | Stutz et al. | Jun 2008 | B2 |
| 7390458 | Burow et al. | Jun 2008 | B2 |
| 7394182 | Pelrine et al. | Jul 2008 | B2 |
| 7396353 | Lorenzen et al. | Jul 2008 | B2 |
| 7399277 | Saidara et al. | Jul 2008 | B2 |
| 7399304 | Gambale et al. | Jul 2008 | B2 |
| 7399401 | Rush et al. | Jul 2008 | B2 |
| 7399772 | Phillips et al. | Jul 2008 | B2 |
| 7402153 | Steil et al. | Jul 2008 | B2 |
| 7402154 | Holst et al. | Jul 2008 | B2 |
| 7405055 | Dunn et al. | Jul 2008 | B2 |
| 7407489 | Holst et al. | Aug 2008 | B2 |
| 7407490 | Bendsen et al. | Aug 2008 | B2 |
| 7410468 | Boecker et al. | Aug 2008 | B2 |
| 7410475 | Krensky et al. | Aug 2008 | B2 |
| 7411204 | Appleby et al. | Aug 2008 | B2 |
| 7416644 | Bonde | Aug 2008 | B2 |
| 7421316 | Gray et al. | Sep 2008 | B2 |
| 7421882 | Leddy et al. | Sep 2008 | B2 |
| 7425294 | Grimmer et al. | Sep 2008 | B2 |
| 7426498 | Denuzzio et al. | Sep 2008 | B2 |
| 7427275 | Deruntz et al. | Sep 2008 | B2 |
| 7429255 | Thompson | Sep 2008 | B2 |
| 7429258 | Angel et al. | Sep 2008 | B2 |
| 7429269 | Schwammenthal et al. | Sep 2008 | B2 |
| 7435250 | Francischelli et al. | Oct 2008 | B2 |
| 7435717 | Bisgaier et al. | Oct 2008 | B2 |
| 7440806 | Whitehurst et al. | Oct 2008 | B1 |
| 7442186 | Blomquist | Oct 2008 | B2 |
| 7442682 | Kitaura et al. | Oct 2008 | B2 |
| 7444436 | Wille | Oct 2008 | B2 |
| 7445616 | Petrakis et al. | Nov 2008 | B2 |
| 7446091 | Van Den Berghe | Nov 2008 | B2 |
| 7449333 | Rolland et al. | Nov 2008 | B2 |
| 7452301 | Yoshioka | Nov 2008 | B2 |
| 7455663 | Bikovsky | Nov 2008 | B2 |
| 7455835 | Cohen et al. | Nov 2008 | B2 |
| 7459305 | Levy | Dec 2008 | B2 |
| 7460152 | Silverbrook et al. | Dec 2008 | B2 |
| 7460350 | Talbot et al. | Dec 2008 | B2 |
| 7460895 | Arnold et al. | Dec 2008 | B2 |
| 7462166 | Cowan et al. | Dec 2008 | B2 |
| 7463934 | Tronnes et al. | Dec 2008 | B2 |
| 7464010 | Yang et al. | Dec 2008 | B2 |
| 7464580 | Zeng et al. | Dec 2008 | B2 |
| 7464704 | Braithwaite | Dec 2008 | B2 |
| 7465285 | Hutchinson et al. | Dec 2008 | B2 |
| 7465375 | Demers et al. | Dec 2008 | B2 |
| 7467027 | Ding et al. | Dec 2008 | B2 |
| 7467613 | Taylor et al. | Dec 2008 | B2 |
| 7468033 | Van Antwerp et al. | Dec 2008 | B2 |
| 7469383 | Busch | Dec 2008 | B2 |
| 7469697 | Lee et al. | Dec 2008 | B2 |
| 7469844 | Conway et al. | Dec 2008 | B2 |
| 7470246 | Mori et al. | Dec 2008 | B2 |
| 7471994 | Ford et al. | Dec 2008 | B2 |
| 7473239 | Wang et al. | Jan 2009 | B2 |
| 7473247 | Mikszta et al. | Jan 2009 | B2 |
| 7474968 | Ding et al. | Jan 2009 | B2 |
| 7475825 | Silverbrook et al. | Jan 2009 | B2 |
| 7476200 | Yair et al. | Jan 2009 | B2 |
| 7476209 | Gara et al. | Jan 2009 | B2 |
| 7479123 | Briggs | Jan 2009 | B2 |
| 7481218 | Djupesland et al. | Jan 2009 | B2 |
| 7481759 | Whitehurst et al. | Jan 2009 | B2 |
| 7481776 | Boecker et al. | Jan 2009 | B2 |
| 7481792 | Gonnelli et al. | Jan 2009 | B2 |
| 7483050 | Silverbrook et al. | Jan 2009 | B2 |
| 7483743 | Mann et al. | Jan 2009 | B2 |
| 7485296 | Powell | Feb 2009 | B2 |
| 7491176 | Boecker et al. | Feb 2009 | B2 |
| 7491187 | Van Den Berghe et al. | Feb 2009 | B2 |
| 7491335 | Reddy et al. | Feb 2009 | B2 |
| 7493154 | Bonner et al. | Feb 2009 | B2 |
| 7493171 | Whitehurst et al. | Feb 2009 | B1 |
| 7494481 | Moberg et al. | Feb 2009 | B2 |
| 7497841 | Alchas | Mar 2009 | B2 |
| 7498563 | Mandro et al. | Mar 2009 | B2 |
| 7500959 | Munk | Mar 2009 | B2 |
| 7503903 | Carlisle et al. | Mar 2009 | B2 |
| 7505869 | Hartlaub | Mar 2009 | B2 |
| 7507220 | Childers et al. | Mar 2009 | B2 |
| 7507235 | Keogh et al. | Mar 2009 | B2 |
| 7509160 | Eigler et al. | Mar 2009 | B2 |
| 7510544 | Vilks et al. | Mar 2009 | B2 |
| 7510552 | Lebel et al. | Mar 2009 | B2 |
| 7511914 | Hiller et al. | Mar 2009 | B2 |
| 7514075 | Hedrick et al. | Apr 2009 | B2 |
| 7514401 | Franco | Apr 2009 | B2 |
| 7515060 | Blomquist | Apr 2009 | B2 |
| 7517332 | Tonelli et al. | Apr 2009 | B2 |
| 7517335 | Gravesen et al. | Apr 2009 | B2 |
| 7517440 | Anex et al. | Apr 2009 | B2 |
| 7517498 | Fredrick | Apr 2009 | B2 |
| 7517530 | Clark | Apr 2009 | B2 |
| 7520867 | Bowman et al. | Apr 2009 | B2 |
| 7524045 | Silverbrook et al. | Apr 2009 | B2 |
| 7524287 | Bharmi | Apr 2009 | B2 |
| 7524293 | Boecker et al. | Apr 2009 | B2 |
| 7524304 | Genosar | Apr 2009 | B2 |
| 7530968 | Gonnelli et al. | May 2009 | B2 |
| 7530975 | Hunter | May 2009 | B2 |
| 7534221 | Pile-Spellman | May 2009 | B2 |
| 7534226 | Mernoe et al. | May 2009 | B2 |
| 7536983 | Layher et al. | May 2009 | B2 |
| 7537571 | Freeman et al. | May 2009 | B2 |
| 7540859 | Claude et al. | Jun 2009 | B2 |
| 7540880 | Nolting et al. | Jun 2009 | B2 |
| 7543581 | Djupesland | Jun 2009 | B2 |
| 7547281 | Boecker et al. | Jun 2009 | B2 |
| 7548314 | Altobelli et al. | Jun 2009 | B2 |
| 7551202 | Silverbrook | Jun 2009 | B2 |
| 7553281 | Hellwig et al. | Jun 2009 | B2 |
| 7553291 | Duffy et al. | Jun 2009 | B2 |
| 7553813 | Unemori | Jun 2009 | B2 |
| 7556613 | Wittman et al. | Jul 2009 | B2 |
| 7556619 | Spohn | Jul 2009 | B2 |
| 7556841 | Kimball et al. | Jul 2009 | B2 |
| 7558629 | Keimel et al. | Jul 2009 | B2 |
| 7559223 | Chen et al. | Jul 2009 | B2 |
| 7559524 | Gray et al. | Jul 2009 | B2 |
| 7563232 | Boecker et al. | Jul 2009 | B2 |
| 7563253 | Tanner et al. | Jul 2009 | B2 |
| 7563255 | Adamis et al. | Jul 2009 | B2 |
| 7569030 | Lebel et al. | Aug 2009 | B2 |
| 7569036 | Domkowski et al. | Aug 2009 | B2 |
| 7569050 | Moberg et al. | Aug 2009 | B2 |
| 7571635 | Lyon | Aug 2009 | B2 |
| 7572789 | Cowen et al. | Aug 2009 | B2 |
| 7577477 | Allen et al. | Aug 2009 | B2 |
| 7582063 | Wurster et al. | Sep 2009 | B2 |
| 7582099 | Boecker et al. | Sep 2009 | B2 |
| 7583190 | Reggiardo et al. | Sep 2009 | B2 |
| 7584846 | Senter | Sep 2009 | B2 |
| 7588046 | Erickson | Sep 2009 | B1 |
| 7588550 | Leonard et al. | Sep 2009 | B2 |
| 7588784 | Mady et al. | Sep 2009 | B2 |
| 7589059 | Wolff et al. | Sep 2009 | B2 |
| 7590443 | Bharmi | Sep 2009 | B2 |
| 7591801 | Brauker et al. | Sep 2009 | B2 |
| 7594889 | St. Ores et al. | Sep 2009 | B2 |
| 7597682 | Moberg et al. | Oct 2009 | B2 |
| 7598031 | Liew | Oct 2009 | B2 |
| 7602310 | Mann et al. | Oct 2009 | B2 |
| 7603174 | Ridder et al. | Oct 2009 | B2 |
| 7604592 | Freeman et al. | Oct 2009 | B2 |
| 7604593 | Parris et al. | Oct 2009 | B2 |
| 7604619 | Eich et al. | Oct 2009 | B2 |
| 7605710 | Crnkovich | Oct 2009 | B2 |
| 7606274 | Mirov et al. | Oct 2009 | B2 |
| 7606615 | Makower et al. | Oct 2009 | B2 |
| 7606868 | Le et al. | Oct 2009 | B1 |
| 7607965 | Frazier | Oct 2009 | B1 |
| 7608060 | Gillespie, Jr. et al. | Oct 2009 | B2 |
| 7608640 | Messadek | Oct 2009 | B2 |
| 7615046 | Shehata | Nov 2009 | B2 |
| 7618369 | Hayter et al. | Nov 2009 | B2 |
| 7618615 | Frey, II et al. | Nov 2009 | B2 |
| 7618954 | Nicolau et al. | Nov 2009 | B2 |
| 7621893 | Moberg et al. | Nov 2009 | B2 |
| 7624409 | Whymark | Nov 2009 | B2 |
| 7625354 | Hochman | Dec 2009 | B2 |
| 7625358 | Mernoe | Dec 2009 | B2 |
| 7625369 | Abboud et al. | Dec 2009 | B2 |
| 7628590 | Jacobsen et al. | Dec 2009 | B2 |
| 7628772 | McConnell et al. | Dec 2009 | B2 |
| 7630748 | Budiman | Dec 2009 | B2 |
| 7630773 | Seeberger et al. | Dec 2009 | B2 |
| 7630791 | Nguyen et al. | Dec 2009 | B2 |
| 7632228 | Brauker et al. | Dec 2009 | B2 |
| 7632247 | Adams et al. | Dec 2009 | B2 |
| 7632248 | Delk et al. | Dec 2009 | B2 |
| 7635349 | Tribe et al. | Dec 2009 | B2 |
| 7635575 | Scherze et al. | Dec 2009 | B2 |
| 7637279 | Amley et al. | Dec 2009 | B2 |
| 7637931 | Heaton et al. | Dec 2009 | B2 |
| 7638095 | Sabol | Dec 2009 | B2 |
| 7641649 | Moberg et al. | Jan 2010 | B2 |
| 7642232 | Green et al. | Jan 2010 | B2 |
| 7644203 | Ingles | Jan 2010 | B2 |
| 7645253 | Gura et al. | Jan 2010 | B2 |
| 7645264 | Marsh et al. | Jan 2010 | B2 |
| 7647107 | Warman et al. | Jan 2010 | B2 |
| 7647115 | Levin et al. | Jan 2010 | B2 |
| 7647237 | Malave et al. | Jan 2010 | B2 |
| 7650190 | Zhou et al. | Jan 2010 | B2 |
| 7651489 | Estes et al. | Jan 2010 | B2 |
| 7651868 | McDevitt et al. | Jan 2010 | B2 |
| 7653425 | Hayter et al. | Jan 2010 | B2 |
| 7653639 | Classen et al. | Jan 2010 | B2 |
| 7654127 | Krulevitch et al. | Feb 2010 | B2 |
| 7654131 | Ascheman et al. | Feb 2010 | B2 |
| 7654484 | Mogensen et al. | Feb 2010 | B2 |
| 7654976 | Peterson et al. | Feb 2010 | B2 |
| 7654982 | Carlisle et al. | Feb 2010 | B2 |
| 7655221 | Rasmussen et al. | Feb 2010 | B2 |
| 7657313 | Rom | Feb 2010 | B2 |
| 7662105 | Hatlestad | Feb 2010 | B2 |
| 7662140 | Heruth et al. | Feb 2010 | B2 |
| 7662558 | Liew | Feb 2010 | B2 |
| 7668731 | Martucci et al. | Feb 2010 | B2 |
| 7674243 | Dacquay et al. | Mar 2010 | B2 |
| 7674485 | Bhaskaran et al. | Mar 2010 | B2 |
| 7676519 | McBride et al. | Mar 2010 | B2 |
| 7678071 | Lebel et al. | Mar 2010 | B2 |
| 7678084 | Judson et al. | Mar 2010 | B2 |
| 7678761 | Coleman | Mar 2010 | B2 |
| 7678762 | Green et al. | Mar 2010 | B2 |
| 7678763 | Green et al. | Mar 2010 | B2 |
| 7678772 | Jia et al. | Mar 2010 | B2 |
| 7678833 | Ott | Mar 2010 | B2 |
| 7681570 | Vendrine et al. | Mar 2010 | B2 |
| 7682338 | Griffin | Mar 2010 | B2 |
| 7682430 | Kraemer et al. | Mar 2010 | B2 |
| 7682563 | Carpenter et al. | Mar 2010 | B2 |
| 7683029 | Hindle et al. | Mar 2010 | B2 |
| 7685865 | Norenberg | Mar 2010 | B2 |
| 7686787 | Moberg et al. | Mar 2010 | B2 |
| 7687272 | Buchwald et al. | Mar 2010 | B1 |
| RE41288 | Coolidge et al. | Apr 2010 | E |
| D613411 | Collins et al. | Apr 2010 | S |
| 7691330 | Winkler et al. | Apr 2010 | B1 |
| 7695454 | Barron et al. | Apr 2010 | B2 |
| 7695627 | Bosch et al. | Apr 2010 | B2 |
| 7697967 | Stafford | Apr 2010 | B2 |
| 7697995 | Cross et al. | Apr 2010 | B2 |
| 7699767 | Mueth et al. | Apr 2010 | B2 |
| 7699775 | Desai et al. | Apr 2010 | B2 |
| 7699808 | Marrs et al. | Apr 2010 | B2 |
| 7699833 | Moberg et al. | Apr 2010 | B2 |
| 7704226 | Mueller, Jr. et al. | Apr 2010 | B2 |
| 7704227 | Moberg et al. | Apr 2010 | B2 |
| 7704237 | Fisher et al. | Apr 2010 | B2 |
| 7704238 | Atterbury et al. | Apr 2010 | B2 |
| 7708717 | Estes et al. | May 2010 | B2 |
| 7708872 | Eidsnes et al. | May 2010 | B2 |
| 7708915 | Castor | May 2010 | B2 |
| 7713238 | Mernoe | May 2010 | B2 |
| 7713240 | Istoc et al. | May 2010 | B2 |
| 7713262 | Adams et al. | May 2010 | B2 |
| 7713574 | Brister et al. | May 2010 | B2 |
| 7714757 | Denison et al. | May 2010 | B2 |
| 7714889 | Silverbrook | May 2010 | B2 |
| 7715917 | Chinchoy et al. | May 2010 | B2 |
| 7716964 | Kurtz et al. | May 2010 | B2 |
| 7717856 | Chen et al. | May 2010 | B2 |
| 7717871 | Odland | May 2010 | B2 |
| 7722536 | Goodnow | May 2010 | B2 |
| 7726955 | Ryser et al. | Jun 2010 | B2 |
| 7727148 | Talbot et al. | Jun 2010 | B2 |
| 7727181 | Rush | Jun 2010 | B2 |
| 7734323 | Blomquist et al. | Jun 2010 | B2 |
| 7736309 | Miller et al. | Jun 2010 | B2 |
| 7736338 | Kavazov et al. | Jun 2010 | B2 |
| 7736344 | Moberg et al. | Jun 2010 | B2 |
| 7737581 | Spurlin et al. | Jun 2010 | B2 |
| 7740708 | Lofton et al. | Jun 2010 | B2 |
| 7743007 | Jung et al. | Jun 2010 | B2 |
| 7744554 | Howard | Jun 2010 | B2 |
| 7744589 | Mounce et al. | Jun 2010 | B2 |
| 7749528 | De Carvalho et al. | Jul 2010 | B2 |
| 7751907 | Blomquist | Jul 2010 | B2 |
| 7753660 | Gray | Jul 2010 | B2 |
| 7753873 | Rush et al. | Jul 2010 | B2 |
| 7753879 | Mernoe | Jul 2010 | B2 |
| 7753885 | Duchon et al. | Jul 2010 | B2 |
| 7756722 | Levine et al. | Jul 2010 | B2 |
| 7758547 | Tonelli et al. | Jul 2010 | B2 |
| 7758568 | Olsen et al. | Jul 2010 | B2 |
| 7760601 | Igi | Jul 2010 | B2 |
| 7762793 | Gray et al. | Jul 2010 | B2 |
| 7766301 | Gray et al. | Aug 2010 | B2 |
| 7766829 | Sloan et al. | Aug 2010 | B2 |
| 7766830 | Fox et al. | Aug 2010 | B2 |
| 7766831 | Essenpreis et al. | Aug 2010 | B2 |
| 7766863 | Gillespie et al. | Aug 2010 | B2 |
| 7766873 | Moberg et al. | Aug 2010 | B2 |
| 7768386 | Hayter et al. | Aug 2010 | B2 |
| 7768408 | Reggiardo et al. | Aug 2010 | B2 |
| 7771385 | Eggers et al. | Aug 2010 | B2 |
| 7771386 | Eggers et al. | Aug 2010 | B2 |
| 7771414 | Trieu et al. | Aug 2010 | B2 |
| 7774145 | Brauker et al. | Aug 2010 | B2 |
| 7775975 | Brister et al. | Aug 2010 | B2 |
| 7776006 | Childers et al. | Aug 2010 | B2 |
| 7776030 | Estes et al. | Aug 2010 | B2 |
| 7776031 | Hartlaub et al. | Aug 2010 | B2 |
| 7778680 | Goode, Jr. et al. | Aug 2010 | B2 |
| 7779183 | Koehler et al. | Aug 2010 | B2 |
| 7780981 | Dipierro et al. | Aug 2010 | B2 |
| 7782192 | Jeckelmann et al. | Aug 2010 | B2 |
| 7785288 | Mernoee et al. | Aug 2010 | B2 |
| 7785293 | Gray et al. | Aug 2010 | B2 |
| 7785313 | Mastrototaro | Aug 2010 | B2 |
| 7788369 | McAllen et al. | Aug 2010 | B2 |
| 7789849 | Busby et al. | Sep 2010 | B2 |
| 7789857 | Moberg et al. | Sep 2010 | B2 |
| 7790103 | Shah et al. | Sep 2010 | B2 |
| 7794426 | Briones et al. | Sep 2010 | B2 |
| 7794427 | Estes et al. | Sep 2010 | B2 |
| 7794428 | Estes et al. | Sep 2010 | B2 |
| 7794434 | Mounce et al. | Sep 2010 | B2 |
| 7797028 | Goode, Jr. et al. | Sep 2010 | B2 |
| 7801582 | Peyser | Sep 2010 | B2 |
| 7806853 | Wittmann et al. | Oct 2010 | B2 |
| 7806854 | Damiano et al. | Oct 2010 | B2 |
| 7806867 | Willis et al. | Oct 2010 | B2 |
| 7806886 | Kanderian, Jr. et al. | Oct 2010 | B2 |
| 7811231 | Jin et al. | Oct 2010 | B2 |
| 7811246 | Koops | Oct 2010 | B2 |
| 7811262 | Moberg et al. | Oct 2010 | B2 |
| 7811279 | John et al. | Oct 2010 | B2 |
| 7815595 | Busby et al. | Oct 2010 | B2 |
| 7815602 | Mann et al. | Oct 2010 | B2 |
| 7815609 | Hines et al. | Oct 2010 | B2 |
| 7815622 | Istoc et al. | Oct 2010 | B2 |
| 7819843 | Mann et al. | Oct 2010 | B2 |
| 7822455 | Hoss et al. | Oct 2010 | B2 |
| RE41956 | Klitgaard et al. | Nov 2010 | E |
| 7826382 | Sicurello et al. | Nov 2010 | B2 |
| 7826879 | Hoss et al. | Nov 2010 | B2 |
| 7828528 | Estes et al. | Nov 2010 | B2 |
| 7828747 | Heske et al. | Nov 2010 | B2 |
| 7828764 | Moberg et al. | Nov 2010 | B2 |
| 7828771 | Chiang et al. | Nov 2010 | B2 |
| 7831310 | Lebel et al. | Nov 2010 | B2 |
| 7833196 | Estes et al. | Nov 2010 | B2 |
| 7835927 | Schlotterbeck et al. | Nov 2010 | B2 |
| 7837647 | Estes et al. | Nov 2010 | B2 |
| 7837648 | Blair et al. | Nov 2010 | B2 |
| 7850641 | Lebel et al. | Dec 2010 | B2 |
| 7850658 | Faust et al. | Dec 2010 | B2 |
| 7851509 | Miller et al. | Dec 2010 | B2 |
| 7857756 | Warren et al. | Dec 2010 | B2 |
| 7857791 | Jacobs et al. | Dec 2010 | B2 |
| 7860544 | Say et al. | Dec 2010 | B2 |
| 7860583 | Condurso et al. | Dec 2010 | B2 |
| 7860674 | Goodnow et al. | Dec 2010 | B2 |
| 7867189 | Childers et al. | Jan 2011 | B2 |
| 7869853 | Say et al. | Jan 2011 | B1 |
| 7874718 | Demers et al. | Jan 2011 | B2 |
| 7875022 | Wenger et al. | Jan 2011 | B2 |
| 7877489 | Salesky et al. | Jan 2011 | B2 |
| 7877703 | Fleming | Jan 2011 | B1 |
| 7879026 | Estes et al. | Feb 2011 | B2 |
| 7881883 | Remde | Feb 2011 | B2 |
| 7882611 | Shah et al. | Feb 2011 | B2 |
| 7883464 | Stafford et al. | Feb 2011 | B2 |
| 7884729 | Regiardo et al. | Feb 2011 | B2 |
| 7885699 | Say et al. | Feb 2011 | B2 |
| 7887505 | Flaherty | Feb 2011 | B2 |
| 7887511 | Mernoee et al. | Feb 2011 | B2 |
| 7887512 | Estes et al. | Feb 2011 | B2 |
| 7890295 | Shin et al. | Feb 2011 | B2 |
| 7892199 | Mhatre et al. | Feb 2011 | B2 |
| 7892206 | Moberg et al. | Feb 2011 | B2 |
| 7896842 | Palmroos | Mar 2011 | B2 |
| 7901394 | Ireland et al. | Mar 2011 | B2 |
| 7905710 | Wang et al. | Mar 2011 | B2 |
| 7905859 | Bynum et al. | Mar 2011 | B2 |
| 7905866 | Haider et al. | Mar 2011 | B2 |
| 7905868 | Moberg et al. | Mar 2011 | B2 |
| 7909267 | Redl et al. | Mar 2011 | B2 |
| 7912674 | Killoren et al. | Mar 2011 | B2 |
| 7914450 | Goode, Jr. et al. | Mar 2011 | B2 |
| 7914499 | Gonnelli et al. | Mar 2011 | B2 |
| 7914500 | Gafner-Geiser et al. | Mar 2011 | B2 |
| 7914742 | Arbogast et al. | Mar 2011 | B2 |
| 7917186 | Kamath et al. | Mar 2011 | B2 |
| 7918825 | O'Connor et al. | Apr 2011 | B2 |
| 7919063 | Sarofim | Apr 2011 | B2 |
| 7920907 | McGarraugh et al. | Apr 2011 | B2 |
| 7922096 | Eilersen | Apr 2011 | B2 |
| 7922458 | Rush et al. | Apr 2011 | B2 |
| 7922462 | Preuthun et al. | Apr 2011 | B2 |
| 7922899 | Vasta et al. | Apr 2011 | B2 |
| 7928850 | Hayter et al. | Apr 2011 | B2 |
| 7931592 | Currie et al. | Apr 2011 | B2 |
| 7931613 | Haueter et al. | Apr 2011 | B2 |
| 7931642 | Tonnies | Apr 2011 | B2 |
| 7931864 | Kloepfer et al. | Apr 2011 | B2 |
| 7933639 | Goode, Jr. et al. | Apr 2011 | B2 |
| 7933780 | De La Huerga | Apr 2011 | B2 |
| 7935074 | Plahey et al. | May 2011 | B2 |
| 7935076 | Estes et al. | May 2011 | B2 |
| 7935079 | Ludin et al. | May 2011 | B2 |
| 7935104 | Yodfat et al. | May 2011 | B2 |
| 7935105 | Miller et al. | May 2011 | B2 |
| 7936499 | Dunn et al. | May 2011 | B2 |
| 7937163 | Sekiguchi | May 2011 | B2 |
| 7938792 | Roger et al. | May 2011 | B2 |
| 7938797 | Estes | May 2011 | B2 |
| 7938801 | Bicknell et al. | May 2011 | B2 |
| 7938803 | Mernoe et al. | May 2011 | B2 |
| 7941200 | Weinert et al. | May 2011 | B2 |
| 7942069 | Peterson | May 2011 | B2 |
| 7942844 | Moberg et al. | May 2011 | B2 |
| 7944366 | Krulevitch et al. | May 2011 | B2 |
| 7945452 | Fathallah et al. | May 2011 | B2 |
| 7946985 | Mastrototaro et al. | May 2011 | B2 |
| 7948370 | Reggiardo et al. | May 2011 | B2 |
| 7951112 | Patzer | May 2011 | B2 |
| 7951114 | Rush et al. | May 2011 | B2 |
| 7951122 | Shekalim | May 2011 | B2 |
| 7955261 | Goode, Jr. et al. | Jun 2011 | B2 |
| 7955295 | Lee et al. | Jun 2011 | B2 |
| 7955305 | Moberg et al. | Jun 2011 | B2 |
| 7955319 | Miesel | Jun 2011 | B2 |
| 7955843 | Barringer, Jr. et al. | Jun 2011 | B2 |
| 7957984 | Vallone | Jun 2011 | B1 |
| 7959569 | Goode et al. | Jun 2011 | B2 |
| 7959598 | Estes | Jun 2011 | B2 |
| 7959608 | Nash | Jun 2011 | B2 |
| 7959715 | Kavazov et al. | Jun 2011 | B2 |
| 7959938 | Rohloff et al. | Jun 2011 | B2 |
| 7963945 | Miller et al. | Jun 2011 | B2 |
| 7963946 | Moubayed et al. | Jun 2011 | B2 |
| 7963954 | Kavazov | Jun 2011 | B2 |
| 7964555 | Zhou | Jun 2011 | B2 |
| 7967010 | Vedrine et al. | Jun 2011 | B2 |
| 7967022 | Grant et al. | Jun 2011 | B2 |
| 7967740 | Mertens et al. | Jun 2011 | B2 |
| 7967752 | Ocvirk et al. | Jun 2011 | B2 |
| 7967773 | Amborn et al. | Jun 2011 | B2 |
| 7967785 | Morgan et al. | Jun 2011 | B2 |
| 7967806 | Jasperson et al. | Jun 2011 | B2 |
| 7967810 | Freedman et al. | Jun 2011 | B2 |
| 7967812 | Jasperson et al. | Jun 2011 | B2 |
| 7970620 | Brown | Jun 2011 | B2 |
| 7972286 | Prausnitz et al. | Jul 2011 | B2 |
| 7972296 | Braig et al. | Jul 2011 | B2 |
| 7972302 | Caizza et al. | Jul 2011 | B2 |
| 7972303 | Caizza et al. | Jul 2011 | B2 |
| 7972304 | Caizza et al. | Jul 2011 | B2 |
| 7973667 | Crnkovich et al. | Jul 2011 | B2 |
| 7976478 | Fujiwara et al. | Jul 2011 | B2 |
| 7976492 | Brauker et al. | Jul 2011 | B2 |
| 7976493 | Carter et al. | Jul 2011 | B2 |
| 7976496 | Kennedy, II et al. | Jul 2011 | B2 |
| 7976499 | Grunhut et al. | Jul 2011 | B2 |
| 7976500 | Adams et al. | Jul 2011 | B2 |
| 7976505 | Hines et al. | Jul 2011 | B2 |
| 7976508 | Hoag | Jul 2011 | B2 |
| 7976514 | Abry et al. | Jul 2011 | B2 |
| 7976530 | Johnson et al. | Jul 2011 | B2 |
| 7976778 | Drucker et al. | Jul 2011 | B2 |
| 7976865 | Kawamura et al. | Jul 2011 | B2 |
| 7976870 | Berner et al. | Jul 2011 | B2 |
| 7979104 | Kamath et al. | Jul 2011 | B2 |
| 7979136 | Young et al. | Jul 2011 | B2 |
| 7981034 | Jennewine et al. | Jul 2011 | B2 |
| 7981042 | Stahmann et al. | Jul 2011 | B2 |
| 7981076 | Sullivan et al. | Jul 2011 | B2 |
| 7981081 | Marsh et al. | Jul 2011 | B2 |
| 7981084 | Estes et al. | Jul 2011 | B2 |
| 7981090 | Plishka et al. | Jul 2011 | B2 |
| 7981102 | Patel et al. | Jul 2011 | B2 |
| 7981105 | Adair et al. | Jul 2011 | B2 |
| 7981107 | Olsen | Jul 2011 | B2 |
| 7983745 | Hatlestad et al. | Jul 2011 | B2 |
| 7985330 | Wang et al. | Jul 2011 | B2 |
| 7986986 | Goode et al. | Jul 2011 | B2 |
| 7988630 | Osorio et al. | Aug 2011 | B1 |
| 7988660 | Byland et al. | Aug 2011 | B2 |
| 7988663 | Schiller et al. | Aug 2011 | B2 |
| 7988674 | Adams et al. | Aug 2011 | B2 |
| 7988687 | Friedli et al. | Aug 2011 | B2 |
| 7988849 | Biewer et al. | Aug 2011 | B2 |
| 7988850 | Roncadi et al. | Aug 2011 | B2 |
| 7990251 | Ford, Jr. | Aug 2011 | B1 |
| 7993108 | Rush et al. | Aug 2011 | B2 |
| 7993140 | Sakezles | Aug 2011 | B2 |
| 7993300 | Nyholm et al. | Aug 2011 | B2 |
| 7993306 | Marrs et al. | Aug 2011 | B2 |
| 7996158 | Hayter et al. | Aug 2011 | B2 |
| 7998110 | Leung et al. | Aug 2011 | B2 |
| 7998111 | Moberg et al. | Aug 2011 | B2 |
| 7998117 | Gross et al. | Aug 2011 | B2 |
| 7999674 | Kamen | Aug 2011 | B2 |
| 7999927 | Braig et al. | Aug 2011 | B2 |
| 8000763 | Mazza et al. | Aug 2011 | B2 |
| 8002700 | Ferek-Petric et al. | Aug 2011 | B2 |
| 8002747 | Lord et al. | Aug 2011 | B2 |
| 8003630 | Zagon et al. | Aug 2011 | B2 |
| 8005524 | Brauker et al. | Aug 2011 | B2 |
| 8005540 | Zhang et al. | Aug 2011 | B2 |
| 8005688 | Coffman et al. | Aug 2011 | B2 |
| 8007460 | Gelfand et al. | Aug 2011 | B2 |
| 8007724 | Guzman | Aug 2011 | B2 |
| RE42682 | Barreras, Sr. et al. | Sep 2011 | E |
| 8011039 | Stryker et al. | Sep 2011 | B2 |
| 8012104 | Escutia et al. | Sep 2011 | B2 |
| 8012114 | Daniel et al. | Sep 2011 | B2 |
| 8012119 | Estes et al. | Sep 2011 | B2 |
| 8012121 | Goodson, IV et al. | Sep 2011 | B2 |
| 8012132 | Lum et al. | Sep 2011 | B2 |
| 8014857 | Doerr | Sep 2011 | B2 |
| 8016740 | Connors et al. | Sep 2011 | B2 |
| 8016772 | Heske et al. | Sep 2011 | B2 |
| 8016783 | Pastore et al. | Sep 2011 | B2 |
| 8016789 | Grant et al. | Sep 2011 | B2 |
| 8016812 | Koh | Sep 2011 | B2 |
| 8016859 | Donofrio et al. | Sep 2011 | B2 |
| 8019721 | Baker et al. | Sep 2011 | B2 |
| 8020564 | Batch | Sep 2011 | B2 |
| 8021299 | Miesel et al. | Sep 2011 | B2 |
| 8021334 | Shekalim et al. | Sep 2011 | B2 |
| 8021680 | Anderson et al. | Sep 2011 | B2 |
| 8022042 | Ko | Sep 2011 | B2 |
| 8022366 | Hartley | Sep 2011 | B2 |
| 8025634 | Moubayed et al. | Sep 2011 | B1 |
| 8026209 | Gaillard et al. | Sep 2011 | B2 |
| 8026215 | Unemori | Sep 2011 | B2 |
| 8026227 | Hausheer | Sep 2011 | B2 |
| 8027740 | Altman et al. | Sep 2011 | B2 |
| 8029245 | Rush et al. | Oct 2011 | B2 |
| 8029250 | Rush et al. | Oct 2011 | B2 |
| 8029454 | Kelly et al. | Oct 2011 | B2 |
| 8029459 | Rush et al. | Oct 2011 | B2 |
| 8029460 | Rush et al. | Oct 2011 | B2 |
| 8030058 | Benedict et al. | Oct 2011 | B1 |
| 8030802 | Lindegger et al. | Oct 2011 | B2 |
| 8030891 | Welsch et al. | Oct 2011 | B2 |
| 8032226 | Miller et al. | Oct 2011 | B2 |
| 8034015 | Braig et al. | Oct 2011 | B2 |
| 8034019 | Nair et al. | Oct 2011 | B2 |
| 8034026 | Grant et al. | Oct 2011 | B2 |
| 8034793 | Heidenreich et al. | Oct 2011 | B2 |
| 8038650 | Shekalim et al. | Oct 2011 | B2 |
| 8038709 | Palasis et al. | Oct 2011 | B2 |
| 8043074 | Tada | Oct 2011 | B2 |
| 8043258 | Ostroot | Oct 2011 | B2 |
| 8043277 | Junker | Oct 2011 | B2 |
| 8043281 | Heruth et al. | Oct 2011 | B2 |
| 8043744 | Traulsen et al. | Oct 2011 | B2 |
| 8046043 | Asano et al. | Oct 2011 | B2 |
| RE42958 | Loeb et al. | Nov 2011 | E |
| 8047202 | Djupesland | Nov 2011 | B2 |
| 8047811 | Rush et al. | Nov 2011 | B2 |
| 8047812 | Rush et al. | Nov 2011 | B2 |
| 8047819 | Lawrence et al. | Nov 2011 | B2 |
| 8048041 | Cefai et al. | Nov 2011 | B2 |
| 8048619 | Chow | Nov 2011 | B2 |
| 8049009 | Vasireddy et al. | Nov 2011 | B2 |
| 8049059 | Bleyer et al. | Nov 2011 | B2 |
| 8050729 | Shekalim | Nov 2011 | B2 |
| 8052614 | Heske et al. | Nov 2011 | B2 |
| 8053429 | Cummng et al. | Nov 2011 | B2 |
| 8056582 | Diperna et al. | Nov 2011 | B2 |
| 8057156 | List | Nov 2011 | B2 |
| 8057426 | Nayak et al. | Nov 2011 | B2 |
| 8057679 | Yu et al. | Nov 2011 | B2 |
| 8060185 | Hunter et al. | Nov 2011 | B2 |
| 8060209 | Jaax et al. | Nov 2011 | B2 |
| 8062249 | Wilinska et al. | Nov 2011 | B2 |
| 8062256 | Carter et al. | Nov 2011 | B2 |
| 8062264 | Moberg et al. | Nov 2011 | B2 |
| 8062513 | Yu et al. | Nov 2011 | B2 |
| 8065096 | Moberg et al. | Nov 2011 | B2 |
| 8065161 | Howard et al. | Nov 2011 | B2 |
| 8066197 | Sheppard | Nov 2011 | B2 |
| 8066198 | Palanchon et al. | Nov 2011 | B2 |
| 8066629 | Dlugos et al. | Nov 2011 | B2 |
| 8066665 | Rush et al. | Nov 2011 | B2 |
| 8066668 | Wayman et al. | Nov 2011 | B2 |
| 8066671 | Busby et al. | Nov 2011 | B2 |
| 8066672 | Mandro | Nov 2011 | B2 |
| 8066680 | Alchas et al. | Nov 2011 | B2 |
| 8066940 | Denkewicz, Jr. et al. | Nov 2011 | B2 |
| 8067031 | Daniloff et al. | Nov 2011 | B2 |
| 8067173 | Liew | Nov 2011 | B2 |
| 8070723 | Bazargan et al. | Dec 2011 | B2 |
| 8070726 | Gonnelli et al. | Dec 2011 | B2 |
| 8070741 | Barrelle et al. | Dec 2011 | B2 |
| 8070842 | Woo et al. | Dec 2011 | B2 |
| 8071075 | Reed et al. | Dec 2011 | B2 |
| 8071722 | Kaplan et al. | Dec 2011 | B2 |
| 8073543 | Pyles | Dec 2011 | B2 |
| 8073549 | Chen | Dec 2011 | B2 |
| 8075503 | Jaeb | Dec 2011 | B2 |
| 8075522 | Larsen et al. | Dec 2011 | B2 |
| 8075527 | Rush et al. | Dec 2011 | B2 |
| 8075919 | Brown et al. | Dec 2011 | B2 |
| 8079983 | Rush et al. | Dec 2011 | B2 |
| 8079984 | Rush et al. | Dec 2011 | B2 |
| 8080002 | Stergiopulos et al. | Dec 2011 | B2 |
| 8081069 | Haueter et al. | Dec 2011 | B2 |
| 8082041 | Radziemski | Dec 2011 | B1 |
| 8083209 | Kozdras et al. | Dec 2011 | B2 |
| 8083711 | Enggaard | Dec 2011 | B2 |
| 8083718 | Rush et al. | Dec 2011 | B2 |
| 8083720 | Solar et al. | Dec 2011 | B2 |
| 8083722 | McKay | Dec 2011 | B2 |
| 8083730 | Miesel | Dec 2011 | B2 |
| 8088098 | Yodfat et al. | Jan 2012 | B2 |
| 8088789 | Yan et al. | Jan 2012 | B2 |
| 8089787 | Melse | Jan 2012 | B2 |
| 8090430 | Makower et al. | Jan 2012 | B2 |
| 8090435 | Gill et al. | Jan 2012 | B2 |
| 8092005 | Silverbrook et al. | Jan 2012 | B2 |
| 8092428 | Ramey et al. | Jan 2012 | B2 |
| 8093038 | Hatziavramidis | Jan 2012 | B2 |
| 8093212 | Gardner et al. | Jan 2012 | B2 |
| 8093214 | Crockford | Jan 2012 | B2 |
| 8093781 | Chiang et al. | Jan 2012 | B2 |
| 8094009 | Allen et al. | Jan 2012 | B2 |
| 8095123 | Gray | Jan 2012 | B2 |
| 8095390 | Bluemler et al. | Jan 2012 | B2 |
| 8096329 | Thuot et al. | Jan 2012 | B2 |
| 8096487 | Hornsby | Jan 2012 | B2 |
| 8096972 | Varner et al. | Jan 2012 | B2 |
| 8096983 | Uchino et al. | Jan 2012 | B2 |
| 8099800 | Sawalski et al. | Jan 2012 | B2 |
| 8100842 | Rousso et al. | Jan 2012 | B2 |
| 8100852 | Moberg et al. | Jan 2012 | B2 |
| 8100871 | Haase | Jan 2012 | B2 |
| 8101358 | Liew | Jan 2012 | B2 |
| 8101402 | Holmes et al. | Jan 2012 | B2 |
| 8101727 | Stover et al. | Jan 2012 | B2 |
| 8105265 | Demers et al. | Jan 2012 | B2 |
| 8105268 | Lebel et al. | Jan 2012 | B2 |
| 8105269 | Zhou | Jan 2012 | B2 |
| 8105279 | Mernoe et al. | Jan 2012 | B2 |
| 8105280 | Iddan et al. | Jan 2012 | B2 |
| 8105351 | Lehman et al. | Jan 2012 | B2 |
| 8106534 | Spurlin et al. | Jan 2012 | B2 |
| 8108051 | Cross, Jr. et al. | Jan 2012 | B2 |
| 8109893 | Lande | Feb 2012 | B2 |
| 8109912 | Alferness et al. | Feb 2012 | B2 |
| 8109921 | Estes et al. | Feb 2012 | B2 |
| 8110224 | Ausborn et al. | Feb 2012 | B2 |
| 8110358 | Liew | Feb 2012 | B2 |
| 8110555 | Jia et al. | Feb 2012 | B2 |
| 8112287 | Paul et al. | Feb 2012 | B1 |
| 8112288 | Paul et al. | Feb 2012 | B1 |
| 8114056 | Niklaus et al. | Feb 2012 | B2 |
| 8114064 | Alfreness et al. | Feb 2012 | B2 |
| 8114066 | Naef et al. | Feb 2012 | B2 |
| 8114350 | Silver et al. | Feb 2012 | B1 |
| 8114430 | Rohloff et al. | Feb 2012 | B2 |
| 8114597 | Liew | Feb 2012 | B2 |
| 8115600 | Stevenson et al. | Feb 2012 | B2 |
| 8116862 | Stevenson et al. | Feb 2012 | B2 |
| 8118571 | Krisher et al. | Feb 2012 | B2 |
| 8118770 | Galley et al. | Feb 2012 | B2 |
| 8118782 | Remde et al. | Feb 2012 | B2 |
| 8119159 | Cumming et al. | Feb 2012 | B2 |
| 8119593 | Richardson et al. | Feb 2012 | B2 |
| 8121689 | Kalgren et al. | Feb 2012 | B2 |
| 8121857 | Galasso et al. | Feb 2012 | B2 |
| 8123717 | Weinert et al. | Feb 2012 | B2 |
| 8123720 | Solomon | Feb 2012 | B2 |
| 8124689 | Loubert et al. | Feb 2012 | B2 |
| 8126728 | Dicks et al. | Feb 2012 | B2 |
| 8126729 | Dicks et al. | Feb 2012 | B2 |
| 8126732 | Dicks et al. | Feb 2012 | B2 |
| 8126733 | Dicks et al. | Feb 2012 | B2 |
| 8126734 | Dicks et al. | Feb 2012 | B2 |
| 8127046 | Grant et al. | Feb 2012 | B2 |
| 8216730 | Dicks et al. | Feb 2012 | B2 |
| 8128589 | Freeman et al. | Mar 2012 | B2 |
| 8128597 | Cross et al. | Mar 2012 | B2 |
| 8128946 | Kawamura et al. | Mar 2012 | B2 |
| 8129429 | Sporn et al. | Mar 2012 | B2 |
| 8130095 | Allen et al. | Mar 2012 | B2 |
| 8133197 | Bloquist et al. | Mar 2012 | B2 |
| 8140275 | Campbell et al. | Mar 2012 | B2 |
| 8140312 | Hayter et al. | Mar 2012 | B2 |
| 8140356 | Dicks et al. | Mar 2012 | B2 |
| 8147511 | Perry et al. | Apr 2012 | B2 |
| 8149117 | Fennell et al. | Apr 2012 | B2 |
| 8149131 | Blomquist | Apr 2012 | B2 |
| 8152764 | Istoc et al. | Apr 2012 | B2 |
| 8155982 | Dicks et al. | Apr 2012 | B2 |
| 8156070 | Buck et al. | Apr 2012 | B2 |
| 8167832 | Bowman et al. | May 2012 | B2 |
| 8172082 | Edwards et al. | May 2012 | B2 |
| 8172798 | Hungerford et al. | May 2012 | B2 |
| 8177739 | Cartledge et al. | May 2012 | B2 |
| 8182447 | Moberg et al. | May 2012 | B2 |
| 8182461 | Pope et al. | May 2012 | B2 |
| 8182462 | Istoc et al. | May 2012 | B2 |
| 8187228 | Bikovsky et al. | May 2012 | B2 |
| 8192394 | Estes et al. | Jun 2012 | B2 |
| 8202267 | Field et al. | Jun 2012 | B2 |
| 8204729 | Sher | Jun 2012 | B2 |
| 8206296 | Jennewine | Jun 2012 | B2 |
| 8206350 | Mann et al. | Jun 2012 | B2 |
| 8206378 | Kalpin et al. | Jun 2012 | B1 |
| 8208984 | Blomquist et al. | Jun 2012 | B2 |
| 8211062 | Estes et al. | Jul 2012 | B2 |
| 8211093 | Miller et al. | Jul 2012 | B2 |
| 8211364 | Drucker et al. | Jul 2012 | B2 |
| 8219222 | Blomquist | Jul 2012 | B2 |
| 8221385 | Estes | Jul 2012 | B2 |
| 8231562 | Buck et al. | Jul 2012 | B2 |
| 8231578 | Fathallah et al. | Jul 2012 | B2 |
| 8234126 | Estes | Jul 2012 | B1 |
| 8234128 | Martucci et al. | Jul 2012 | B2 |
| 8235938 | Eggers | Aug 2012 | B2 |
| 8237715 | Buck et al. | Aug 2012 | B2 |
| 8251906 | Brauker et al. | Aug 2012 | B2 |
| 8257259 | Brauker et al. | Sep 2012 | B2 |
| 8257300 | Budiman et al. | Sep 2012 | B2 |
| 8257652 | Drucker et al. | Sep 2012 | B2 |
| 8257653 | Drucker et al. | Sep 2012 | B2 |
| 8267893 | Moberg et al. | Sep 2012 | B2 |
| 8282627 | Shelton et al. | Oct 2012 | B2 |
| 8285328 | Caffey et al. | Oct 2012 | B2 |
| 8287454 | Wolpert et al. | Oct 2012 | B2 |
| 8287487 | Estes | Oct 2012 | B2 |
| 8287495 | Michaud et al. | Oct 2012 | B2 |
| 8287521 | Kriesel et al. | Oct 2012 | B2 |
| 8292876 | Kriesel et al. | Oct 2012 | B2 |
| 8294581 | Kamen | Oct 2012 | B2 |
| 8298183 | Menot et al. | Oct 2012 | B2 |
| 8298184 | Diperna et al. | Oct 2012 | B2 |
| 8313433 | Cohen et al. | Nov 2012 | B2 |
| 8317752 | Cozmi et al. | Nov 2012 | B2 |
| 8326754 | Estes et al. | Dec 2012 | B2 |
| 8328793 | Birkenbach et al. | Dec 2012 | B2 |
| 8344847 | Moberg et al. | Jan 2013 | B2 |
| 8348886 | Kanderian et al. | Jan 2013 | B2 |
| 8348923 | Kanderian, Jr. et al. | Jan 2013 | B2 |
| 8361030 | Carter et al. | Jan 2013 | B2 |
| 8376943 | Kovach et al. | Feb 2013 | B2 |
| 8380536 | Howard et al. | Feb 2013 | B2 |
| 8395581 | Graaskov et al. | Mar 2013 | B2 |
| 8398592 | Leibner-Druska | Mar 2013 | B2 |
| 8407063 | Brown | Mar 2013 | B2 |
| 8408421 | Diperna et al. | Apr 2013 | B2 |
| 8414563 | Kamen et al. | Apr 2013 | B2 |
| 8444592 | Williams et al. | May 2013 | B2 |
| 8449524 | Braig et al. | May 2013 | B2 |
| 8452953 | Buck et al. | May 2013 | B2 |
| 8454562 | Sims et al. | Jun 2013 | B1 |
| 8457901 | Beshan et al. | Jun 2013 | B2 |
| 8461985 | Fennell et al. | Jun 2013 | B2 |
| 8502662 | Pohlman et al. | Aug 2013 | B2 |
| 8512276 | Talbot et al. | Aug 2013 | B2 |
| 8517991 | Clemente | Aug 2013 | B2 |
| 8562558 | Kamath et al. | Oct 2013 | B2 |
| 8568357 | Ortega et al. | Oct 2013 | B2 |
| 8573027 | Rosinko et al. | Nov 2013 | B2 |
| 8579853 | Reggiardo et al. | Nov 2013 | B2 |
| 8601465 | Bernstein et al. | Dec 2013 | B2 |
| 8663201 | Hill et al. | Mar 2014 | B2 |
| 8726266 | Kiaie et al. | May 2014 | B2 |
| 8938306 | Lebel et al. | Jan 2015 | B2 |
| 8977883 | Imhof et al. | Mar 2015 | B2 |
| 8992475 | Mann et al. | Mar 2015 | B2 |
| 9114210 | Estes | Aug 2015 | B2 |
| 9132227 | Bryant, Jr. et al. | Sep 2015 | B2 |
| 9238100 | Kruse et al. | Jan 2016 | B2 |
| 9335910 | Farnan et al. | May 2016 | B2 |
| 9474856 | Blomquist | Oct 2016 | B2 |
| 9486571 | Rosinko | Nov 2016 | B2 |
| 9565718 | Swanson | Feb 2017 | B2 |
| 9675756 | Kamen | Jun 2017 | B2 |
| 9715327 | Rosinko et al. | Jul 2017 | B2 |
| 9737656 | Rosinko | Aug 2017 | B2 |
| 9814935 | Kruse et al. | Nov 2017 | B2 |
| 10213547 | Rosinko | Feb 2019 | B2 |
| 10434253 | Diperna et al. | Oct 2019 | B2 |
| 20010000262 | Poleshuk et al. | Apr 2001 | A1 |
| 20010027791 | Wallace et al. | Oct 2001 | A1 |
| 20010041869 | Causey | Nov 2001 | A1 |
| 20020004015 | Carlisle et al. | Jan 2002 | A1 |
| 20020018720 | Carlisle et al. | Feb 2002 | A1 |
| 20020019714 | Carlisle et al. | Feb 2002 | A1 |
| 20020029776 | Blomquist | Mar 2002 | A1 |
| 20020040208 | Flaherty et al. | Apr 2002 | A1 |
| 20020045265 | Bergh et al. | Apr 2002 | A1 |
| 20020048536 | Bergh et al. | Apr 2002 | A1 |
| 20020055787 | Lennox et al. | May 2002 | A1 |
| 20020059959 | Qatu et al. | May 2002 | A1 |
| 20020065484 | Douglas et al. | May 2002 | A1 |
| 20020072733 | Flaherty | Jun 2002 | A1 |
| 20020076679 | Aman | Jun 2002 | A1 |
| 20020117214 | Tucker et al. | Aug 2002 | A1 |
| 20020120234 | Kong | Aug 2002 | A1 |
| 20020154571 | Cefai et al. | Oct 2002 | A1 |
| 20020173769 | Gray et al. | Nov 2002 | A1 |
| 20020193679 | Malave | Dec 2002 | A1 |
| 20030014016 | Purdy | Jan 2003 | A1 |
| 20030032930 | Branch | Feb 2003 | A1 |
| 20030036725 | Lavi et al. | Feb 2003 | A1 |
| 20030055380 | Flaherty et al. | Mar 2003 | A1 |
| 20030060765 | Campbell | Mar 2003 | A1 |
| 20030065287 | Spohn et al. | Apr 2003 | A1 |
| 20030065308 | Lebel et al. | Apr 2003 | A1 |
| 20030078547 | Shekalim | Apr 2003 | A1 |
| 20030093105 | Huffmaster | May 2003 | A1 |
| 20030097082 | Purdy et al. | May 2003 | A1 |
| 20030100863 | Shekalim | May 2003 | A1 |
| 20030109836 | Shekalim | Jun 2003 | A1 |
| 20030130577 | Purdy et al. | Jul 2003 | A1 |
| 20030161744 | Vilks et al. | Aug 2003 | A1 |
| 20030163088 | Blomquist | Aug 2003 | A1 |
| 20030163789 | Blomquist | Aug 2003 | A1 |
| 20030183289 | Seuret et al. | Oct 2003 | A1 |
| 20030199378 | Saviano | Oct 2003 | A1 |
| 20030212364 | Mann et al. | Nov 2003 | A1 |
| 20030216683 | Shekalim | Nov 2003 | A1 |
| 20040010207 | Flaherty et al. | Jan 2004 | A1 |
| 20040019325 | Shekalim | Jan 2004 | A1 |
| 20040051368 | Caputo et al. | Mar 2004 | A1 |
| 20040068230 | Estes et al. | Apr 2004 | A1 |
| 20040073095 | Causey et al. | Apr 2004 | A1 |
| 20040073161 | Tachibana | Apr 2004 | A1 |
| 20040074785 | Holker et al. | Apr 2004 | A1 |
| 20040078028 | Flaherty et al. | Apr 2004 | A1 |
| 20040092865 | Flaherty et al. | May 2004 | A1 |
| 20040116866 | Gorman et al. | Jun 2004 | A1 |
| 20040116905 | Pedersen et al. | Jun 2004 | A1 |
| 20040122353 | Shahmirian et al. | Jun 2004 | A1 |
| 20040133220 | Lashinski et al. | Jul 2004 | A1 |
| 20040138744 | Lashinski et al. | Jul 2004 | A1 |
| 20040152622 | Keith et al. | Aug 2004 | A1 |
| 20040153146 | Lashinski et al. | Aug 2004 | A1 |
| 20040167478 | Mooney et al. | Aug 2004 | A1 |
| 20040171987 | Bridle et al. | Sep 2004 | A1 |
| 20040176727 | Shekalim | Sep 2004 | A1 |
| 20040193025 | Steil | Sep 2004 | A1 |
| 20040193090 | Lebel et al. | Sep 2004 | A1 |
| 20040204673 | Flaherty | Oct 2004 | A1 |
| 20040220551 | Falherty et al. | Nov 2004 | A1 |
| 20040225252 | Gillespie et al. | Nov 2004 | A1 |
| 20040235446 | Flaherty et al. | Nov 2004 | A1 |
| 20040260233 | Garibotto et al. | Dec 2004 | A1 |
| 20050004514 | Hochman et al. | Jan 2005 | A1 |
| 20050020980 | Inoue et al. | Jan 2005 | A1 |
| 20050022274 | Campbell et al. | Jan 2005 | A1 |
| 20050027182 | Siddiqui et al. | Feb 2005 | A1 |
| 20050038379 | Beebe et al. | Feb 2005 | A1 |
| 20050043710 | Hadzic et al. | Feb 2005 | A1 |
| 20050054994 | Cioanta et al. | Mar 2005 | A1 |
| 20050060030 | Lashinski et al. | Mar 2005 | A1 |
| 20050065464 | Talbot et al. | Mar 2005 | A1 |
| 20050096593 | Pope et al. | May 2005 | A1 |
| 20050115622 | Bennett et al. | Jun 2005 | A1 |
| 20050137530 | Campbell et al. | Jun 2005 | A1 |
| 20050137578 | Heruthh et al. | Jun 2005 | A1 |
| 20050143864 | Blomquist | Jun 2005 | A1 |
| 20050148832 | Reghabi et al. | Jul 2005 | A1 |
| 20050171512 | Flaherty | Aug 2005 | A1 |
| 20050171513 | Mann et al. | Aug 2005 | A1 |
| 20050171569 | Girard et al. | Aug 2005 | A1 |
| 20050177395 | Blomquist | Aug 2005 | A1 |
| 20050182366 | Vogt et al. | Aug 2005 | A1 |
| 20050203360 | Brauker | Sep 2005 | A1 |
| 20050211322 | Lobeck | Sep 2005 | A1 |
| 20050238507 | Djanni et al. | Oct 2005 | A1 |
| 20050240092 | Shah et al. | Oct 2005 | A1 |
| 20050240119 | Draudt et al. | Oct 2005 | A1 |
| 20050245867 | Olsen et al. | Nov 2005 | A1 |
| 20050246416 | Blomquist | Nov 2005 | A1 |
| 20050267550 | Hess et al. | Dec 2005 | A1 |
| 20050272989 | Shah et al. | Dec 2005 | A1 |
| 20060031094 | Cohen et al. | Feb 2006 | A1 |
| 20060041229 | Garibotto et al. | Feb 2006 | A1 |
| 20060042695 | Gonia | Mar 2006 | A1 |
| 20060076236 | Shah et al. | Apr 2006 | A1 |
| 20060093785 | Hickle | May 2006 | A1 |
| 20060116757 | Lashinski et al. | Jun 2006 | A1 |
| 20060139354 | Suma | Jun 2006 | A1 |
| 20060147313 | Zengerle et al. | Jul 2006 | A1 |
| 20060149214 | Breiter et al. | Jul 2006 | A1 |
| 20060150747 | Mallett | Jul 2006 | A1 |
| 20060150748 | Mallett | Jul 2006 | A1 |
| 20060173444 | Choy et al. | Aug 2006 | A1 |
| 20060178633 | Garibotto et al. | Aug 2006 | A1 |
| 20060189895 | Neel et al. | Aug 2006 | A1 |
| 20060195064 | Plahey et al. | Aug 2006 | A1 |
| 20060202859 | Mastrototaro et al. | Sep 2006 | A1 |
| 20060206029 | Yair et al. | Sep 2006 | A1 |
| 20060206054 | Shekalim et al. | Sep 2006 | A1 |
| 20060224109 | Steil | Oct 2006 | A1 |
| 20060229557 | Fathallah et al. | Oct 2006 | A1 |
| 20060243804 | Christoffersen et al. | Nov 2006 | A1 |
| 20060253086 | Moberg et al. | Nov 2006 | A1 |
| 20060253296 | Liisberg et al. | Nov 2006 | A1 |
| 20060264835 | Nielsen et al. | Nov 2006 | A1 |
| 20060271022 | Steinbach et al. | Nov 2006 | A1 |
| 20060272652 | Stocker et al. | Dec 2006 | A1 |
| 20060281980 | Randlov et al. | Dec 2006 | A1 |
| 20060282290 | Flaherty et al. | Dec 2006 | A1 |
| 20060293576 | Van Antwerp et al. | Dec 2006 | A1 |
| 20060293577 | Morrison et al. | Dec 2006 | A1 |
| 20070000337 | Gross et al. | Jan 2007 | A1 |
| 20070003434 | Padmanabhan et al. | Jan 2007 | A1 |
| 20070016170 | Kovelman | Jan 2007 | A1 |
| 20070016449 | Cohen et al. | Jan 2007 | A1 |
| 20070033074 | Nitzan et al. | Feb 2007 | A1 |
| 20070060869 | Tolle et al. | Mar 2007 | A1 |
| 20070060870 | Tolle et al. | Mar 2007 | A1 |
| 20070061735 | Hoffberg | Mar 2007 | A1 |
| 20070066956 | Finkel | Mar 2007 | A1 |
| 20070073129 | Shah et al. | Mar 2007 | A1 |
| 20070073236 | Mernoe et al. | Mar 2007 | A1 |
| 20070088267 | Shekalim et al. | Apr 2007 | A1 |
| 20070093786 | Goldsmith et al. | Apr 2007 | A1 |
| 20070100222 | Mastrototaro et al. | May 2007 | A1 |
| 20070100235 | Kennedy et al. | May 2007 | A1 |
| 20070112261 | Enegren et al. | May 2007 | A1 |
| 20070112301 | Preuthun et al. | May 2007 | A1 |
| 20070118405 | Campbell et al. | May 2007 | A1 |
| 20070123819 | Mernoe et al. | May 2007 | A1 |
| 20070124002 | Estes et al. | May 2007 | A1 |
| 20070142822 | Remde | Jun 2007 | A1 |
| 20070149926 | Moberg et al. | Jun 2007 | A1 |
| 20070150019 | Youker et al. | Jun 2007 | A1 |
| 20070156033 | Causey et al. | Jul 2007 | A1 |
| 20070156092 | Estes et al. | Jul 2007 | A1 |
| 20070161955 | Bynum et al. | Jul 2007 | A1 |
| 20070167905 | Estes et al. | Jul 2007 | A1 |
| 20070167912 | Causey et al. | Jul 2007 | A1 |
| 20070173712 | Shah et al. | Jul 2007 | A1 |
| 20070173762 | Estes et al. | Jul 2007 | A1 |
| 20070179444 | Causey et al. | Aug 2007 | A1 |
| 20070201992 | Mernoe et al. | Aug 2007 | A1 |
| 20070203459 | Mernoe | Aug 2007 | A1 |
| 20070219480 | Kamen et al. | Sep 2007 | A1 |
| 20070219496 | Kamen et al. | Sep 2007 | A1 |
| 20070219597 | Kamen et al. | Sep 2007 | A1 |
| 20070227907 | Shah et al. | Oct 2007 | A1 |
| 20070228071 | Kamen et al. | Oct 2007 | A1 |
| 20070250007 | Shekalim | Oct 2007 | A1 |
| 20070251835 | Mehta et al. | Nov 2007 | A1 |
| 20070253021 | Mehta et al. | Nov 2007 | A1 |
| 20070253380 | Jollota et al. | Nov 2007 | A1 |
| 20070254593 | Jollota et al. | Nov 2007 | A1 |
| 20070255116 | Mehta et al. | Nov 2007 | A1 |
| 20070255125 | Moberg et al. | Nov 2007 | A1 |
| 20070255126 | Moberg et al. | Nov 2007 | A1 |
| 20070255348 | Holtzclaw | Nov 2007 | A1 |
| 20070258395 | Jollota et al. | Nov 2007 | A1 |
| 20070264130 | Mallett et al. | Nov 2007 | A1 |
| 20070287985 | Estes et al. | Dec 2007 | A1 |
| 20070288176 | Carlisle et al. | Dec 2007 | A1 |
| 20070293843 | Ireland et al. | Dec 2007 | A1 |
| 20080004601 | Jennewine et al. | Jan 2008 | A1 |
| 20080015510 | Sandoz et al. | Jan 2008 | A1 |
| 20080026473 | Wang | Jan 2008 | A1 |
| 20080029173 | Diperna et al. | Feb 2008 | A1 |
| 20080033350 | Wilson et al. | Feb 2008 | A1 |
| 20080033357 | Mann et al. | Feb 2008 | A1 |
| 20080033360 | Evans et al. | Feb 2008 | A1 |
| 20080033361 | Evans et al. | Feb 2008 | A1 |
| 20080033402 | Blomquist | Feb 2008 | A1 |
| 20080033749 | Blomquist | Feb 2008 | A1 |
| 20080034323 | Blomquist | Feb 2008 | A1 |
| 20080045891 | Maule et al. | Feb 2008 | A1 |
| 20080045902 | Estes et al. | Feb 2008 | A1 |
| 20080045903 | Estes et al. | Feb 2008 | A1 |
| 20080045904 | Estes et al. | Feb 2008 | A1 |
| 20080045931 | Estes et al. | Feb 2008 | A1 |
| 20080051697 | Mounce et al. | Feb 2008 | A1 |
| 20080051698 | Mounce et al. | Feb 2008 | A1 |
| 20080051709 | Mounce et al. | Feb 2008 | A1 |
| 20080051711 | Mounce et al. | Feb 2008 | A1 |
| 20080051716 | Stutz | Feb 2008 | A1 |
| 20080051727 | Moberg et al. | Feb 2008 | A1 |
| 20080051765 | Mounce et al. | Feb 2008 | A1 |
| 20080058697 | Kamen et al. | Mar 2008 | A1 |
| 20080065007 | Peterson et al. | Mar 2008 | A1 |
| 20080065016 | Peterson et al. | Mar 2008 | A1 |
| 20080071220 | Rhinehart et al. | Mar 2008 | A1 |
| 20080071580 | Marcus et al. | Mar 2008 | A1 |
| 20080082040 | Kubler et al. | Apr 2008 | A1 |
| 20080082363 | Habashi | Apr 2008 | A1 |
| 20080092969 | Diperna et al. | Apr 2008 | A1 |
| 20080097289 | Steil et al. | Apr 2008 | A1 |
| 20080097291 | Hanson et al. | Apr 2008 | A1 |
| 20080097309 | Enegren et al. | Apr 2008 | A1 |
| 20080097327 | Bente et al. | Apr 2008 | A1 |
| 20080097375 | Bikovsky et al. | Apr 2008 | A1 |
| 20080103554 | Dicks et al. | May 2008 | A1 |
| 20080114228 | McCluskey et al. | May 2008 | A1 |
| 20080116647 | Anderson et al. | May 2008 | A1 |
| 20080119705 | Patel et al. | May 2008 | A1 |
| 20080125700 | Moberg et al. | May 2008 | A1 |
| 20080126969 | Blomquist | May 2008 | A1 |
| 20080139910 | Mastrototaro et al. | Jun 2008 | A1 |
| 20080147004 | Mann et al. | Jun 2008 | A1 |
| 20080147050 | Mann et al. | Jun 2008 | A1 |
| 20080148235 | Foresti et al. | Jun 2008 | A1 |
| 20080154513 | Kovatchev | Jun 2008 | A1 |
| 20080156661 | Cooper et al. | Jul 2008 | A1 |
| 20080160492 | Campell et al. | Jul 2008 | A1 |
| 20080171967 | Blomquist et al. | Jul 2008 | A1 |
| 20080172026 | Blomquist | Jul 2008 | A1 |
| 20080172027 | Blomquist | Jul 2008 | A1 |
| 20080172028 | Blomquist | Jul 2008 | A1 |
| 20080172029 | Blomquist | Jul 2008 | A1 |
| 20080172030 | Blomquist | Jul 2008 | A1 |
| 20080172031 | Blomquist | Jul 2008 | A1 |
| 20080177154 | Hansen et al. | Jul 2008 | A1 |
| 20080177155 | Hansen et al. | Jul 2008 | A1 |
| 20080183060 | Steil et al. | Jul 2008 | A1 |
| 20080188723 | Kristensen et al. | Aug 2008 | A1 |
| 20080196762 | Mallett et al. | Aug 2008 | A1 |
| 20080197801 | Manor et al. | Aug 2008 | A1 |
| 20080200868 | Alberti et al. | Aug 2008 | A1 |
| 20080200869 | Bedingfield | Aug 2008 | A1 |
| 20080206799 | Blomquist | Aug 2008 | A1 |
| 20080221523 | Moberg et al. | Sep 2008 | A1 |
| 20080228056 | Blomquist et al. | Sep 2008 | A1 |
| 20080234637 | McConnell et al. | Sep 2008 | A1 |
| 20080243062 | Destefano et al. | Oct 2008 | A1 |
| 20080249470 | Malave et al. | Oct 2008 | A1 |
| 20080269584 | Shekalim | Oct 2008 | A1 |
| 20080269680 | Ibranyan et al. | Oct 2008 | A1 |
| 20080269681 | Kavazov et al. | Oct 2008 | A1 |
| 20080269682 | Kavazov et al. | Oct 2008 | A1 |
| 20080269714 | Mastrototaro et al. | Oct 2008 | A1 |
| 20080269723 | Mastrototaro et al. | Oct 2008 | A1 |
| 20080281276 | Shekalim | Nov 2008 | A1 |
| 20080287887 | Mack et al. | Nov 2008 | A1 |
| 20080287922 | Panduro | Nov 2008 | A1 |
| 20080294094 | Mhatre et al. | Nov 2008 | A1 |
| 20080294108 | Briones et al. | Nov 2008 | A1 |
| 20080294109 | Estes et al. | Nov 2008 | A1 |
| 20080294142 | Patel et al. | Nov 2008 | A1 |
| 20080300534 | Blomquist | Dec 2008 | A1 |
| 20080300572 | Rankers et al. | Dec 2008 | A1 |
| 20080300651 | Gerber et al. | Dec 2008 | A1 |
| 20080304365 | Jarvis et al. | Dec 2008 | A1 |
| 20080306434 | Dobbles et al. | Dec 2008 | A1 |
| 20080306444 | Brister et al. | Dec 2008 | A1 |
| 20080312584 | Montgomery et al. | Dec 2008 | A1 |
| 20080317605 | Amley et al. | Dec 2008 | A1 |
| 20090006129 | Thukral et al. | Jan 2009 | A1 |
| 20090014458 | Heffron | Jan 2009 | A1 |
| 20090018495 | Panduro | Jan 2009 | A1 |
| 20090018779 | Cohen et al. | Jan 2009 | A1 |
| 20090026146 | Carlisle et al. | Jan 2009 | A1 |
| 20090030733 | Cohen et al. | Jan 2009 | A1 |
| 20090036870 | Mounce et al. | Feb 2009 | A1 |
| 20090037020 | Brown | Feb 2009 | A1 |
| 20090043290 | Villegas et al. | Feb 2009 | A1 |
| 20090062767 | Van Antwerp et al. | Mar 2009 | A1 |
| 20090062887 | Mass et al. | Mar 2009 | A1 |
| 20090063187 | Johnson et al. | Mar 2009 | A1 |
| 20090067989 | Estes et al. | Mar 2009 | A1 |
| 20090069745 | Estes et al. | Mar 2009 | A1 |
| 20090069746 | Miller et al. | Mar 2009 | A1 |
| 20090069749 | Miller et al. | Mar 2009 | A1 |
| 20090069784 | Estes et al. | Mar 2009 | A1 |
| 20090069785 | Miller et al. | Mar 2009 | A1 |
| 20090069787 | Estes et al. | Mar 2009 | A1 |
| 20090077179 | Bi | Mar 2009 | A1 |
| 20090082728 | Bikovsky | Mar 2009 | A1 |
| 20090085768 | Patel et al. | Apr 2009 | A1 |
| 20090088701 | Larsen et al. | Apr 2009 | A1 |
| 20090088731 | Campbell et al. | Apr 2009 | A1 |
| 20090099866 | Newman | Apr 2009 | A1 |
| 20090099867 | Newman | Apr 2009 | A1 |
| 20090101549 | Kamen et al. | Apr 2009 | A1 |
| 20090107335 | Wilt et al. | Apr 2009 | A1 |
| 20090108016 | Brown et al. | Apr 2009 | A1 |
| 20090112626 | Talbot et al. | Apr 2009 | A1 |
| 20090113295 | Halpern et al. | Apr 2009 | A1 |
| 20090131863 | Carlisle et al. | May 2009 | A1 |
| 20090137987 | Ali | May 2009 | A1 |
| 20090143661 | Taub et al. | Jun 2009 | A1 |
| 20090143732 | O'Connor et al. | Jun 2009 | A1 |
| 20090144089 | Heywood et al. | Jun 2009 | A1 |
| 20090150186 | Cohen et al. | Jun 2009 | A1 |
| 20090150484 | Roberts | Jun 2009 | A1 |
| 20090150865 | Young et al. | Jun 2009 | A1 |
| 20090156990 | Wenger et al. | Jun 2009 | A1 |
| 20090156991 | Roberts et al. | Jun 2009 | A1 |
| 20090157202 | Roberts et al. | Jun 2009 | A1 |
| 20090157622 | Roberts et al. | Jun 2009 | A1 |
| 20090157695 | Roberts | Jun 2009 | A1 |
| 20090158274 | Roberts | Jun 2009 | A1 |
| 20090163855 | Shin et al. | Jun 2009 | A1 |
| 20090170056 | Nam et al. | Jul 2009 | A1 |
| 20090171269 | Jennewine et al. | Jul 2009 | A1 |
| 20090171324 | Chong et al. | Jul 2009 | A1 |
| 20090177142 | Blomquist et al. | Jul 2009 | A1 |
| 20090177147 | Blomquist et al. | Jul 2009 | A1 |
| 20090177154 | Blomquist | Jul 2009 | A1 |
| 20090177248 | Roberts | Jul 2009 | A1 |
| 20090177249 | Roberts et al. | Jul 2009 | A1 |
| 20090177769 | Roberts | Jul 2009 | A1 |
| 20090177991 | Davis et al. | Jul 2009 | A1 |
| 20090191067 | Diperna et al. | Jul 2009 | A1 |
| 20090192366 | Mensinger et al. | Jul 2009 | A1 |
| 20090192724 | Brauker et al. | Jul 2009 | A1 |
| 20090192745 | Kamath et al. | Jul 2009 | A1 |
| 20090204113 | Macadam et al. | Aug 2009 | A1 |
| 20090212966 | Panduro | Aug 2009 | A1 |
| 20090217982 | Diperna et al. | Sep 2009 | A1 |
| 20090221890 | Saffer et al. | Sep 2009 | A1 |
| 20090221891 | Yu et al. | Sep 2009 | A1 |
| 20090227855 | Hill et al. | Sep 2009 | A1 |
| 20090227888 | Salmi et al. | Sep 2009 | A1 |
| 20090229374 | Carlisle et al. | Sep 2009 | A1 |
| 20090234594 | Carlisle et al. | Sep 2009 | A1 |
| 20090240193 | Mensinger et al. | Sep 2009 | A1 |
| 20090246035 | Patzer | Oct 2009 | A1 |
| 20090247931 | Damgaard-Sorensen | Oct 2009 | A1 |
| 20090247982 | Krulevitch et al. | Oct 2009 | A1 |
| 20090254037 | Bryant, Jr. et al. | Oct 2009 | A1 |
| 20090256527 | Welsch et al. | Oct 2009 | A1 |
| 20090259183 | Chong et al. | Oct 2009 | A1 |
| 20090259198 | Chong et al. | Oct 2009 | A1 |
| 20090259209 | Chong et al. | Oct 2009 | A1 |
| 20090264825 | Cote | Oct 2009 | A1 |
| 20090267774 | Enegren et al. | Oct 2009 | A1 |
| 20090267775 | Eneren et al. | Oct 2009 | A1 |
| 20090270705 | Enegren et al. | Oct 2009 | A1 |
| 20090270810 | Debelser et al. | Oct 2009 | A1 |
| 20090270811 | Mounce | Oct 2009 | A1 |
| 20090270833 | Debelser et al. | Oct 2009 | A1 |
| 20090272928 | Alvarez et al. | Nov 2009 | A1 |
| 20090275886 | Blomquist et al. | Nov 2009 | A1 |
| 20090275887 | Estes | Nov 2009 | A1 |
| 20090275896 | Kamen et al. | Nov 2009 | A1 |
| 20090281393 | Smith | Nov 2009 | A1 |
| 20090287153 | Bresina et al. | Nov 2009 | A1 |
| 20090287180 | Diperna et al. | Nov 2009 | A1 |
| 20090289916 | Dai | Nov 2009 | A1 |
| 20090292245 | Basso et al. | Nov 2009 | A1 |
| 20090299438 | Nolan et al. | Dec 2009 | A1 |
| 20090321675 | Alvarez et al. | Dec 2009 | A1 |
| 20090326458 | Chong et al. | Dec 2009 | A1 |
| 20100008795 | Diperna | Jan 2010 | A1 |
| 20100010330 | Rankers et al. | Jan 2010 | A1 |
| 20100010647 | Schroeder et al. | Jan 2010 | A1 |
| 20100016791 | Chong et al. | Jan 2010 | A1 |
| 20100022937 | Bedingfield et al. | Jan 2010 | A1 |
| 20100028206 | Shekalim et al. | Feb 2010 | A1 |
| 20100030045 | Gottlieb et al. | Feb 2010 | A1 |
| 20100030092 | Kristensen et al. | Feb 2010 | A1 |
| 20100032041 | Diperna | Feb 2010 | A1 |
| 20100036327 | Diperna et al. | Feb 2010 | A1 |
| 20100037680 | Moberg et al. | Feb 2010 | A1 |
| 20100038572 | Alavarez et al. | Feb 2010 | A1 |
| 20100043738 | Grandvallet et al. | Feb 2010 | A1 |
| 20100049126 | Bronfeld et al. | Feb 2010 | A1 |
| 20100049164 | Estes | Feb 2010 | A1 |
| 20100050236 | Miller | Feb 2010 | A1 |
| 20100063765 | Carlisle et al. | Mar 2010 | A1 |
| 20100064257 | Buck et al. | Mar 2010 | A1 |
| 20100065578 | Diperna | Mar 2010 | A1 |
| 20100065579 | Diperna et al. | Mar 2010 | A1 |
| 20100069890 | Graeskov et al. | Mar 2010 | A1 |
| 20100071446 | Brown | Mar 2010 | A1 |
| 20100081993 | O'Connor | Apr 2010 | A1 |
| 20100087777 | Hopping et al. | Apr 2010 | A1 |
| 20100094114 | Robinson et al. | Apr 2010 | A1 |
| 20100094251 | Estes | Apr 2010 | A1 |
| 20100095229 | Dixon et al. | Apr 2010 | A1 |
| 20100096019 | Diperna | Apr 2010 | A1 |
| 20100100026 | Morris | Apr 2010 | A1 |
| 20100100037 | Cozmi et al. | Apr 2010 | A1 |
| 20100105999 | Dixon et al. | Apr 2010 | A1 |
| 20100106100 | Petersen | Apr 2010 | A1 |
| 20100114015 | Kanderian, Jr. et al. | May 2010 | A1 |
| 20100114027 | Jacobson et al. | May 2010 | A1 |
| 20100119414 | Eisenhardt et al. | May 2010 | A1 |
| 20100121169 | Petische | May 2010 | A1 |
| 20100121170 | Rule | May 2010 | A1 |
| 20100121306 | Yodfat et al. | May 2010 | A1 |
| 20100121415 | Skelton et al. | May 2010 | A1 |
| 20100125241 | Prud'homme et al. | May 2010 | A1 |
| 20100130933 | Holland et al. | May 2010 | A1 |
| 20100134305 | Lu et al. | Jun 2010 | A1 |
| 20100137833 | Glynn | Jun 2010 | A1 |
| 20100138197 | Sher | Jun 2010 | A1 |
| 20100145262 | Bengtsson et al. | Jun 2010 | A1 |
| 20100145303 | Yodfat et al. | Jun 2010 | A1 |
| 20100152658 | Hanson et al. | Jun 2010 | A1 |
| 20100152674 | Kavazov et al. | Jun 2010 | A1 |
| 20100160740 | Cohen et al. | Jun 2010 | A1 |
| 20100161236 | Cohen et al. | Jun 2010 | A1 |
| 20100161346 | Getschmann et al. | Jun 2010 | A1 |
| 20100162786 | Keenan et al. | Jul 2010 | A1 |
| 20100164727 | Bazargan et al. | Jul 2010 | A1 |
| 20100165795 | Elder et al. | Jul 2010 | A1 |
| 20100168538 | Keenan et al. | Jul 2010 | A1 |
| 20100168539 | Palerm et al. | Jul 2010 | A1 |
| 20100168543 | Kamath et al. | Jul 2010 | A1 |
| 20100168670 | Srisathapat et al. | Jul 2010 | A1 |
| 20100168711 | Bazargan et al. | Jul 2010 | A1 |
| 20100174230 | Istoc et al. | Jul 2010 | A1 |
| 20100174266 | Estes | Jul 2010 | A1 |
| 20100174553 | Kaufman et al. | Jul 2010 | A1 |
| 20100179402 | Goode, Jr. et al. | Jul 2010 | A1 |
| 20100185142 | Kamen et al. | Jul 2010 | A1 |
| 20100185175 | Kamen et al. | Jul 2010 | A1 |
| 20100191084 | Appling et al. | Jul 2010 | A1 |
| 20100192686 | Kamen et al. | Aug 2010 | A1 |
| 20100198034 | Thomas et al. | Aug 2010 | A1 |
| 20100198107 | Groll et al. | Aug 2010 | A1 |
| 20100198142 | Sloan et al. | Aug 2010 | A1 |
| 20100198143 | Estes et al. | Aug 2010 | A1 |
| 20100198183 | Lanigan et al. | Aug 2010 | A1 |
| 20100198520 | Breton et al. | Aug 2010 | A1 |
| 20100205001 | Knudsen et al. | Aug 2010 | A1 |
| 20100217192 | Moberg et al. | Aug 2010 | A1 |
| 20100217193 | Moberg et al. | Aug 2010 | A1 |
| 20100218132 | Soni et al. | Aug 2010 | A1 |
| 20100218586 | Rosinko et al. | Sep 2010 | A1 |
| 20100222735 | Plahey et al. | Sep 2010 | A1 |
| 20100222765 | Blomquist et al. | Sep 2010 | A1 |
| 20100224192 | Dixon et al. | Sep 2010 | A1 |
| 20100228186 | Estes et al. | Sep 2010 | A1 |
| 20100234709 | Say et al. | Sep 2010 | A1 |
| 20100235439 | Goodnow | Sep 2010 | A1 |
| 20100241065 | Moberg et al. | Sep 2010 | A1 |
| 20100249530 | Rankers et al. | Sep 2010 | A1 |
| 20100249566 | Suess et al. | Sep 2010 | A1 |
| 20100249706 | Clemente | Sep 2010 | A1 |
| 20100250697 | Hansen et al. | Sep 2010 | A1 |
| 20100251114 | Wehba et al. | Sep 2010 | A1 |
| 20100253768 | El-Maraghi et al. | Oct 2010 | A1 |
| 20100256466 | Shekalim et al. | Oct 2010 | A1 |
| 20100256561 | Gillespie, Jr. et al. | Oct 2010 | A1 |
| 20100256565 | Mernoe et al. | Oct 2010 | A1 |
| 20100256598 | Mernoe et al. | Oct 2010 | A1 |
| 20100261987 | Kamath et al. | Oct 2010 | A1 |
| 20100262078 | Blomquist | Oct 2010 | A1 |
| 20100262434 | Shaya | Oct 2010 | A1 |
| 20100274192 | Mernoe | Oct 2010 | A1 |
| 20100274515 | Hoss et al. | Oct 2010 | A1 |
| 20100274592 | Nitzan et al. | Oct 2010 | A1 |
| 20100277119 | Montague et al. | Nov 2010 | A1 |
| 20100280329 | Randloev et al. | Nov 2010 | A1 |
| 20100280442 | Shahmirian et al. | Nov 2010 | A1 |
| 20100280486 | Khair et al. | Nov 2010 | A1 |
| 20100286563 | Bryer et al. | Nov 2010 | A1 |
| 20100292556 | Golden | Nov 2010 | A1 |
| 20100298662 | Yu et al. | Nov 2010 | A1 |
| 20100298681 | Say et al. | Nov 2010 | A1 |
| 20100298685 | Hayter et al. | Nov 2010 | A1 |
| 20100299156 | Jorgensen | Nov 2010 | A1 |
| 20100305421 | Ow-Wing | Dec 2010 | A1 |
| 20100305545 | Kanderian, Jr. et al. | Dec 2010 | A1 |
| 20100312082 | Batman et al. | Dec 2010 | A1 |
| 20100317950 | Galley et al. | Dec 2010 | A1 |
| 20100317951 | Rutkowski et al. | Dec 2010 | A1 |
| 20100323431 | Rutowski et al. | Dec 2010 | A1 |
| 20100324382 | Cantwell et al. | Dec 2010 | A1 |
| 20100324392 | Say et al. | Dec 2010 | A1 |
| 20100324853 | Wang et al. | Dec 2010 | A1 |
| 20100324932 | Galley et al. | Dec 2010 | A1 |
| 20100331651 | Groll | Dec 2010 | A1 |
| 20100331652 | Groll et al. | Dec 2010 | A1 |
| 20100331824 | Moberg et al. | Dec 2010 | A1 |
| 20110004188 | Shekalim | Jan 2011 | A1 |
| 20110006876 | Moberg et al. | Jan 2011 | A1 |
| 20110009725 | Hill et al. | Jan 2011 | A1 |
| 20110009798 | Kelly et al. | Jan 2011 | A1 |
| 20110009813 | Rankers | Jan 2011 | A1 |
| 20110009823 | Chong et al. | Jan 2011 | A1 |
| 20110009825 | Chong et al. | Jan 2011 | A1 |
| 20110009846 | Istoc et al. | Jan 2011 | A1 |
| 20110010105 | Shah et al. | Jan 2011 | A1 |
| 20110015509 | Peyser | Jan 2011 | A1 |
| 20110021898 | Wei et al. | Jan 2011 | A1 |
| 20110022025 | Savoie et al. | Jan 2011 | A1 |
| 20110028937 | Powers et al. | Feb 2011 | A1 |
| 20110030845 | Chong et al. | Feb 2011 | A1 |
| 20110033833 | Blomquist et al. | Feb 2011 | A1 |
| 20110034788 | Cadio et al. | Feb 2011 | A1 |
| 20110040247 | Mandro et al. | Feb 2011 | A1 |
| 20110040251 | Blomquist et al. | Feb 2011 | A1 |
| 20110044333 | Sicurello et al. | Feb 2011 | A1 |
| 20110046051 | Moerman | Feb 2011 | A1 |
| 20110046454 | Ejlersen et al. | Feb 2011 | A1 |
| 20110046469 | Nelson et al. | Feb 2011 | A1 |
| 20110046697 | Gerber et al. | Feb 2011 | A1 |
| 20110046892 | Moerman | Feb 2011 | A1 |
| 20110047499 | Mandro et al. | Feb 2011 | A1 |
| 20110048938 | Shah et al. | Mar 2011 | A1 |
| 20110048941 | Shah et al. | Mar 2011 | A1 |
| 20110050428 | Istoc | Mar 2011 | A1 |
| 20110053121 | Heaton | Mar 2011 | A1 |
| 20110054281 | Shah et al. | Mar 2011 | A1 |
| 20110054390 | Searle et al. | Mar 2011 | A1 |
| 20110054391 | Ward et al. | Mar 2011 | A1 |
| 20110054397 | Menot et al. | Mar 2011 | A1 |
| 20110056264 | Kaplan et al. | Mar 2011 | A1 |
| 20110058485 | Sloan | Mar 2011 | A1 |
| 20110060280 | Caffey et al. | Mar 2011 | A1 |
| 20110060281 | Aeschlimann et al. | Mar 2011 | A1 |
| 20110060328 | Swarek et al. | Mar 2011 | A1 |
| 20110066108 | Geipel et al. | Mar 2011 | A1 |
| 20110066555 | Dicks et al. | Mar 2011 | A1 |
| 20110071464 | Palerm | Mar 2011 | A1 |
| 20110071465 | Wang et al. | Mar 2011 | A1 |
| 20110071765 | Yodfat et al. | Mar 2011 | A1 |
| 20110072372 | Slaon et al. | Mar 2011 | A1 |
| 20110077481 | Say et al. | Mar 2011 | A1 |
| 20110077493 | Shadforth et al. | Mar 2011 | A1 |
| 20110077554 | Roe et al. | Mar 2011 | A1 |
| 20110077963 | Knudsen et al. | Mar 2011 | A1 |
| 20110078441 | Dicks et al. | Mar 2011 | A1 |
| 20110082439 | Wenger et al. | Apr 2011 | A1 |
| 20110087195 | Uhland et al. | Apr 2011 | A1 |
| 20110092788 | Long et al. | Apr 2011 | A1 |
| 20110092894 | McGill et al. | Apr 2011 | A1 |
| 20110092907 | Krogh et al. | Apr 2011 | A1 |
| 20110092921 | Beling et al. | Apr 2011 | A1 |
| 20110093285 | Dicks et al. | Apr 2011 | A1 |
| 20110093286 | Dicks et al. | Apr 2011 | A1 |
| 20110097480 | Budiman et al. | Apr 2011 | A1 |
| 20110098637 | Hill | Apr 2011 | A1 |
| 20110098638 | Chawla et al. | Apr 2011 | A1 |
| 20110098674 | Vicente et al. | Apr 2011 | A1 |
| 20110098676 | Chiang et al. | Apr 2011 | A1 |
| 20110101995 | Shah et al. | May 2011 | A1 |
| 20110105873 | Feldman et al. | May 2011 | A1 |
| 20110105877 | Wilt et al. | May 2011 | A1 |
| 20110105955 | Yudovsky et al. | May 2011 | A1 |
| 20110105979 | Schlaepper et al. | May 2011 | A1 |
| 20110106011 | Cinar et al. | May 2011 | A1 |
| 20110106049 | Damiano et al. | May 2011 | A1 |
| 20110106050 | Yodfat et al. | May 2011 | A1 |
| 20110106318 | Ledford | May 2011 | A1 |
| 20110106480 | Shah et al. | May 2011 | A1 |
| 20110107853 | Studer | May 2011 | A1 |
| 20110108158 | Huwiler et al. | May 2011 | A1 |
| 20110111794 | Bochenko et al. | May 2011 | A1 |
| 20110112478 | Gregor et al. | May 2011 | A1 |
| 20110112504 | Causey et al. | May 2011 | A1 |
| 20110112505 | Starkweather et al. | May 2011 | A1 |
| 20110112508 | Starkweather et al. | May 2011 | A1 |
| 20110118578 | Timmerman | May 2011 | A1 |
| 20110118662 | Mhatre et al. | May 2011 | A1 |
| 20110118699 | Yodfat et al. | May 2011 | A1 |
| 20110118700 | Remde | May 2011 | A1 |
| 20110119087 | Drucker et al. | May 2011 | A1 |
| 20110120206 | Troughton et al. | May 2011 | A1 |
| 20110124996 | Reinke et al. | May 2011 | A1 |
| 20110124999 | Reggiardo et al. | May 2011 | A1 |
| 20110125085 | McGill et al. | May 2011 | A1 |
| 20110125095 | Lebel et al. | May 2011 | A1 |
| 20110125530 | Drucker et al. | May 2011 | A1 |
| 20110126188 | Bernstein et al. | May 2011 | A1 |
| 20110130746 | Budiman | Jun 2011 | A1 |
| 20110133946 | Kopp et al. | Jun 2011 | A1 |
| 20110137239 | Debelser et al. | Jun 2011 | A1 |
| 20110144569 | Britton et al. | Jun 2011 | A1 |
| 20110144586 | Michaud et al. | Jun 2011 | A1 |
| 20110144616 | Michaud et al. | Jun 2011 | A1 |
| 20110149759 | Jollota | Jun 2011 | A1 |
| 20110151571 | Wollridge | Jun 2011 | A1 |
| 20110152653 | Shekalim et al. | Jun 2011 | A1 |
| 20110152654 | Wang et al. | Jun 2011 | A1 |
| 20110152757 | Beck et al. | Jun 2011 | A1 |
| 20110152769 | Ramey et al. | Jun 2011 | A1 |
| 20110152770 | Diperna et al. | Jun 2011 | A1 |
| 20110152824 | Diperna et al. | Jun 2011 | A1 |
| 20110152970 | Jollota et al. | Jun 2011 | A1 |
| 20110154237 | Bush et al. | Jun 2011 | A1 |
| 20110160650 | Chong et al. | Jun 2011 | A1 |
| 20110160654 | Hanson et al. | Jun 2011 | A1 |
| 20110160666 | Hanson et al. | Jun 2011 | A1 |
| 20110160667 | Bazargan et al. | Jun 2011 | A1 |
| 20110160678 | Chong et al. | Jun 2011 | A1 |
| 20110160695 | Sigrist et al. | Jun 2011 | A1 |
| 20110163125 | Beavis et al. | Jul 2011 | A1 |
| 20110166544 | Verhoef et al. | Jul 2011 | A1 |
| 20110166875 | Hayter et al. | Jul 2011 | A1 |
| 20110172744 | Davis et al. | Jul 2011 | A1 |
| 20110178461 | Chong et al. | Jul 2011 | A1 |
| 20110178462 | Moberg et al. | Jul 2011 | A1 |
| 20110184264 | Galasso et al. | Jul 2011 | A1 |
| 20110190614 | Brister et al. | Aug 2011 | A1 |
| 20110190694 | Lanier, Jr. et al. | Aug 2011 | A1 |
| 20110190700 | Kavazov et al. | Aug 2011 | A1 |
| 20110190701 | Remde et al. | Aug 2011 | A1 |
| 20110192478 | Chong et al. | Aug 2011 | A1 |
| 20110193704 | Harper et al. | Aug 2011 | A1 |
| 20110196213 | Thukral et al. | Aug 2011 | A1 |
| 20110196248 | Grunwald | Aug 2011 | A1 |
| 20110196289 | Plahey et al. | Aug 2011 | A1 |
| 20110205065 | Strachan et al. | Aug 2011 | A1 |
| 20110208122 | Shekalim et al. | Aug 2011 | A1 |
| 20110208123 | Gray et al. | Aug 2011 | A1 |
| 20110208155 | Palerm et al. | Aug 2011 | A1 |
| 20110213225 | Berstein et al. | Sep 2011 | A1 |
| 20110213306 | Hanson et al. | Sep 2011 | A1 |
| 20110224522 | Fennell | Sep 2011 | A1 |
| 20110224601 | Shekalim | Sep 2011 | A1 |
| 20110230821 | Babic | Sep 2011 | A1 |
| 20110230825 | Kamen et al. | Sep 2011 | A1 |
| 20110238033 | Prod et al. | Sep 2011 | A1 |
| 20110247397 | Friedli et al. | Oct 2011 | A1 |
| 20110251557 | Powers et al. | Oct 2011 | A1 |
| 20110252579 | Aklog et al. | Oct 2011 | A1 |
| 20110256024 | Cole et al. | Oct 2011 | A1 |
| 20110257895 | Brauker et al. | Oct 2011 | A1 |
| 20110309107 | Shekalim et al. | Dec 2011 | A1 |
| 20110319862 | Friedman et al. | Dec 2011 | A1 |
| 20120013625 | Blomquist et al. | Jan 2012 | A1 |
| 20120013802 | Blomquist et al. | Jan 2012 | A1 |
| 20120017688 | Shekalim et al. | Jan 2012 | A1 |
| 20120022452 | Welsch et al. | Jan 2012 | A1 |
| 20120029433 | Michaud et al. | Feb 2012 | A1 |
| 20120029468 | Diperna et al. | Feb 2012 | A1 |
| 20120029486 | Laerdal et al. | Feb 2012 | A1 |
| 20120029708 | Miller et al. | Feb 2012 | A1 |
| 20120029941 | Malave et al. | Feb 2012 | A1 |
| 20120030610 | Diperna et al. | Feb 2012 | A1 |
| 20120041415 | Estes et al. | Feb 2012 | A1 |
| 20120059353 | Kovatchev et al. | Mar 2012 | A1 |
| 20120059673 | Cohen et al. | Mar 2012 | A1 |
| 20120232520 | Sloan et al. | Sep 2012 | A1 |
| 20120330227 | Budiman et al. | Dec 2012 | A1 |
| 20130053816 | Diperna et al. | Feb 2013 | A1 |
| 20130150766 | Olde et al. | Jun 2013 | A1 |
| 20130204542 | Olde et al. | Aug 2013 | A1 |
| 20130283196 | Farnan et al. | Oct 2013 | A1 |
| 20130298024 | Rhee et al. | Nov 2013 | A1 |
| 20130306191 | Metzmaker et al. | Nov 2013 | A1 |
| 20130324928 | Kruse | Dec 2013 | A1 |
| 20130332874 | Rosinko et al. | Dec 2013 | A1 |
| 20130345625 | Causey et al. | Dec 2013 | A1 |
| 20140012511 | Mensinger et al. | Jan 2014 | A1 |
| 20140039805 | Sharpe, Jr. et al. | Feb 2014 | A1 |
| 20140200426 | Taub | Jul 2014 | A1 |
| 20140323961 | Blomquist et al. | Oct 2014 | A1 |
| 20150052511 | Kiaie et al. | Feb 2015 | A1 |
| 20150174320 | Grant | Jun 2015 | A1 |
| 20160121047 | Kruse et al. | May 2016 | A1 |
| 20160199571 | Rosinko et al. | Jul 2016 | A1 |
| 20160271325 | Farnan et al. | Sep 2016 | A1 |
| 20170056590 | Diperna et al. | Mar 2017 | A1 |
| 20170300206 | Rosinko et al. | Oct 2017 | A1 |
| 20170312423 | Rosinko | Nov 2017 | A1 |
| 20180064873 | Kruse et al. | Mar 2018 | A1 |
| 20180361060 | Rosinko | Dec 2018 | A9 |
| 20190175823 | Rosinko | Jun 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 1229347 | Sep 1999 | CN |
| 2668155 | Jan 2005 | CN |
| 2668847 | Jan 2005 | CN |
| 399065 | Jul 1924 | DE |
| 19819407 | Nov 1999 | DE |
| 0055836 | Jul 1982 | EP |
| 0272530 | Jun 1988 | EP |
| 0376894 | Jul 1990 | EP |
| 0385916 | Sep 1990 | EP |
| 0494042 | Jul 1992 | EP |
| 0560571 | Sep 1993 | EP |
| 0385916 | Jan 1994 | EP |
| 1217275 | Jun 2002 | EP |
| 1217275 | Sep 2004 | EP |
| 1938750 | Jul 2008 | EP |
| 2416826 | Feb 2012 | EP |
| 2159496 | Dec 1985 | GB |
| H0616165 | Apr 1994 | JP |
| H08312820 | Nov 1996 | JP |
| 2952037 | Sep 1999 | JP |
| 2002143293 | May 2002 | JP |
| 2006009944 | Jan 2006 | JP |
| 2006101985 | Apr 2006 | JP |
| 2009148591 | Jul 2009 | JP |
| 2010075736 | Apr 2010 | JP |
| 1020010080519 | Aug 2001 | KR |
| 9013795 | Nov 1990 | WO |
| 9100753 | Jan 1991 | WO |
| 9426329 | Nov 1994 | WO |
| 9532013 | Nov 1995 | WO |
| 9608049 | Mar 1996 | WO |
| 9625189 | Aug 1996 | WO |
| 9819627 | May 1998 | WO |
| 9857683 | Dec 1998 | WO |
| 9901088 | Jan 1999 | WO |
| 0010628 | Mar 2000 | WO |
| 0035527 | Jun 2000 | WO |
| 0040346 | Jul 2000 | WO |
| 0072900 | Dec 2000 | WO |
| 0130422 | May 2001 | WO |
| 0211049 | Feb 2002 | WO |
| 0211791 | Feb 2002 | WO |
| 0226102 | Apr 2002 | WO |
| 0228532 | Apr 2002 | WO |
| 03081052 | Oct 2003 | WO |
| 03082091 | Oct 2003 | WO |
| 03102737 | Dec 2003 | WO |
| 2004009152 | Jan 2004 | WO |
| 2004009160 | Jan 2004 | WO |
| 2004036150 | Apr 2004 | WO |
| 20040476777 | Jun 2004 | WO |
| 2004056412 | Jul 2004 | WO |
| 2004060464 | Jul 2004 | WO |
| 2004088148 | Oct 2004 | WO |
| 2004093648 | Nov 2004 | WO |
| 2004105827 | Dec 2004 | WO |
| 2005018507 | Mar 2005 | WO |
| 2005082450 | Sep 2005 | WO |
| 2006001024 | Jan 2006 | WO |
| 2006108219 | Oct 2006 | WO |
| 2006127841 | Nov 2006 | WO |
| 2007038059 | Apr 2007 | WO |
| 2007038060 | Apr 2007 | WO |
| 2007038091 | Apr 2007 | WO |
| 2007056504 | May 2007 | WO |
| 2007056592 | May 2007 | WO |
| 2007065944 | Jun 2007 | WO |
| 2007089983 | Aug 2007 | WO |
| 2007098265 | Aug 2007 | WO |
| 2007098287 | Aug 2007 | WO |
| 2007106232 | Sep 2007 | WO |
| 2007119149 | Oct 2007 | WO |
| 2008024812 | Feb 2008 | WO |
| 2008028509 | Mar 2008 | WO |
| 2008037270 | Apr 2008 | WO |
| 2008037271 | Apr 2008 | WO |
| 2008037272 | Apr 2008 | WO |
| 2008037273 | Apr 2008 | WO |
| 2008043381 | Apr 2008 | WO |
| 200805363 | May 2008 | WO |
| 2008050126 | May 2008 | WO |
| 2008050128 | May 2008 | WO |
| 2008071220 | Jun 2008 | WO |
| 2008103175 | Aug 2008 | WO |
| 2008121599 | Oct 2008 | WO |
| 2008144693 | Nov 2008 | WO |
| 2008144695 | Nov 2008 | WO |
| 2008144697 | Nov 2008 | WO |
| 2008144698 | Nov 2008 | WO |
| 2009016636 | Feb 2009 | WO |
| 2009032399 | Mar 2009 | WO |
| 2009032400 | Mar 2009 | WO |
| 2009032402 | Mar 2009 | WO |
| 2009035753 | Mar 2009 | WO |
| 2009035759 | Mar 2009 | WO |
| 2009035761 | Mar 2009 | WO |
| 2009035762 | Mar 2009 | WO |
| 2009044221 | Apr 2009 | WO |
| 2009094590 | Jul 2009 | WO |
| 2009098648 | Aug 2009 | WO |
| 2009106233 | Sep 2009 | WO |
| 2009108639 | Sep 2009 | WO |
| 2009124133 | Oct 2009 | WO |
| 2009143188 | Nov 2009 | WO |
| 2009147680 | Dec 2009 | WO |
| 2010016977 | Feb 2010 | WO |
| 2010016978 | Feb 2010 | WO |
| 2010033634 | Mar 2010 | WO |
| 2010033878 | Mar 2010 | WO |
| 2010038031 | Apr 2010 | WO |
| 2010096449 | Aug 2010 | WO |
| 2010097774 | Sep 2010 | WO |
| 2010099490 | Sep 2010 | WO |
| 2010113162 | Oct 2010 | WO |
| 2011014704 | Feb 2011 | WO |
| 2011017667 | Feb 2011 | WO |
| 2012019726 | Feb 2012 | WO |
| 2012034084 | Mar 2012 | WO |
| 2016086033 | Jun 2017 | WO |
| Entry |
|---|
| merriam-webster.com/dictionary/depict definition of “depict”. (Year: 2024). |
| www.merriam-webster.com/dictionary/depiction definition of depiction (Year: 2024). |
| Angiodynamics. “Samrt Port, Power-Injectable Ports,” Product Brochure, 2010, 4 pages. |
| Arrow, “International Europe Web Page for: Multiple Lumen Peripheral Catheter,” Product No. IV-01150, retrieved from internet on Nov. 15, 2011, 3 pages. |
| Canadian Examiner's Report for Canadian Application No. 2,769,030 dated Aug. 27, 2014, 2 pages. |
| Examination Report No. 1 for Australian Patent Application No. 2009249132 dated Jan. 23, 2014, 4 pages. |
| I-Port, “Advance Product Brochure,” Patton Medical Devices and Manufactured by Unomedical, a Cardiovascular Company, 2010. 2 pages. |
| Miller E.J. “The Reciprocating Pump, Theory, Design and Use,” Second Edition, Krieger Publishing Company, Malabar, Florida 1995, 47 pages. |
| Spring, “Zone Insulin Pump,” Spring Zone Insulin Delivery System Product Brochure, a D-Medical company, Copyright 2011, 4 pages. |
| U.S. Appl. No. 60/789,243, filed Apr. 5, 2006, Beavis, 22 pages. |
| Written Opinion for Application No. PCT/US2008/058044, mailed on Aug. 11, 2008, 4 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20220184303 A1 | Jun 2022 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61230061 | Jul 2009 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 17478530 | Sep 2021 | US |
| Child | 17689882 | US | |
| Parent | 16580573 | Sep 2019 | US |
| Child | 17478530 | US | |
| Parent | 16502248 | Jul 2019 | US |
| Child | 16580573 | US | |
| Parent | 15340417 | Nov 2016 | US |
| Child | 16502248 | US | |
| Parent | 12846688 | Jul 2010 | US |
| Child | 15340417 | US |
